000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|||0|0|0|0|JAS|0|1|0|100|SEK|1596|3162|lyfalmen|V0045|1588||20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1596||1596|3162| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|32649|42857|lyfsjukr||||2|0|24,0000|Icepharma hf|Roche|Epóetín||32649||32649|42857| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|49048|63438|lyfsjukr||||2|0|36,0000|Icepharma hf|Roche|Epóetín||49048||49048|63438| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|10345|15130|lyfalmen|V0457|5046||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10345||10345|15130| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|30152|40386|lyfalmen|V0475|19998||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30152||30152|40386| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|39214|51759|lyfalmen|V0540|30860||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39214||39214|51759| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|21093|29017|lyfalmen|V0456|10819||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21093||21093|29017| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|4912|7089|lyfsjukr||||1|0|0,0400|Vistor hf|Ferring|Atosíban||4912||4912|7089| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|7430|14439|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||7430||7430|14439| 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|13157|18395|lyfsjukr||||5|0|0,2300|Vistor hf|Ferring|Atosíban||13157||13157|18395| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|19789|27380|lyfalmen||||0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19789||19789|27380| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|38411|50751|lyfalmen||||1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||38411||38411|50751| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|||0|0|E|0|MSD|0|0|0|100|DKK|5222|8122|lyfalmen||||6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5222||5222|8122| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr||||5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|3206|5365|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3206|5365| 000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|||0|0|0|0|SPM|0|0|0|100|XEU|27320|36832|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27320||27320|36832| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|1796|3436|lyfalmen||||5|0||Vistor hf|Laboratoires THEA|Ketotifen||1796||1796|3436| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|4774|7509|lyfalmen||||2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4774||4774|7509| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|||0|0|E|0|JAS|0|0|0|100|SEK|3659|5984|lyfalmen||||60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3659||3659|5984| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|||0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|5335|8277|lyfalmen||||24|0||Vistor hf|Laboratoires THEA|Ketotifen||5335||5335|8277| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|6954|10036|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||6954||6954|10036| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3009|5095|lyfalmen||||30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3009||3009|5095| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|3705|6047|lyfalmen||||2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3705||3705|6047| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|||0|1|0|1|MSE|0|0|0|100|SEK|168514|213368|lyfsjukr||||6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||168514||168514|213368| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|21952|29432|lyfsjukr||||1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||21952||21952|29432| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|5602|8085|lyfsjukr||||0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5602||5602|8085| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|||0|0|E|0|PER|0|0|1|100|DKK|1430|2935|lyfalmen|V0037|2376||10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1430||1430|2935| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|6244|9520|lyfalmen||||30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6244||6244|9520| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|20662|28476|lyfalmen|V0115|18735||100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||20662||20662|28476| 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|2338|4177|lyfalmen||||100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2338||2338|4177| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|28008|37033|lyfsjukr||||2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28008||28008|37033| 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|2513|1835|lyfalmen|V0278|1835||28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||626||626|1835| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5997|9182|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5997||5997|9182| 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|||0|0|E|0|SNO|0|0|0|100|NOK|4238|6776|lyfalmen||||100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4238||4238|6776| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|883|2187|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2456|4339|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|21586|28973|lyfsjukr||||4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21586||21586|28973| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|||0|0|E|0|VIF|0|0|1|100|CHF|15023|21399|lyfalmen|V0034|18986||25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15023||15023|21399| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|31453|41356|lyfsjukr||||6160|0||Icepharma hf|Fresenius Kabi|Blöndur||31453||31453|41356| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|||0|0|0|1|NOH|0|0|0|100|DKK|2380|3435|lyfsjukr||||10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2380||2380|3435| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|4274|6826|lyfalmen|V0444|6826||15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4274||4274|6826| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|839|2127|lyfalmen|V0004|428||7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||839||839|2127| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|6936|10467|lyfalmen|V0294|10467||60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|||0|0|0|0|BIG|0|0|1|100|SEK|4302|6864|lyfalmen||||45|0||Icepharma hf|Bioglan AB|Capsaicin||4302||4302|6864| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|3353|5566|lyfalmen|V0292|5566||60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|9358|13780|lyfalmen||||100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9358||9358|13780| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|4373|6961|lyfalmen|V0004|1712||28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4373||4373|6961| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|5263|8178|lyfalmen|V0293|8178||60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|8683|12857|lyfalmen|V0011|3079||56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8683||8683|12857| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|1379|2865|lyfalmen|V0005|454||7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1379||1379|2865| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|6120|9351|lyfalmen|V0005|1815||28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6120||6120|9351| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5339|8282|lyfalmen||||100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5339||5339|8282| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|5359|8310|lyfalmen|V0011|2749||50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5359||5359|8310| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|25410|33772|lyfsjukr||||5760|0||Icepharma hf|Fresenius Kabi|Blöndur||25410||25410|33772| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|13308|7196|lyfalmen|V0011|5498||100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4545||4545|7196| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|9760|14330|lyfalmen|V0012|2749||50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9760||9760|14330| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|||0|0|*|0|NAS|0|0|0|100|DKK|3071|5180|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3071||3071|5180| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|17697|24755|lyfalmen|V0012|5498||100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17697||17697|24755| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|||0|0|B|0|MSD|0|0|0|100|DKK|16850|23692|lyfalmen|V0492|19304||98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||16850||16850|23692| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|100674|128228|lyfsjukr||||1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||100674|128228| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|51315|66283|lyfsjukr||||1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||51315|66283| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|26567|35224|lyfsjukr||||1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||26567|35224| 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|||0|0|0|0|BYP|0|0|0|100|SEK|3210|5370|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3210|5370| 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|||0|0|0|0|BYP|0|0|0|100|SEK|3210|5370|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3210||3210|5370| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|1628|2288|lyfalmen|V0362|2273||100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||957||957|2288| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000|31.07.2012|R|||0|1|0|1|NOO|0|0|0|100|DKK|218235|275767|lyfsjukr||||1|0||Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||218235||218235|275767| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|SEK|3472|6057|vetorma||||10|0||Icepharma hf|Bayer Animal Health GmbH|||3472||3472|6057| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|||0|0|*|0|SAO|0|0|0|100|XEU|1237|2671|lyfalmen||||5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1237||1237|2671| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|||0|1|0|1|ALL|0|0|0|100|SEK|30500|40160|lyfsjukr||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||30500||30500|40160| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13926|15129|lyfalmen|V0089|2780||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10344||10344|15129| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|10294|15061|lyfalmen|V0515|5917||100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10294||10294|15061| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|||0|1|0|1|ZEP|0|0|0|100|DKK|242132|305758|lyfsjukr||||2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||242132||242132|305758| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|17772|24849|lyfalmen|V0253|8987||100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17772||17772|24849| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|34532|45883|lyfalmen|V0516|17852||100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34532||34532|45883| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|10332|15113|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10332||10332|15113| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|15359|21821|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15359||15359|21821| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|||0|0|0|1|BYP|0|0|0|100|SEK|190800|241337|lyfsjukr||||150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||190800||190800|241337| 003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|9339|13754|lyfalmen|V0356|12569||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9339||9339|13754| 003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|||0|0|0|0|AZD|0|0|0|100|SEK|8657|12821|lyfalmen||||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8657||8657|12821| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|58504|75968|lyfalmen|V0567|75968||100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||58504||58504|75968| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|4405|7005|lyfalmen||||28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4405||4405|7005| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|||0|0|E|0|PER|0|0|0|100|DKK|3183|5333|lyfalmen||||60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3183||3183|5333| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|15219|21645|lyfalmen||||98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15219||15219|21645| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|6662|10092|lyfalmen||||28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6662||6662|10092| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|22739|31083|lyfalmen||||98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22739||22739|31083| 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|||0|0|E|0|SCP|0|0|1|100|DKK|863|2159|lyfalmen||||10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||863||863|2159| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|1017|2049|lyfalmen|V0151|2049||28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|581|1774|lyfalmen||||20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||581||581|1774| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2389|4247|lyfalmen|V0322|4247||98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|71923|92146|lyfsjukr||||300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||71923||71923|92146| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|2105|3858|lyfalmen|V0469|2407||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2105||2105|3858| 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|21577|28962|lyfsjukr||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21577||21577|28962| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|7832|11693|lyfalmen||||250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7832||7832|11693| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|||0|0|B|0|GSK|0|0|0|100|GBP|4280|6834|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4280||4280|6834| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|586|1781|lyfalmen||||7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||586||586|1781| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|||0|0|0|0|MAB|0|0|1|100|DKK|1048|2413|lyfalmen||||30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1048||1048|2413| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|5416|8388|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5416||5416|8388| 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|7907|11795|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7907||7907|11795| 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|11106|16171|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11106||11106|16171| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|628|1838|lyfalmen|V0366|923||10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||628||628|1838| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5866|9003|lyfalmen||||66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5866||5866|9003| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|20846|28044|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||20846||20846|28044| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|1637|3218|lyfalmen|V0366|2770||30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1637||1637|3218| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|||0|0|E|0|GSK|0|0|0|100|GBP|7387|11084|lyfalmen||||10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7387||7387|11084| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|4583|7248|lyfalmen|V0458|6304||100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4583||4583|7248| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|||0|0|0|0|BOI|0|0|0|100|DKK|4746|9286|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||4746||4746|9286| 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|3213|5374|lyfalmen||||56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3213||3213|5374| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|||0|0|B|0|REP|0|0|0|100|SEK|643|1858|lyfalmen||||100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||643||643|1858| 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|4286|6842|lyfalmen|V0226|2728||56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4286||4286|6842| 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|6053|9259|lyfalmen|V0227|4162||56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6053||6053|9259| 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|8057|12000|lyfalmen|V0228|5360||56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8057||8057|12000| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|2268|4081|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2268||2268|4081| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|||0|0|*|0|AVP|0|0|0|100|NOK|3563|5853|lyfalmen|V0494|3232||90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||3563||3563|5853| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2556|4475|lyfalmen|V0318|4475||100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4475| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|36126|47221|lyfsjukr||||1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||36126||36126|47221| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|||0|0|0|0|AGT|0|0|1|100|DKK|1403|2898|lyfalmen||||25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1403||1403|2898| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|3348|5559|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3348||3348|5559| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1836|2164|lyfalmen|V0071|2164||28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|5614|7418|lyfalmen|V0320|7418||100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7418| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|776|2040|lyfalmen|V0062|2040||28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|2040| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2703|4676|lyfalmen|V0317|4676||100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4676| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|926|1921|lyfalmen|V0067|1921||28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1921| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1753| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|||0|1|0|1|BIA|0|0|0|100|DKK|37714|49214|lyfsjukr||||5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||37714||37714|49214| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1778|3411|lyfalmen|V0318|2506||56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007|31.05.2012|R|||0|1|0|1|BIA|0|0|0|100|DKK|142871|181186|lyfsjukr||||19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||142871||142871|181186| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|180630|228573|lyfsjukr||||5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||180630||180630|228573| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|||0|0|*|0|SDE|0|0|0|100|NOK|10570|15438|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10570||10570|15438| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|6810|7380|lyfalmen|V0250|4783||100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4679||4679|7380| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|8799|8592|lyfalmen|V0251|4769||100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5565||5565|8592| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|642|1857|lyfalmen||||24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||642||642|1857| 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|14708|7608|lyfalmen|V0282|7252||56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||4846||4846|7608| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|||0|0|0|1|PER|0|0|0|100|DKK|5360|7736|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5360||5360|7736| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|||0|0|0|0|AGT|0|0|1|100|DKK|370|1485|lyfalmen|V0352|709||8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||370||370|1485| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|649|1867|lyfalmen|V0352|1241||14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||649||649|1867| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|1228|2659|lyfalmen|V0352|2659||30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1228||1228|2659| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|1837|3492|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1837||1837|3492| 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2289|4110|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2289|4110| 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|8666|7013|lyfalmen|V0148|4010||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4411||4411|7013| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2193|3979|lyfalmen||||30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2193||2193|3979| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|2526|4434|lyfalmen||||20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2526||2526|4434| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|3453|5702|lyfalmen||||30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3453||3453|5702| 005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|28017|37706|lyfalmen|V0356|37706||360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28017||28017|37706| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|||0|0|0|0|AZA|0|1|0|100|SEK|51476|67148|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||51476||51476|67148| 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|||0|0|E|0|ASZ|0|0|0|100|SEK|3376|5597|lyfalmen||||10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3376||3376|5597| 005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|||0|0|E|0|LEP|0|0|1|100|DKK|1114|2503|lyfalmen||||2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1114||1114|2503| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|||0|1|*|0|AZA|0|0|0|100|SEK|62261|80683|lyfalmen|V0451|78072||1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||62261||62261|80683| 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|||0|0|B|0|BOI|0|0|0|100|DKK|1470|2990|lyfalmen||||200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1470||1470|2990| 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|*|0|ELD|0|1|0|100|XEU|29212|18231|lyfalmen|V0283|9507||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12499||12499|18231| 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|37153|49172|lyfalmen||||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37153||37153|49172| 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|||0|0|0|0|BAP|0|0|0|100|SEK|1246|2683|lyfalmen|V0545|2682||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1246||1246|2683| 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6192|9449|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6192||6192|9449| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6525|9905|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6525|9905| 005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|||0|0|0|0|BAX|0|0|0|100|USD|4296|6856|lyfalmen||||0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4296||4296|6856| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|1580|3140|lyfalmen||||30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1580||1580|3140| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|2755|4748|lyfalmen|V0020|3662||60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2755||2755|4748| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|7315|10985|lyfalmen|V0020|10985||180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7315||7315|10985| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|4020|6478|lyfalmen|V0020|5493||90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4020||4020|6478| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|1768|3397|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1768||1768|3397| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6574|8992|lyfalmen|V0324|3277||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5858||5858|8992| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|3117|4917|lyfalmen|V0035|3607||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2879||2879|4917| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|||0|0|0|0|MEF|0|0|0|100|XEU|17738|30943|vetorma||||5|0||Vistor hf|Merial (MSD)|||17738||17738|30943| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6196|9455|lyfalmen|V0325|3092||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6196||6196|9455| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|10454|14065|lyfalmen|V0325|5522||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9566||9566|14065| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|5007|7412|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4703||4703|7412| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3036|5132|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3036||3036|5132| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|||0|0|0|0|ROC|0|0|0|100|DKK|3457|5708|lyfalmen||||8|0|2,0000|Icepharma hf|Roche|Meflókvín||3457||3457|5708| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|||0|0|*|0|ELD|0|1|0|100|XEU|872|2172|lyfalmen||||1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||872||872|2172| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|10408|15217|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10408||10408|15217| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|16184|20672|lyfalmen|V0326|5292||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14444||14444|20672| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|3531|5809|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3531||3531|5809| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6395|8680|lyfalmen|V0246|4470||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5630||5630|8680| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|9341|12373|lyfalmen|V0072|3121||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8329||8329|12373| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|12531|18272|lyfalmen|V0327|2964||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12531||12531|18272| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|4641|7328|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4641||4641|7328| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|12695|17669|lyfalmen|V0073|3195||98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12051||12051|17669| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|83254|106366|lyfsjukr||||2|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||83254||83254|106366| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5719|8802|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5719||5719|8802| 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|103254|131466|lyfsjukr||||1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||103254||103254|131466| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|||0|0|*|0|NAS|0|0|0|100|DKK|5548|8568|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5548||5548|8568| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYC|0|0|0|100|DKK|155033|196449|lyfsjukr||||3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||155033||155033|196449| 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|78854|100844|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||78854||78854|100844| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|||0|0|0|0|REP|0|0|1|100|SEK|2583|4512|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2583||2583|4512| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|1|0|0|100|DKK|8721|16918|vetalmen||||50|0||Vistor hf|Boehringer Ingelheim|||8721||8721|16918| 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|6781|10255|lyfalmen||||5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6781||6781|10255| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13491|19476|lyfalmen||||10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13491||13491|19476| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|||0|0|B|0|LEP|0|0|0|100|DKK|6908|10429|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6908||6908|10429| 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002|31.05.2012|R|||0|0|B|0|LEP|0|0|0|100|DKK|13016|18880|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13016||13016|18880| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|534756|673001|lyfsjukr||||35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||534756||534756|673001| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|||0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa||||2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|||0|0|0|0|MSD|0|0|0|100|DKK|14486|20725|lyfalmen||||98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14486||14486|20725| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|4564|7222|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4564||4564|7222| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|0|0|SNO|0|1|0|100|NOK|717|1960|lyfalmen||||100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||717||717|1960| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|||0|0|0|0|BID|0|0|0|100|DKK|25136|48437|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim Danmark|||25136||25136|48437| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|13798|19862|lyfalmen|V0117|19862||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13798||13798|19862| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|2099|3850|lyfalmen||||100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2099||2099|3850| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|6883|10394|lyfalmen||||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6883||6883|10394| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|20829|28686|lyfalmen|V0118|28686||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20829||20829|28686| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|5330|8270|lyfalmen||||100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5330||5330|8270| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|8650|12812|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8650||8650|12812| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|26056|35245|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26056||26056|35245| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|168857|213798|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||168857||168857|213798| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|322234|406286|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||322234||322234|406286| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|3018|5107|lyfalmen|V0377|4378||3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3018||3018|5107| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|97210|123881|lyfsjukr||||3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||97210||97210|123881| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|||0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|277913|350663|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||277913||277913|350663| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|3195|5350|lyfalmen|V0374|4287||2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3195||3195|5350| 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|||0|0|0|1|CPS|0|0|0|100|SEK|8674|12519|lyfsjukr||||50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8674||8674|12519| 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|||0|0|0|1|OPO|0|0|0|100|XEU|116921|148618|lyfsjukr||||100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||116921||116921|148618| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|||0|0|0|1|ABS|0|0|0|100|DKK|23125|30904|lyfsjukr||||250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||23125||23125|30904| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|||0|0|0|0|BAN|0|0|0|100|DKK|1947|3396|vetorma||||7|0||Icepharma hf|Bayer Animal Health GmbH|||||1947|3396| 007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6178|9430|lyfalmen||||30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6178||6178|9430| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|||0|0|0|0|AZD|0|0|0|100|SEK|3671|6001|lyfalmen|V0079|6001||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3671||3671|6001| 007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|||0|0|0|0|SPL|0|0|0|100|DKK|4904|7687|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4904||4904|7687| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|||0|0|0|1|BRS|0|0|0|100|DKK|4445|6415|lyfsjukr||||1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4445||4445|6415| 007541|J07BL0101|Stamaril|bóluefni|||0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|21236|29196|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21236||21236|29196| 007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|9558|14054|lyfalmen||||60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9558||9558|14054| 007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6343|9656|lyfalmen||||30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6343||6343|9656| 007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|21534|29570|lyfalmen||||100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21534||21534|29570| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|||0|0|*|0|ACA|0|1|0|100|IKR|1728|3099|lyfalmen|V0290|3099||60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|||0|0|0|0|ORG|0|0|0|100|DKK|3958|6393|lyfalmen||||3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3958||3958|6393| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|||0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa||||2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|||0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa||||5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|||0|0|0|0|ALC|0|0|0|100|USD|1365|2846|lyfalmen||||5|0||K.Pétursson hf|Alcon|Ólópatadín||1365||1365|2846| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|185394|234552|lyfsjukr||||1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||185394||185394|234552| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|20278|27331|lyfsjukr||||10|0||Ísaga ehf|AGA AB|Nituroxíđ||20278||20278|27331| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen||||30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|46355|60058|lyfsjukr||||1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||46355||46355|60058| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|||0|0|*|0|MCK|0|0|0|100|SEK|611|1815|lyfalmen||||30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||611||611|1815| 008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|23923|31906|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||23923||23923|31906| 008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|29681|39132|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||29681||29681|39132| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|||0|0|E|0|MSD|0|0|0|100|DKK|5447|8430|lyfalmen||||6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5447||5447|8430| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|54622|70433|lyfsjukr||||4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||54622||54622|70433| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|109245|138985|lyfsjukr||||4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||109245||109245|138985| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|87055|111137|lyfsjukr||||4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||87055||87055|111137| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|128784|163506|lyfsjukr||||4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||128784||128784|163506| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|151283|191743|lyfsjukr||||4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||151283||151283|191743| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|||0|0|B|0|ASP|0|0|1|100|XEU|1508|3042|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1508||1508|3042| 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|||0|0|B|0|GSK|0|0|1|100|GBP|298|1387|lyfalmen||||20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||298||298|1387| 008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|37013|48334|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||37013||37013|48334| 008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|28983|38256|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||28983||28983|38256| 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|||0|0|B|0|GSK|0|0|1|100|GBP|582|1775|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||582||582|1775| 008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|33865|44383|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||33865||33865|44383| 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|881|2035|lyfalmen||||20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||772||772|2035| 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|||0|0|B|0|GSK|0|0|1|100|GBP|1313|2775|lyfalmen||||100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1313||1313|2775| 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|2846|4872|lyfalmen|V0226|4872||100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2846||2846|4872| 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|4717|7432|lyfalmen|V0227|7432||100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4717||4717|7432| 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|6366|9571|lyfalmen|V0228|9571||100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6281||6281|9571| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|||0|1|0|1|GEZ|0|0|0|100|XEU|151984|192622|lyfsjukr||||2|0||Vistor hf|Genzyme BV|Thýrótrópín||151984||151984|192622| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|828|2112|lyfalmen|V0153|2112||100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||828||828|2112| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|720|1964|lyfalmen|V0154|1964||100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||720||720|1964| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|||0|0|0|0|CHP|0|0|0|100|USD|5263|9181|vetorma||||1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5263||5263|9181| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|||0|0|0|0|CHP|1|0|0|100|XEU|12550|24270|vetalmen||||50|0||Icepharma hf|Chanelle Pharmaceuticals |||12550||12550|24270| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|ţpakki||R06AX22|01.04.1998||R|||0|0|E|0|APS|0|0|1|100|DKK|4298|6858|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4298||4298|6858|31.05.2012 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|||0|0|E|0|NAS|0|0|0|100|DKK|2859|4890|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2859||2859|4890| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|107963|137376|lyfsjukr||||2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||107963||107963|137376| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|113889|144813|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||113889||113889|144813| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|3044|5143|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||3044||3044|5143| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|||0|0|0|0|PER|0|0|0|100|DKK|1915|3599|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1915||1915|3599| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5971|9147|lyfalmen|V0145|8535||4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||5971|9147| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|11763|17070|lyfalmen|V0145|17070||8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11763|17070| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|5136|8005|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||5136||5136|8005| 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8663|12503|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8663||8663|12503| 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8663|12503|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8663||8663|12503| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|||0|0|0|0|IPI|0|0|1|100|DKK|14142|20293|lyfalmen||||10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14142||14142|20293| 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8663|12503|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8663||8663|12503| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|51588|66625|lyfsjukr||||30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||51588||51588|66625| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1802| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5383|8343|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5383||5383|8343| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1128|2522|lyfalmen||||8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1128||1128|2522| 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1245|2682|lyfalmen|V0130|1666||8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1245||1245|2682| 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1439|2947|lyfalmen|V0131|2441||8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1439||1439|2947| 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1803|3445|lyfalmen|V0132|2709||8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1803||1803|3445| 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7326|10573|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7326||7326|10573| 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7326|10573|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7326||7326|10573| 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7326|10573|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7326||7326|10573| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|196926|249025|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||196926||196926|249025| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5214|8111|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5214||5214|8111| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|||0|1|0|1|GIS|0|0|0|100|DKK|58928|75837|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||58928||58928|75837| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|||0|0|0|0|DPL|0|0|1|100|XEU|8608|12754|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||8608||8608|12754| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8102|12062|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8102||8102|12062| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7950|11854|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7950||7950|11854| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|9317|13724|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9317||9317|13724| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8116|12081|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8116||8116|12081| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|7978|11892|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||7978||7978|11892| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|2149|3919|lyfalmen|V0329|2455||30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2149||2149|3919| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|4091|6575|lyfalmen|V0330|2823||30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4091||4091|6575| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5846|8976|lyfalmen||||30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5846||5846|8976| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|||0|0|0|1|ROA|0|0|0|100|DKK|224048|283063|lyfsjukr||||60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||224048||224048|283063| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|7185|10370|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7185||7185|10370| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|12698|18481|lyfalmen|V0331|5176||96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12698||12698|18481| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|17905|25016|lyfalmen|V0332|8494||96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||17905||17905|25016| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|||0|0|E|0|LBK|0|0|0|100|DKK|14153|20307|lyfalmen||||50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14153|20307| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|||0|0|E|0|LBK|0|0|0|100|DKK|22943|31339|lyfalmen||||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||22943||22943|31339| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008|31.07.2012|R|||0|0|0|0|BII|0|0|0|100|DKK|3760|6122|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3760||3760|6122| 010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|||0|0|0|0|SPM|0|0|0|100|XEU|7289|10950|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7289||7289|10950| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12412|18122|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12412||12412|18122| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|||0|0|0|0|ELA|0|0|0|100|DKK|73243|127769|vetorma||||1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||73243||73243|127769| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|||0|0|B|0|TIL|0|0|0|100|SEK|6899|10416|lyfalmen||||60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6899||6899|10416| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|7311|10552|lyfsjukr||||2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7311||7311|10552| 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|9114|13154|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9114||9114|13154| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|||0|0|0|0|SAO|0|0|1|100|XEU|1174|2585|lyfalmen||||5|0||Icepharma hf|Santen Oy|Levófloxacín||1174||1174|2585| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|5651|8709|lyfalmen|V0207|1125||4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5651||5651|8709| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|5999|8658|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5999||5999|8658| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9226|13315|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9226||9226|13315| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4082|5891|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4082||4082|5891| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2340|3377|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2340||2340|3377| 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|8885|13133|lyfalmen|V0377|13133||9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8885||8885|13133| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9214|13298|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9214||9214|13298| 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|2425|3088|lyfalmen|V0006|2566||56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1542||1542|3088| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|6615|9547|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6615||6615|9547| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4015|5795|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4015||4015|5795| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|14608|5902|lyfalmen|V0207|3374||12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3599||3599|5902| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2161|3119|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2161||2161|3119| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACT|0|0|0|100|DKK|349847|440940|lyfsjukr||||56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||349847||349847|440940| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACL|0|0|0|100|DKK|349847|440940|lyfsjukr||||56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||349847||349847|440940| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1344|2029|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||768||768|2029| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|XEU|4884|5317|lyfalmen|V0006|4583||100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||3171||3171|5317| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|XEU|3148|3096|lyfalmen|V0006|2566||56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1548||1548|3096| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|49285|63735|lyfsjukr||||10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||49285||49285|63735| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|||0|0|0|1|REP|0|0|0|100|SEK|3191|4605|lyfsjukr||||10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3191||3191|4605| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2938|4998|lyfalmen||||28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2938||2938|4998| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|20035|27689|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20035||20035|27689| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|19802|27397|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19802||19802|27397| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|34112|45356|lyfalmen||||56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34112||34112|45356| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|33880|45065|lyfalmen||||56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33880||33880|45065| 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|||0|0|B|0|AZD|0|0|0|100|SEK|19220|26666|lyfalmen||||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19220||19220|26666| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4475|7100|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4475||4475|7100| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4650|7340|lyfalmen||||28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4650||4650|7340| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|20133|26253|lyfalmen|V0327|5292||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18891||18891|26253| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|1187|2603|lyfalmen||||7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1187||1187|2603| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|761|2020|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||761||761|2020| 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|7338|5046|lyfalmen|V0457|5046||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2973||2973|5046| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|||0|0|*|0|LBK|0|1|0|100|DKK|12076|17701|lyfalmen||||5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12076||12076|17701| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1052|2418|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1052||1052|2418| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|||0|0|B|0|ACA|0|0|0|100|XEU|2903|2481|lyfalmen|V0069|2440||98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1098||1098|2481| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|9366|13791|lyfalmen|V0357|12602||60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9366||9366|13791| 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|7230|10869|lyfalmen||||30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7230||7230|10869| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|9205|13285|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9205||9205|13285| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|2412|3481|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Esketamín||2412||2412|3481| 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|9490|13961|lyfalmen||||30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9490||9490|13961| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|||0|0|0|0|CHP|1|0|0|100|XEU|1910|3799|vetalmen||||25|0||Icepharma hf|Chanelle Pharmaceuticals |||1910||1910|3799| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|4916|7095|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Esketamín||4916||4916|7095| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|||0|0|E|0|OYL|0|0|0|100|SEK|1614|3187|lyfalmen||||64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1614||1614|3187| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|||0|1|0|1|ROA|0|0|0|100|DKK|87619|111844|lyfsjukr||||168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||87619||87619|111844| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|10218|14957|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||10218||10218|14957| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1486|2049|lyfalmen|V0152|2049||28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|4738|6676|lyfalmen|V0323|6676||98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6676| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|4460|6437|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4460||4460|6437| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|2580|3724|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2580||2580|3724| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|||0|0|E|0|LBK|0|0|0|100|DKK|7926|11821|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7926|11821| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|||0|1|0|1|MSD|0|0|0|100|DKK|40291|52448|lyfsjukr||||30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40291||40291|52448| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|||0|0|E|0|GSK|0|0|0|100|GBP|13574|19581|lyfalmen||||90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13574||13574|19581| 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|||0|0|E|0|GSK|0|0|0|100|GBP|4725|7442|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4725||4725|7442| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|5951|9120|lyfalmen||||4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5951||5951|9120| 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|||1|0|0|0|JAS|0|0|0|100|SEK|12091|17719|lyfalmen||||30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12091||12091|17719| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|||0|1|0|1|WTE|0|0|0|100|DKK|443658|558673|lyfsjukr||||1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||443658||443658|558673| 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|||0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen||||80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961| 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|||0|0|0|0|JCI|0|0|0|100|SEK|4731|7451|lyfalmen||||9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4731||4731|7451| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|||0|0|E|0|LBI|0|0|0|100|SEK|6847|10345|lyfalmen||||30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6847||6847|10345| 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3325|4783|lyfalmen|V0250|4783||100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2781||2781|4783| 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3621|4769|lyfalmen|V0251|4769||100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2771||2771|4769| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|6120|9351|lyfalmen||||30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6120||6120|9351| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|6913|13447|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||6913||6913|13447| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|9240|13619|lyfalmen||||30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9240||9240|13619| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1740|3461|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1740||1740|3461| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|21975|29461|lyfsjukr||||2|0||Ísaga ehf|AGA AB|Nituroxíđ||21975||21975|29461| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|||0|0|0|1|ZLB|0|0|0|100|SEK|7092|10236|lyfsjukr||||2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7092||7092|10236| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|29328|38689|lyfsjukr||||250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||29328||29328|38689| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|49641|64182|lyfsjukr||||500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||49641||49641|64182| 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|||0|0|E|0|ANO|0|0|0|100|XEU|3340|4660|lyfalmen|V0042|4660||100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2691||2691|4660| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|4540|8890|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4540||4540|8890| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|10594|20515|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||10594||10594|20515| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1111|2210|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1111||1111|2210| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BAL|0|0|0|100|SEK|151011|191401|lyfsjukr||||1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||151011|191401| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|||0|1|0|1|AZD|0|0|0|100|SEK|411672|457825|lyfsjukr||||30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||363301||363301|457825| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|26561|35217|lyfsjukr||||1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||26561|35217| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|100674|128228|lyfsjukr||||1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||100674|128228| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|51315|66283|lyfsjukr||||1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||51315|66283| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|5379|8337|lyfalmen||||28|0||Vistor hf|M.S.D.|Ezetimíb||5379||5379|8337| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|||0|0|0|0|MSD|0|0|0|100|DKK|18315|25530|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||18315||18315|25530| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|1305|2764|lyfalmen||||5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1305||1305|2764| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|2496|4393|lyfalmen||||10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2496||2496|4393| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|||0|0|E|0|SNO|0|0|0|100|NOK|1453|2886|lyfalmen||||40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1394||1394|2886| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|412|1542|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||412||412|1542| 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|37123|48472|lyfsjukr||||5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||37123||37123|48472| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|4659|7352|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4659||4659|7352| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|958|2289|lyfalmen||||1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||958|2289| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|||0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|6157|9401|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6157||6157|9401| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|2564|4486|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2564||2564|4486| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|4599|7270|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4599||4599|7270| 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|176275|223108|lyfsjukr||||60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||176275||176275|223108| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|374713|472147|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||374713||374713|472147| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|||0|0|*|0|NAS|0|0|0|100|DKK|2482|4374|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2482||2482|4374| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|||0|0|0|1|AZD|0|0|0|100|SEK|9123|13167|lyfsjukr||||50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9123||9123|13167| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|||0|0|0|0|UCB|0|0|0|100|DKK|18004|25140|lyfalmen||||300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18004||18004|25140| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|||0|0|0|0|ELD|0|0|0|100|XEU|56698|73701|lyfalmen||||3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||56698||56698|73701| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|29556|38975|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||29556||29556|38975| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|28096|37806|lyfalmen|V0357|37806||180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28096||28096|37806| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|||0|0|0|0|IGB|0|0|0|100|SEK|1561|3114|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1561||1561|3114| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|19632|26521|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||19632||19632|26521| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|25700|34136|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||25700||25700|34136| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|||0|0|0|0|PCO|0|0|1|100|NOK|2614|4555|lyfalmen||||100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2614||2614|4555| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|||0|0|0|0|VET|0|0|0|100|XEU|2271|4517|vetalmen||||45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2271|4517| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|||0|0|0|0|BOY|0|0|0|100|SEK|18615|25907|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18615||18615|25907| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|||0|1|0|1|GIS|0|0|0|100|DKK|82099|104917|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||82099|104917| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|||0|0|0|0|PAL|0|0|0|100|XEU|5645|11012|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5645||5645|11012| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|239233|302120|lyfsjukr||||60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||239233||239233|302120| 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|||1|0|E|0|NOP|0|0|0|100|DKK|2280|4098|lyfalmen||||28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2280||2280|4098| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|1351|2827|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1351||1351|2827| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|62528|80355|lyfsjukr||||2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||62528||62528|80355| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|100042|127435|lyfsjukr||||2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||100042||100042|127435| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|||0|0|E|0|MYL|0|0|0|100|SEK|888|2194|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||888|2194| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|19159|26590|lyfalmen||||60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19159||19159|26590| 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|57813|75100|lyfalmen||||60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||57813||57813|75100| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|38482|50840|lyfalmen||||60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38482||38482|50840| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|776|2040|lyfalmen||||10|0|17,8571|Vistor hf|Meda AB|Azelastínum||776||776|2040| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|3166|5310|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3166||3166|5310| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|||0|0|*|0|NAS|0|0|0|100|DKK|8536|12656|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8536||8536|12656| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|1096|2455|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1079||1079|2455| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen||||100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754| 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|||0|0|E|0|NOH|0|0|0|100|DKK|1082|2459|lyfalmen|V0129|1686||8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1082||1082|2459| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2000|2612|lyfalmen|V0234|2407||6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1194||1194|2612| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2857|3003|lyfalmen|V0233|2780||12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1480||1480|3003| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|||0|0|*|0|NAS|0|0|0|100|DKK|10171|14892|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10171||10171|14892| 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|343073|432439|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||343073||343073|432439| 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|91187|116322|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||91187||91187|116322| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5273|8192|lyfalmen||||30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5273||5273|8192| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13407|19371|lyfalmen||||100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13407||13407|19371| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5273|8192|lyfalmen||||30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5273||5273|8192| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|14493|20734|lyfalmen||||100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14493||14493|20734| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|69948|89667|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||69948||69948|89667| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|69948|89667|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||69948||69948|89667| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|60825|78218|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||60825||60825|78218| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5273|8192|lyfalmen||||30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5273||5273|8192| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13266|19194|lyfalmen||||100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13266||13266|19194| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|69948|89667|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||69948||69948|89667| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|22430|30695|lyfalmen||||120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22430||22430|30695| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|46720|61179|lyfalmen||||120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||46720||46720|61179| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3164|5519|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||3164||3164|5519| 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|4446|7756|vetorma||||12|0||Icepharma hf|Bayer Animal Health GmbH|||4446||4446|7756| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2822|4923|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2822||2822|4923| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3539|6174|vetorma||||3|0||Icepharma hf|Bayer Animal Health GmbH|||3539||3539|6174| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|||0|0|B|0|SGM|0|0|0|100|DKK|4509|7147|lyfalmen|V0200|5454||50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4509||4509|7147| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3965|6917|vetorma||||8|0||Icepharma hf|Bayer Animal Health GmbH|||3965||3965|6917| 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|||0|0|E|0|ASP|0|0|1|100|XEU|1990|3701|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1990|3701| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|||0|0|E|0|ASP|0|0|1|100|XEU|2235|4036|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2235||2235|4036| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1621|3196|lyfalmen||||10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1621||1621|3196| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3164|5519|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||3164||3164|5519| 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|||0|0|0|0|GSK|0|1|0|100|GBP|2069|3809|lyfalmen||||28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2069||2069|3809| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|14965|21326|lyfalmen|V0117|20267||100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14965||14965|21326| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1204|2626|lyfalmen||||10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1204||1204|2626| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|22408|30667|lyfalmen|V0118|29271||100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22408||22408|30667| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|||1|0|0|0|MAP|0|0|0|100|GBP|1277|2726|lyfalmen||||20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1277||1277|2726| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|||0|0|E|0|ALM|0|0|0|100|SEK|2559|4479|lyfalmen|V0236|3847||3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2559||2559|4479| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005|31.07.2012|L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.09.2004|31.05.2012|R|||0|0|*|0|JAS|0|1|0|100|SEK|8090|12046|lyfalmen||||28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8090||8090|12046| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2639|4589|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2639||2639|4589| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|6644|10068|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6644||6644|10068| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|||0|1|E|0|MSE|0|0|0|100|SEK|5162|8040|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5162||5162|8040| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|10075|14761|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10075||10075|14761| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|1740|3359|lyfalmen||||14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1740||1740|3359| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|14637|20915|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14637||14637|20915| 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|8786|12998|lyfalmen||||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8786||8786|12998| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.08.2004|31.05.2012|R|||0|0|*|0|JAS|0|1|0|100|SEK|4294|6853|lyfalmen||||28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4294||4294|6853| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|95603|121864|lyfsjukr||||70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||95603||95603|121864| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|||0|1|0|1|PER|0|0|0|100|DKK|4233|6109|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4233||4233|6109| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2597|4531|lyfalmen||||56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2597||2597|4531| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|17463|24461|lyfalmen||||28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17463||17463|24461| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7114| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|34112|45356|lyfalmen||||56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34112||34112|45356| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367||12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|||0|1|0|1|ROC|0|0|0|100|DKK|183908|232687|lyfsjukr||||2|0|120,0000|Icepharma hf|Roche|Epóetín||183908||183908|232687| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|7785|11628|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7785||7785|11628| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|3048|5148|lyfalmen|V0240|5148||200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3048||3048|5148| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|5625|8674|lyfalmen|V0433|8674||200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5625||5625|8674| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|60853|78916|lyfalmen||||28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||60853||60853|78916| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|89667|115077|lyfalmen||||28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||89667||89667|115077| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|28977|38911|lyfalmen||||28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28977||28977|38911| 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|78191|100012|lyfsjukr||||5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||78191||78191|100012| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2000|3715|lyfalmen||||14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2000||2000|3715| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|||0|0|0|0|PER|0|0|0|100|DKK|3537|5817|lyfalmen|V0007|5817||56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3537|5817| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|7799|11648|lyfalmen|V0007|10180||98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7799||7799|11648| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|||0|1|0|1|GIS|0|0|0|100|XEU|39513|51471|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||39513||39513|51471| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|13876|19960|lyfalmen||||98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||13876||13876|19960| 016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|3133|5265|lyfalmen||||4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3133||3133|5265| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|||0|0|0|0|PAL|0|0|0|100|DKK|18715|36108|vetalmen||||60|0||Icepharma hf|Pfizer Oy Animal Health|||18715||18715|36108| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|25410|33772|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||25410||25410|33772| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|1524|3064|lyfalmen||||3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1524||1524|3064| 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|||0|0|E|0|DSG|0|0|0|100|XEU|1427|2931|lyfalmen||||100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1427||1427|2931| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|||0|1|0|1|SKY|0|0|0|100|DKK|263105|332079|lyfsjukr||||5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||263105||263105|332079| 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|||0|0|B|0|FRO|0|0|0|100|DKK|7877|11754|lyfalmen||||60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7877||7877|11754| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|||0|1|0|1|JCI|0|0|0|100|SEK|181143|229217|lyfsjukr||||1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||181143||181143|229217| 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|||0|0|0|1|ROC|0|0|0|100|DKK|40157|52280|lyfsjukr||||6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||40157||40157|52280| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|1359|2838|lyfalmen|V0046|2242||100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1359||1359|2838| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|||0|1|0|1|BIB|0|0|0|100|XEU|127382|161747|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||127382||127382|161747| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|47725|62440|lyfalmen||||28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||47725||47725|62440| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|148206|188544|lyfalmen||||84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||148206||148206|188544| 017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|5439|8419|lyfalmen||||4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5439||5439|8419| 017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|10356|15145|lyfalmen||||4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10356||10356|15145| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|2688|4656|lyfalmen||||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2688||2688|4656| 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|||0|0|0|1|MSD|0|0|0|100|DKK|8998|12986|lyfsjukr||||3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8998||8998|12986| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|XEU|883|2187|lyfalmen||||20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||883||883|2187| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|||0|0|E|0|REP|0|0|1|100|SEK|3031|5125|lyfalmen||||30|0|150,0000|Vistor hf|Recip AB|Prednisón||3031||3031|5125| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1459|2724|lyfalmen|V0168|2641||20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2724| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|6679|12997|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||6679||6679|12997| 017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|40870|32200|lyfalmen|V0350|27851||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||23629||23629|32200| 017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|13316|11931|lyfalmen|V0348|10830||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||8006||8006|11931| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|10397|15201|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10397||10397|15201| 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|43929|57676|lyfalmen||||84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||43929||43929|57676| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|9494|13966|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9494||9494|13966| 018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|||0|0|0|0|BYP|0|0|0|100|SEK|7230|10869|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7230||7230|10869| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2262|4073|lyfalmen||||28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2262||2262|4073| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|3321|5522|lyfalmen||||28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3321||3321|5522| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|10720|15643|lyfalmen||||98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10720||10720|15643| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|7462|11187|lyfalmen||||98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7462||7462|11187| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|3911|6329|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3911||3911|6329| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|4271|6821|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4271||4271|6821| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|8866|13107|lyfalmen||||98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8866||8866|13107| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|||0|0|E|0|GSK|0|0|0|100|IKR|1499|2025|lyfalmen|V0243|1679||42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||765||765|2025| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2778|4779|lyfalmen||||28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2778||2778|4779| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|8227|12233|lyfalmen||||30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8227||8227|12233| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|13641|19002|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13641||13641|19002| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|20171|27860|lyfalmen|V0441|27860||90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20171||20171|27860| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|2912|4962|lyfalmen||||28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2912||2912|4962| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|||0|0|B|0|MKA|0|0|1|100|SEK|979|2318|lyfalmen|V0414|2022||100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||979||979|2318| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|5826|8949|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5826||5826|8949| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|16423|23156|lyfalmen|V0440|23156||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16423||16423|23156| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|34318|45614|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||34318||34318|45614| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|||0|1|0|1|TEP|0|0|0|100|NOK|123879|157351|lyfsjukr||||28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||123879||123879|157351| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|ţpakki||R06AX22|01.10.2005||R|||0|0|E|0|APS|0|0|1|100|DKK|3087|5202|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3087||3087|5202|31.05.2012 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|ţpakki||R06AX22|01.10.2005||R|||0|0|E|0|APS|0|0|1|100|DKK|9974|14623|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9974||9974|14623|31.05.2012 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|62073|79784|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||62073||62073|79784| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|594|1791|lyfalmen||||100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||594||594|1791| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|1324|2634|vetalmen||||100|0||Icepharma hf|Kela Laboratoria NV|||1324||1324|2634| 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|10338|15121|lyfalmen|V0221|11229||5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10338||10338|15121| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|21559|28939|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21559||21559|28939| 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|7389|11087|lyfalmen|V0220|8880||5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7389||7389|11087| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|24331|32418|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||24331||24331|32418| 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|4097|6583|lyfalmen|V0219|5568||5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4097||4097|6583| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|33779|44275|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||33779||33779|44275| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|34636|45351|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||34636||34636|45351| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|42321|54995|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||42321||42321|54995| 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|9617|14134|lyfalmen|V0223|12922||5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9617||9617|14134| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|14248|20426|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14248||14248|20426| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|4886|7663|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4886||4886|7663| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|||0|1|0|1|NYC|0|0|0|100|DKK|51740|66816|lyfsjukr||||1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||51740||51740|66816| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|||0|1|0|1|THE|0|0|0|100|XEU|738792|929066|lyfsjukr||||10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||738792||738792|929066| 019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen||||10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|||0|0|0|0|VET|0|0|0|100|DKK|21065|40621|vetalmen||||1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21065|40621| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6795|10274|lyfalmen||||56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6795||6795|10274| 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|52148|67328|lyfsjukr||||4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||52148||52148|67328| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6795|10274|lyfalmen||||56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6795||6795|10274| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|597|1796|lyfalmen||||100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||597||597|1796| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|3721|5370|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3721||3721|5370| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|||0|0|E|0|NYC|0|0|0|100|DKK|624|1833|lyfalmen||||250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||624||624|1833| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|16345|22395|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16345||16345|22395| 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|193651|244915|lyfsjukr||||16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||193651||193651|244915| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|||0|0|0|0|MYL|0|0|1|100|SEK|1126|2519|lyfalmen|V0159|2518||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1126||1126|2519| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|||0|1|0|1|ELD|0|0|0|100|XEU|197030|249155|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||197030||197030|249155| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12812|18624|lyfalmen||||28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12812||12812|18624| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12812|18624|lyfalmen||||28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12812||12812|18624| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|||0|1|E|0|ORG|0|0|0|100|DKK|55418|72095|lyfalmen||||1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||55418||55418|72095| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12812|18624|lyfalmen||||28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12812||12812|18624| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12812|18624|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12812||12812|18624| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|12812|18624|lyfalmen||||28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12812||12812|18624| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|||0|1|0|1|BIA|0|0|0|100|DKK|782291|983658|lyfsjukr||||6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||782291||782291|983658| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|410|1540|lyfalmen||||12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||410||410|1540| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|||0|1|0|1|GGL|0|0|0|100|GBP|70340|90159|lyfsjukr||||30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||70340||70340|90159| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|||0|0|0|0|MYL|0|0|1|100|SEK|1686|3232|lyfalmen|V0160|3231||30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1647||1647|3232| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|2898|4943|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2898||2898|4943| 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|27426|36965|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||27426||27426|36965| 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|||0|0|0|0|LVR|0|0|0|100|NOK|2817|4832|lyfalmen||||50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2817||2817|4832| 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|||0|0|0|0|PER|0|1|0|100|DKK|575|1765|lyfalmen|V0333|1592||7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||575||575|1765| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|6765|10233|lyfalmen||||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6765||6765|10233| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|52802|68812|lyfalmen||||2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||52802||52802|68812| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|6513|6474|lyfalmen|V0530|5839||84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4017||4017|6474| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|14511|7680|lyfalmen|V0531|6919||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4899||4899|7680| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|23828|32449|lyfalmen||||2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23828||23828|32449| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|600|1800|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||600||600|1800| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|5666|8730|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5666||5666|8730| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1827|3478|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1827||1827|3478| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|16501|23254|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16501||16501|23254| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|||0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|||0|0|0|0|MES|0|0|0|100|XEU|2208|3852|vetorma||||8|0||Vistor hf|Merial SAS|||2208||2208|3852| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|||0|1|0|1|WTE|0|0|0|100|DKK|155389|196896|lyfsjukr||||4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||155389||155389|196896| 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|||0|0|0|0|VEB|0|0|0|100|XEU|2582|4504|vetorma||||52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2582||2582|4504| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2009|3727|lyfalmen|V0174|3727||3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2009||2009|3727| 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|||0|0|0|0|LLS|0|0|0|100|DKK|2995|5076|lyfalmen||||30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2995||2995|5076| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|||0|0|0|0|GAN|0|0|0|100|SEK|2513|4417|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2513||2513|4417| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen||||12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|2367||12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389||30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|||0|0|E|0|GEM|0|0|0|100|XEU|1010|2361|lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1010||1010|2361| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116||100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|||0|0|E|0|BAP|0|0|0|100|SEK|17496|24503|lyfalmen|V0546|24503||4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17496||17496|24503| 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|9920|14549|lyfalmen|V0437|14327||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9920||9920|14549| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|17047|23939|lyfalmen|V0490|10510||98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17047||17047|23939| 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|7068|10648|lyfalmen|V0436|10648||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7068||7068|10648| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|||0|0|E|0|DAC|0|0|1|100|SEK|1691|3241|lyfalmen|V0443|3241||120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1654||1654|3241| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|||0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|17317|24278|lyfalmen|V0491|19304||98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17317||17317|24278| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|1572|2269|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Própófól||1572||1572|2269| 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|4370|6957|lyfalmen||||30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4370||4370|6957| 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|13375|19331|lyfalmen||||100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13375||13375|19331| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|14631|20907|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14631||14631|20907| 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|7068|10648|lyfalmen||||30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||7068||7068|10648| 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|||0|0|B|0|FER|0|0|0|100|DKK|15019|21394|lyfalmen||||60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15019||15019|21394| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|15723|21615|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Própófól||15723||15723|21615| 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|22514|30800|lyfalmen||||100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22514||22514|30800| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|15723|21615|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||15723||15723|21615| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24201|32917|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24201||24201|32917| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|4561|7218|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4561||4561|7218| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|9041|13048|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||9041||9041|13048| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|4563|6586|lyfsjukr||||50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4563||4563|6586| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19375||19375|26861| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|3805|6184|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3805||3805|6184| 021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|21462|28817|lyfsjukr||||2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21462||21462|28817| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|5259|8173|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5259||5259|8173| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|18122|25288|lyfalmen||||98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18122||18122|25288| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19375||19375|26861| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|83430|106587|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||83430||83430|106587| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|||0|0|0|1|BAM|0|0|0|100|SEK|125104|158888|lyfsjukr||||1200|0||Icepharma hf|Baxter Medical AB|Albúmín||125104||125104|158888| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|7160|10773|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7160||7160|10773| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8391|12457|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8391||8391|12457| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|||0|0|0|0|MSD|0|0|0|100|DKK|25732|34839|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||25732||25732|34839| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|||0|0|*|0|SAA|0|0|0|100|NOK|5497|8499|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5497||5497|8499| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8949|13221|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8949||8949|13221| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|291975|368311|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||291975||291975|368311| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|322218|406266|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||322218||322218|406266| 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|11230|19590|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||11230||11230|19590| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|||0|1|0|0|ALL|0|0|0|100|SEK|24930|33832|lyfalmen||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||24930||24930|33832| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2258|3939|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||2258||2258|3939| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|1291|2745|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1291||1291|2745| 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|||0|0|0|0|BAN|0|0|0|100|DKK|1375|2399|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1375|2399| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3813|2704|lyfalmen|V0056|1781||100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1261||1261|2704| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|6704|3718|lyfalmen|V0057|2200||100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2002||2002|3718| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2138|3730|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2138||2138|3730| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|625|1834|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||625||625|1834| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|||0|0|B|0|ASP|0|0|1|100|XEU|1874|3542|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1874||1874|3542| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|1384|2414|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||1384||1384|2414| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|||0|0|0|0|NOH|0|0|0|100|DKK|4658|7351|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4658||4658|7351| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|2129|2993|lyfalmen|V0321|2993||100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1554|2046|lyfalmen|V0321|1796||60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046| 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4749| 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|26983|36409|lyfalmen||||8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||26983||26983|36409| 022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|||0|1|0|1|GEU|0|0|0|100|SEK|229113|289419|lyfsjukr||||3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||229113||229113|289419| 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13492|19478|lyfalmen||||4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13492||13492|19478| 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|20259|27970|lyfalmen||||6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||20259||20259|27970| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2864| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196| 022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24201|32917|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24201||24201|32917| 022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19375||19375|26861| 023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5632|8683|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5632||5632|8683| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|||0|1|0|1|GIS|0|0|0|100|DKK|83424|106580|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||83424||83424|106580| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|25613|34689|lyfalmen||||90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25613||25613|34689| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|39988|52730|lyfalmen||||90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||39988||39988|52730| 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|20250|27959|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20250||20250|27959| 023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5689|8761|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5689||5689|8761| 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|20456|28217|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20456||20456|28217| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|4920|5012|lyfalmen|V0250|4783||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2948||2948|5012| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|3684|6018|lyfalmen|V0251|4769||100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3684||3684|6018| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|||0|0|0|0|DED|0|0|1|100|XEU|18348|25572|lyfalmen||||34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18348||18348|25572| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|7369|10635|lyfsjukr||||0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7369||7369|10635| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|28336|37444|lyfsjukr||||0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||28336||28336|37444| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|21457|28811|lyfsjukr||||0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||21457||21457|28811| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|51101|66014|lyfsjukr||||0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||51101||51101|66014| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|34531|45219|lyfsjukr||||0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||34531||34531|45219| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|8594|12403|lyfsjukr||||10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8594||8594|12403| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|102922|131050|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||102922||102922|131050| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|21485|28846|lyfsjukr||||25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21485||21485|28846| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|14812|20472|lyfsjukr||||0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||14812||14812|20472| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|37364|48774|lyfsjukr||||50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||37364||37364|48774| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|74729|95667|lyfsjukr||||100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||74729||74729|95667| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|||0|1|0|1|AMG|0|0|0|100|DKK|179364|226984|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||179364||179364|226984| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|149459|189454|lyfsjukr||||200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||149459||149459|189454| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.07.2012|R|||0|0|E|0|GGL|0|0|0|100|GBP|14354|20559|lyfalmen||||4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14354||14354|20559| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|134549|170741|lyfsjukr||||120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||134549||134549|170741| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|||0|0|E|0|SBM|0|0|0|100|NOK|27067|31479|lyfalmen|V0029|8326||100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||23055||23055|31479| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|||0|0|*|0|SAO|0|0|0|100|XEU|3585|5883|lyfalmen||||12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3585||3585|5883| 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|||0|0|0|1|BAX|0|0|0|100|SEK|157542|199598|lyfsjukr||||1500|0||Icepharma hf|Baxter|Sevóflúran||157542||157542|199598| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|||0|1|0|1|ROC|0|0|0|100|DKK|56419|72688|lyfsjukr||||120|0|33,3300|Icepharma hf|Roche|Saquínavír||56419||56419|72688| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|76384|97744|lyfsjukr||||90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||76384||76384|97744| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|||0|0|E|0|MSD|0|0|0|100|DKK|2920|4973|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2920||2920|4973| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007|31.07.2012|R|||0|0|0|1|WTE|0|0|0|100|DKK|79110|101166|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||79110||79110|101166| 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|||1|0|E|0|JAS|0|0|0|100|SEK|2608|4547|lyfalmen||||5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2608||2608|4547| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|19299|26765|lyfalmen||||30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19299||19299|26765| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|||0|0|0|1|BAM|0|0|0|100|SEK|1841|2657|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1841||1841|2657| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|22577|30217|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||22577||22577|30217| 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|14369|10819|lyfalmen|V0456|10819||28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||7193||7193|10819| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|63652|82428|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||63652||63652|82428| 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24201|32917|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24201||24201|32917| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7619|11401|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7619||7619|11401| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|440|1581|lyfalmen||||100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||440||440|1581| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7619|11401|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7619||7619|11401| 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12837|18656|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12837||12837|18656| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12859|18683|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12859||12859|18683| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12990|18848|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12990||12990|18848| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5493|8493|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5493||5493|8493| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|||0|1|0|0|NOE|0|0|0|100|DKK|69793|90135|lyfalmen||||100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||69793||69793|90135| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|12990|18848|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12990||12990|18848| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1564|3118|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1564||1564|3118| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5493|8493|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5493||5493|8493| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7619|11401|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7619||7619|11401| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7619|11401|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7619||7619|11401| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1564|3118|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1564||1564|3118| 024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|376|1493|lyfalmen|V0563|1493||30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||376||376|1493| 025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|||0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||| 025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|753|2009|lyfalmen|V0562|2009||100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||753||753|2009| 025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|914|2229|lyfalmen|V0564|2229||100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||914||914|2229| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|633|1845|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||633||633|1845| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19375||19375|26861| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|1929|3618|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1929||1929|3618| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19375||19375|26861| 025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|||0|0|0|0|MSD|0|0|0|100|DKK|13758|19811|lyfalmen||||12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13758||13758|19811| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|83768|107011|lyfsjukr||||30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||83768||83768|107011| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|78243|100077|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||78243||78243|100077| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|||0|0|0|0|BOI|1|0|0|100|DKK|9601|18608|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim|||9601||9601|18608| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|16619|23402|lyfalmen||||30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16619||16619|23402| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|19726|27301|lyfalmen||||98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19726||19726|27301| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|6310|9611|lyfalmen||||28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6310||6310|9611| 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2309|2928|lyfalmen|V0462|2928||90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1425||1425|2928| 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2513|3060|lyfalmen|V0471|3060||90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1521||1521|3060| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|||0|0|*|0|DAC|0|0|0|100|DKK|1888|3562|lyfalmen|V0369|2969||5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1888||1888|3562| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|5257|8170|lyfalmen|V0205|1572||1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5257||5257|8170| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|14089|20227|lyfalmen|V0205|4716||3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14089||14089|20227| 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2701|3318|lyfalmen|V0472|3318||90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1710||1710|3318| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|53385|69543|lyfalmen||||100|0||Vistor hf|ALK-Abello A/S|grasfrjó||53385||53385|69543| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|||0|0|0|1|AZD|0|0|0|100|SEK|7503|10829|lyfsjukr||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7503||7503|10829| 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24201|32917|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24201||24201|32917| 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|||0|1|0|1|CEE|0|0|0|100|XEU|57595|74164|lyfsjukr||||28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||57595|74164| 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|13354|19304|lyfalmen|V0492|19304||98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||13354||13354|19304| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|||0|0|E|0|MYL|0|0|1|100|SEK|1022|2377|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1022||1022|2377| 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|16197|19304|lyfalmen|V0491|19304||98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||13354||13354|19304| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|4707|8211|vetorma||||1|0||Vistor hf|Merial (MSD)|||4707||4707|8211| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|||0|0|E|0|MYL|0|0|1|100|SEK|531|1705|lyfalmen||||25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||531||531|1705| 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|13660|10529|lyfalmen|V0490|10510||98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||6981||6981|10529| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991|31.07.2012|R|||0|0|E|0|MYL|0|0|1|100|SEK|2698|3534|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1868||1868|3534| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||| 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|SEK|2699|5355|vetalmen||||10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2699||2699|5355| 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|||0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101||100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|9274|16178|vetorma||||2|0||Vistor hf|Merial (MSD)|||9274||9274|16178| 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|23120|19998|lyfalmen|V0475|19998||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||13907||13907|19998| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19375||19375|26861| 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|42735|55515|lyfsjukr||||2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||42735||42735|55515| 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|213698|270073|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||213698||213698|270073| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|1821|3470|lyfalmen||||14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1821|3470| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|6899|10416|lyfalmen||||56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6899|10416| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|3597|5899|lyfalmen||||14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3597|5899| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|14246|20424|lyfalmen||||56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14246|20424| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|21348|29337|lyfalmen||||56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21348|29337| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|28451|38251|lyfalmen||||56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||28451|38251| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1475|2997|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1475||1475|2997| 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1646|3231|lyfalmen|V0160|3231||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1646||1646|3231| 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1170|2518|lyfalmen|V0159|2518||20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1125||1125|2518| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|439|1579|lyfalmen||||50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||439||439|1579| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|||0|0|B|0|SGM|0|0|0|100|DKK|2705|4679|lyfalmen|V0199|3487||50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2705||2705|4679| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|||0|0|*|0|ALA|0|0|0|100|USD|2565|4488|lyfalmen||||5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2565||2565|4488| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|||0|0|*|0|MYL|0|0|0|100|SEK|7211|10843|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7211||7211|10843| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|29561|16854|lyfalmen|V0341|15300||100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||11605||11605|16854| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|33176|18314|lyfalmen|V0342|16662||100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||12565||12565|18314| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|7449|11169|lyfalmen||||56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7449||7449|11169| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|9816|14407|lyfalmen||||56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9816||9816|14407| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|||0|0|B|0|NYC|0|0|0|100|DKK|842|2131|lyfalmen|V0153|2112||100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||842||842|2131| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|||0|0|B|0|NYC|0|0|0|100|DKK|841|2129|lyfalmen|V0154|1964||100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||841||841|2129| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|||0|1|0|1|SPE|0|0|0|100|DKK|100698|128258|lyfsjukr||||105|0|5,2500|Vistor hf|SP Europe|Posacónazól||100698||100698|128258| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|20547|28332|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20547||20547|28332| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|31950|41980|lyfsjukr||||1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||31950|41980| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|23747|32348|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23747||23747|32348| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|47079|60967|lyfsjukr||||1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||47079||47079|60967| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|59305|76310|lyfsjukr||||1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||59305|76310| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|||0|0|0|0|BAP|0|0|0|100|SEK|5143|8014|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5143||5143|8014| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|24320|33067|lyfalmen|V0386|33067||196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||24320||24320|33067| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3677|4800|lyfalmen|V0364|4800||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2793||2793|4800| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009|31.07.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4040|6505|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4040|6505| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|18817|26160|lyfalmen|V0120|26160||196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||18817|26160| 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|56803|73170|lyfsjukr||||1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||56803||56803|73170| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2530|4440|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2530||2530|4440| 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|21236|29196|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21236||21236|29196| 028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|||0|0|0|0|MEX|0|0|0|100|SEK|10556|15419|lyfalmen||||1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||10556||10556|15419| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1924|3611|lyfalmen|V0202|3611||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1924||1924|3611| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2157|3930|lyfalmen|V0428|3413||50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2157||2157|3930| 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|||0|0|B|0|FRO|0|0|0|100|DKK|5269|8187|lyfalmen||||60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5269||5269|8187| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen||||56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|5812|6720|lyfalmen|V0245|5015||98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||4197||4197|6720| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|10358|11162|lyfalmen|V0232|9723||98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||7444||7444|11162| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|797|1133|lyfalmen|V0266|1133||30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||113||113|1133| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|||0|0|0|0|OCO|1|0|0|100|DKK|7968|15472|vetalmen||||10|0||Icepharma hf|Orion Corporation (I)|||7968||7968|15472| 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|4590|7258|lyfalmen||||28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4590||4590|7258| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|5187|2817|lyfalmen|V0267|2817||100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1344||1344|2817| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|18702|9980|lyfalmen|V0269|9980||100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||6580||6580|9980| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0179|1824||7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0179|7816||30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0180|875||1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0180|1749||2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757| 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|||0|0|E|0|GSK|0|0|1|100|GBP|1142|2541|lyfalmen||||16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1142|2541| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|7606|11384|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Agómelatín||7606||7606|11384| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|21695|29772|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Agómelatín||21695||21695|29772| 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|2903|4950|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2903||2903|4950| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|267|1344|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||267|1344| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|||0|0|0|0|LVR|0|0|0|100|XEU|7572|9256|lyfalmen|V0109|1942||98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6051||6051|9256| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|||0|1|0|1|EIS|0|0|0|100|SEK|66130|84876|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Eribulin||66130||66130|84876| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|22564|30200|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22564||22564|30200| 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|5834|8420|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5834||5834|8420| 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4482|6469|lyfsjukr||||5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4482||4482|6469| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5225|8126|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5225|8126| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16409|23138|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16409|23138| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5225|8126|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5225|8126| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16409|23138|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16409|23138| 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|||0|0|0|0|GAN|0|0|1|100|SEK|6647|10072|lyfalmen||||56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6647||6647|10072| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|100609|128147|lyfsjukr||||1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||100609||100609|128147| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|201217|254410|lyfsjukr||||1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||201217||201217|254410| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|4945|4014|lyfalmen|V0148|4010||90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2219||2219|4014| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|23328|31822|lyfalmen||||98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||23328||23328|31822| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|||0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa||||60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|9260|13646|lyfalmen|V0277|13646||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9260||9260|13646| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|0|0|NOH|0|1|0|100|DKK|2954|5020|lyfalmen||||100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2954||2954|5020| 030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|16151|28175|vetorma||||40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16151|28175| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|1425|2928|lyfalmen|V0051|2928||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1425||1425|2928| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|2252|4060|lyfalmen||||100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2252||2252|4060| 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|||0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen||||2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2670| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|||0|0|*|0|ELD|0|0|0|100|XEU|3158|5299|lyfalmen||||10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3158||3158|5299| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|65769|84423|lyfsjukr||||20|0||Vistor hf|Schering-Plough|Temozolomid||65769||65769|84423| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|80129|102444|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||80129||80129|102444| 031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|176660|223591|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||176660||176660|223591| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|||0|0|B|0|REP|0|0|0|100|SEK|2163|3938|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2163||2163|3938| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5959|9131|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5959||5959|9131| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|||0|0|0|1|FEL|0|0|0|100|DKK|23340|31174|lyfsjukr||||5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23340||23340|31174| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|2064|3802|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2064||2064|3802| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|9667|13952|lyfsjukr||||4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9667|13952| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|14130|19616|lyfsjukr||||10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14130|19616| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|48889|63238|lyfsjukr||||50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||48889|63238| 032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|||0|0|*|0|OTS|0|1|0|100|DKK|21185|29132|lyfalmen||||150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21185||21185|29132| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|3809|6645|vetorma||||50|0||Vistor hf|Merial (MSD)|||3809||3809|6645| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|14865|25931|vetorma||||200|0||Vistor hf|Merial (MSD)|||14865||14865|25931| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|21472|29493|lyfalmen||||1|0|29,6300|Vistor hf|Ferring|Degarelix||||21472|29493| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|42825|56291|lyfalmen||||2|0|88,8900|Vistor hf|Ferring|Degarelix||||42825|56291| 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|||0|0|0|0|NOB|1|0|0|100|XEU|1228|2142|vetorma||||7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1228|2142| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|9192|17823|vetalmen||||100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9192|17823| 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|||0|0|E|0|ALC|0|0|1|100|USD|1319|2783|lyfalmen||||5|0||K.Pétursson hf|Alcon|Dexametasón||1319||1319|2783| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|46762|24342|lyfalmen|V0185|24342||100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||17368||17368|24342| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|83005|106054|lyfsjukr||||60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||83005||83005|106054| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|108267|137758|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||108267||108267|137758| 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|2491|4955|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2491|4955| 034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|||0|0|0|0|SPM|0|0|1|100|XEU|749|2003|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||749||749|2003| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|23883|31856|lyfsjukr||||25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||23883||23883|31856| 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|||0|0|0|0|IAG|0|0|0|100|SEK|15456|21942|lyfalmen||||0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15456||15456|21942| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|8158|12139|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8158|12139| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|8158|12139|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8158|12139| 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|77109|98654|lyfsjukr||||40|0||Vistor hf|Orion Corporation|Dexmedetómid||77109||77109|98654| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|1841|3497|lyfalmen|V0367|2649||6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1841||1841|3497| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|3157|5298|lyfalmen|V0367|5298||12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3157||3157|5298| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|178644|226081|lyfsjukr||||2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||178644||178644|226081| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|||0|0|0|1|LEP|0|0|0|100|DKK|7500|10824|lyfsjukr||||25|0||Vistor hf|LEO Pharma A/S|Prótamín||7500||7500|10824| 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|2278|3288|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2278||2278|3288| 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|16076|22721|lyfalmen||||300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16076||16076|22721| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3671|6001|lyfalmen|V0079|6001||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3671|6001| 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1047|2411|lyfalmen||||100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1047||1047|2411|30.06.2012 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|||0|0|E|0|ACA|0|0|0|100|IKR|1844|2711|lyfalmen|V0244|2711||56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1266||1266|2711| 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1339|2649|lyfalmen|V0048|2649||100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1221||1221|2649| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006|31.07.2012|R|||0|1|0|1|PER|0|0|0|100|DKK|124059|157577|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Pegaptaníb||124059||124059|157577| 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|2390|4248|lyfalmen|V0049|4248||100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2390||2390|4248| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|10526|15378|lyfalmen|V0080|4793||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10526||10526|15378| 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|5223|7416|lyfalmen|V0054|7416||100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4706||4706|7416| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|||0|0|0|0|GZE|0|0|0|100|XEU|30682|37345|lyfalmen||||180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||27729||27729|37345| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|146478|185712|lyfsjukr||||2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||146478||146478|185712| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|||0|0|E|0|MAS|0|0|1|100|SEK|6120|9351|lyfalmen||||60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6120||6120|9351| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3003|5087|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3003||3003|5087| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8748|12946|lyfalmen|V0081|4793||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8748||8748|12946| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|||0|1|0|1|ABL|0|0|0|100|DKK|6103|8808|lyfsjukr||||30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6103||6103|8808| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|197962|250325|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||197962||197962|250325| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|394852|497422|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||394852||394852|497422| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|788044|990878|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||788044||788044|990878| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|837|2124|lyfalmen||||20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||837||837|2124| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|1472|2993|lyfalmen||||60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1472||1472|2993| 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|||0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa||||30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|2905|4953|lyfalmen||||125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2905||2905|4953| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|881|2184|lyfalmen||||30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||881||881|2184| 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|12704|18489|lyfalmen||||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12704||12704|18489| 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|23322|31814|lyfalmen||||84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||23322||23322|31814| 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|45610|59786|lyfalmen||||84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||45610||45610|59786| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|||0|0|E|0|ROC|0|0|0|100|DKK|2528|4437|lyfalmen|V0434|4437||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2528||2528|4437| 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|1156|2560|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1156||1156|2560| 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2259| 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3664| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8620|12771|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8620|12771| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|664|1499|lyfalmen||||20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993|31.07.2012|R|||0|0|B|0|GSK|0|1|0|100|IKR|1766|2374|lyfalmen||||60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2374| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|2667|3155|lyfalmen|V0321|2993||100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|1047|2411|lyfalmen||||50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1047||1047|2411| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2647|4600|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2647||2647|4600| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|||0|1|0|1|AEU|0|0|0|100|DKK|175619|222284|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||175619||175619|222284| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|||0|1|0|1|WTE|0|0|0|100|DKK|75906|97145|lyfsjukr||||4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||75906||75906|97145| 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|42049|54654|lyfsjukr||||10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||42049||42049|54654| 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|70292|90099|lyfsjukr||||20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||70292||70292|90099| 039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|16004|22630|lyfalmen|V0031|21078||42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||16004|22630| 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|||0|0|0|0|GLB|0|0|0|100|GBP|7409|11005|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7329||7329|11005| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|4678|7378|lyfalmen||||20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4678|7378| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|22919|31308|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22919|31308| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|3399|5629|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3399||3399|5629| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|||0|0|B|0|MYL|0|0|0|100|SEK|588|1630|lyfalmen|V0541|1578||98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||476||476|1630| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|661|1682|lyfalmen|V0542|1627||98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||514||514|1682| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|||0|0|0|0|PER|0|0|1|100|DKK|1297|2753|lyfalmen||||15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1297||1297|2753| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|1870|3537|lyfalmen||||22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1870||1870|3537| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|||0|1|0|1|BAM|0|0|0|100|SEK|489|706|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||489||489|706| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|0|0|AGP|0|0|0|100|IKR|1630|3049|lyfalmen|V0110|2500||98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|3049| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|8889|9096|lyfalmen|V0182|9096||42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5934||5934|9096| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|||0|1|0|1|BAM|0|0|0|100|SEK|668|964|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||668||668|964| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|1925|2112|lyfalmen|V0033|2112||10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||828||828|2112| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|||0|1|0|1|BAM|0|0|0|100|SEK|1360|1963|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1360||1360|1963| 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|1309|2770|lyfalmen|V0366|2770||30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1309||1309|2770| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|||0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723| 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2527| 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|||0|0|0|0|BYP|0|0|0|100|SEK|3399|5629|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3399||3399|5629| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|||0|0|0|0|IPF|1|0|0|100|DKK|28104|49026|vetorma||||240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||28104|49026| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|4401|7677|vetorma||||100|0||Vistor hf|Intervet International BV|||4401||4401|7677| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|||0|0|B|0|MYL|0|1|0|100|SEK|1216|2642|lyfalmen||||90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1216|2642| 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|4025|1852|lyfalmen|V0005|1815||28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||638||638|1852| 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|1563|3117|lyfalmen||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1563||1563|3117| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|13155|18392|lyfsjukr||||500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13155||13155|18392| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2541|3667|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2541||2541|3667| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|3072|4434|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3072||3072|4434| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4349|6277|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4349||4349|6277| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4457|6433|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4457||4457|6433| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5678|8195|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5678||5678|8195| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009|31.05.2012|R|||0|0|0|0|REB|0|0|0|100|GBP|2431|4304|lyfalmen||||500|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2431|4304| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|7008|10114|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7008||7008|10114| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3797|5480|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3797||3797|5480| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2907|4196|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2907||2907|4196| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2221|3205|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2221||2221|3205| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2781|4014|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2781||2781|4014| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3649|5266|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3649||3649|5266| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2492|3597|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2492||2492|3597| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1795|2591|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1795||1795|2591| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|6093|8794|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6093||6093|8794| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2033|2934|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2033||2033|2934| 042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|773|2036|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||773||773|2036| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|||0|0|0|1|FRP|0|0|0|100|DKK|2879|4155|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2879||2879|4155| 042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|14772|21084|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14772||14772|21084| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1343|2671|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1343||1343|2671| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2002|3982|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2002||2002|3982| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2684|5326|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2684||2684|5326| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|5370|10484|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5370||5370|10484| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|6174|12028|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6174||6174|12028| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2424|3498|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2424||2424|3498| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|543|1722|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||543||543|1722| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|3258|4702|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3258||3258|4702| 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|23881|17852|lyfalmen|V0516|17852||100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||12197||12197|17852| 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|||0|0|B|0|GSK|0|0|1|100|GBP|5126|6187|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3807||3807|6187| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|6024|8694|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6024||6024|8694| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|||0|0|0|0|PER|0|0|1|100|DKK|564|1750|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||564||564|1750| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|||0|0|E|0|ORG|0|0|0|100|DKK|1227|2657|lyfalmen||||30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1227||1227|2657| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|||0|0|E|0|LVR|0|0|1|100|CHF|13100|18986|lyfalmen|V0034|18986||25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13100||13100|18986| 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|381460|480615|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||381460|480615| 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|538308|677459|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||538308|677459| 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|23165|31617|lyfalmen||||100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||23165||23165|31617| 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|88484|113593|lyfalmen||||100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||88484||88484|113593| 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|2681|4646|lyfalmen||||10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2681||2681|4646| 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|||0|0|0|0|OCO|0|0|0|100|DKK|2088|4153|vetalmen||||3|0||Icepharma hf|Orion Corporation (I)|||2088||2088|4153| 045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|7385|11081|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7385||7385|11081| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1050|2300|lyfalmen|V0109|1942||98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2300| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|868|2095|lyfalmen|V0108|1786||98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2095| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|2943|4247|lyfsjukr||||10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2943||2943|4247| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|5887|8496|lyfsjukr||||10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5887||5887|8496| 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|||0|0|0|0|AGT|0|0|1|100|XEU|376|1493|lyfalmen||||10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||376||376|1493| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|||0|0|0|0|PFV|0|0|0|100|DKK|21171|40824|vetalmen||||10|0||Icepharma hf|Pfizer vet.|||21171||21171|40824| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1028|2385|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1028||1028|2385| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|3936|6363|lyfalmen|V0382|6363||10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3936||3936|6363| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|677|1905|lyfalmen|V0021|1905||90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||677||677|1905| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1112|2500|lyfalmen|V0022|2500||90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1112||1112|2500| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1398|2891|lyfalmen|V0023|2891||90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1398||1398|2891| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|6555|9946|lyfalmen|V0383|9946||20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6555||6555|9946| 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|5265|5839|lyfalmen|V0530|5839||84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||3553||3553|5839| 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|6605|6919|lyfalmen|V0531|6919||84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||4342||4342|6919| 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|10419|10366|lyfalmen|V0283|9507||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||6862||6862|10366| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|||0|0|0|0|POF|0|0|0|100|XEU|10824|4716|lyfalmen|V0205|4716||3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||2732||2732|4716| 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|3362|2492|lyfalmen|V0279|2415||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1106||1106|2492| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1042|2404|lyfalmen||||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1042||1042|2404| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr||||10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr||||50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|||0|1|0|1|WTE|0|0|0|100|DKK|147141|186544|lyfsjukr||||4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||147141||147141|186544| 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|26791|36168|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||26791||26791|36168| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|12605|9901|lyfalmen|V0420|8321||30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||6522||6522|9901| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|23870|21083|lyfalmen|V0421|19567||30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||14771||14771|21083| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|5415|7815|lyfsjukr||||250|0||Icepharma hf|Baxter Medical AB|Albúmín||5415||5415|7815| 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8759|12641|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8759||8759|12641| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|8547|12335|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Albúmín||8547||8547|12335| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|2700|3277|lyfalmen|V0324|3277||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1680||1680|3277| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|2508|3607|lyfalmen|V0035|3607||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1921||1921|3607| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7784|5522|lyfalmen|V0325|5522||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3321||3321|5522| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7647|5292|lyfalmen|V0326|5292||100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3153||3153|5292| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|3922|4470|lyfalmen|V0246|4470||28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2552||2552|4470| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|15292|5292|lyfalmen|V0327|5292||100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3153||3153|5292| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|||0|0|E|0|MAB|0|0|0|100|DKK|1172|2582|lyfalmen||||100|0||Vistor hf|Meda AB|Klídín og geđlyf||1172||1172|2582| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|13926|20022|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||13926||13926|20022| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|||0|0|B|0|REP|0|0|0|100|SEK|4223|6756|lyfalmen||||100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4223||4223|6756| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|||0|0|0|0|ORG|0|0|0|100|DKK|1797|3437|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1797||1797|3437| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|61750|76645|lyfalmen|V0187|43249||150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59044||59044|76645| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|||0|1|0|1|GZE|0|0|0|100|XEU|987121|1240719|lyfsjukr||||1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||987121||987121|1240719| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|||0|0|0|0|GSH|0|0|1|100|DKK|482|1638|lyfalmen|V0230|1548||100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||482||482|1638| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|||0|0|E|0|ACA|0|0|0|100|XEU|2445|4324|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2445||2445|4324| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|17369|24343|lyfalmen||||3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17369||17369|24343| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|||0|0|E|0|BOI|0|0|0|100|DKK|2401|4263|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2401||2401|4263| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|||0|0|0|0|GAN|0|0|1|100|CHF|6687|10126|lyfalmen||||5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6687||6687|10126| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1059|2095|lyfalmen|V0108|1786||98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2095| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1154|2300|lyfalmen|V0109|1942||98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2300| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|1827|3091|lyfalmen|V0110|2551||100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3091| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|||0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3837||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1195|2600|lyfalmen|V0496|2600||100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1185||1185|2600| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa||||30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|||0|0|B|0|ACA|0|0|0|100|XEU|2463|3638|lyfalmen||||100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1944||1944|3638| 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|61750|80041|lyfalmen|V0470|75525||300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||61750||61750|80041| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|||0|1|0|1|BAP|0|0|0|100|SEK|579794|729524|lyfsjukr||||112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||579794||579794|729524| 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|71899|92116|lyfsjukr||||7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||71899|92116| 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|7524|3209|lyfalmen|V0012|3079||56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1630||1630|3209| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|3316|5515|lyfalmen||||14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3316||3316|5515| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|12991|18849|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12991||12991|18849| 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|||0|0|E|0|PER|0|0|0|100|DKK|5514|5166|lyfalmen|V0042|4660||100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3061||3061|5166| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|0|0|AGT|0|0|0|100|XEU|4885|6977|lyfalmen|V0002|6977||100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4385||4385|6977| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|4694|4709|lyfalmen|V0006|4583||100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2727||2727|4709| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|11216|5317|lyfalmen||||100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3171||3171|5317| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1703|3309|lyfalmen||||100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1703||1703|3309| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|||0|0|B|0|DAC|0|0|0|100|DKK|6907|8552|lyfalmen||||60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5536||5536|8552| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1759|3385|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1759||1759|3385| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1459|2616|lyfalmen|V0363|2616||30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1197||1197|2616| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3967|5555|lyfalmen|V0365|5555||100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3345||3345|5555| 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|||0|0|0|1|UCB|0|0|0|100|DKK|30393|40026|lyfsjukr||||50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||30393||30393|40026| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|1575|1781|lyfalmen|V0056|1781||100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||586||586|1781| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|2665|2200|lyfalmen|V0057|2200||100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||893||893|2200| 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|sk|1|stauk||R03AC03|01.07.2012||R|||0|0|B|0|AZD|0|0|1|100|SEK|1007|2356|lyfalmen||||100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1007||1007|2356| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|219|1278|lyfalmen|V0047|1278||20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||219||219|1278| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|515|1683|lyfalmen|V0305|1003||50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||515||515|1683| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|343935|433521|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||343935||343935|433521| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|365|1478|lyfalmen|V0439|1478||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||365|1478| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|1172|2582|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1172||1172|2582| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|751|2006|lyfalmen|V0305|2006||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||751||751|2006| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|718481|903576|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||718481||718481|903576| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|636801|801068|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||636801||636801|801068| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|||0|0|*|0|ALL|0|0|0|100|SEK|3861|6261|lyfalmen||||3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3861||3861|6261| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|37197|48565|lyfsjukr||||8212|0||Icepharma hf|Fresenius Kabi|Blöndur||37197||37197|48565| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|30239|39832|lyfsjukr||||7698|0||Icepharma hf|Fresenius Kabi|Blöndur||30239||30239|39832| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|31922|41945|lyfsjukr||||7680|0||Icepharma hf|Fresenius Kabi|Blöndur||31922||31922|41945| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|26708|35401|lyfsjukr||||7200|0||Icepharma hf|Fresenius Kabi|Blöndur||26708||26708|35401| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|35918|46960|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||35918||35918|46960| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|33352|43739|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||33352||33352|43739| 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|||0|0|*|0|NAS|0|0|0|100|DKK|15526|22030|lyfalmen||||6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15526||15526|22030| 052979|J01CF0103|Dicloxacillin Arrow|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.06.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|1928|3566|lyfalmen||||30|1|3,7500|Distica|Distica - óskráđ lyf|Díkloxacillín||1891||1891|3566| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|0|100|SEK|2438|4136|lyfalmen|V0313|4136||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2308||2308|4136| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|||0|0|0|0|BAP|0|0|0|100|SEK|2292|4114|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2292||2292|4114| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|||0|1|0|1|ABT|0|0|0|100|DKK|62541|80371|lyfsjukr||||120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||62541||62541|80371| 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|||0|0|B|0|SNO|0|0|0|100|NOK|5656|8716|lyfalmen||||100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5656||5656|8716| 053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|6418|9758|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6418||6418|9758| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|39912|52635|lyfalmen|V0453|43528||100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||39912||39912|52635| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|33502|44590|lyfalmen|V0454|39243||100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||33502||33502|44590| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|1|100|SEK|649|1761|lyfalmen|V0060|1054||20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||572||572|1761| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|||1|0|0|0|MAP|0|0|0|100|GBP|16398|23125|lyfalmen||||10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16398||16398|23125| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|||0|0|0|0|OTS|0|1|0|100|DKK|1556|3107|lyfalmen||||1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1556||1556|3107| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|1160|2566|lyfalmen||||30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1160||1160|2566| 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|7839|10724|lyfalmen|V0490|10724||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7124||7124|10724| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|||0|0|0|0|MEX|0|0|0|100|XEU|2618|4560|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2618||2618|4560| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|2742|4730|lyfalmen||||15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2742||2742|4730| 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|3781|6151|lyfalmen||||20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3781||3781|6151| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|||0|1|0|1|ROA|0|0|0|100|DKK|64927|83366|lyfsjukr||||56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||64927||64927|83366| 054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012||R|||0|0|0|1|OCT|0|0|0|100|DKK|9898|14285|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Albúmín||9898||9898|14285| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|||0|0|0|0|UCN|0|0|1|100|SEK|1120|2511|lyfalmen||||200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1120||1120|2511| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|||0|0|0|0|ACA|0|1|0|100|XEU|1706|3313|lyfalmen|V0061|3313||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1706||1706|3313| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|||1|0|0|0|REB|0|0|0|100|DKK|4824|9435|vetalmen||||10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4824|9435| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|||0|0|0|0|PAL|1|0|0|100|DKK|7812|13628|vetorma||||20|0||Icepharma hf|Pfizer Oy Animal Health|||7812||7812|13628| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|||0|0|0|0|ALA|0|0|1|100|USD|1825|3475|lyfalmen||||5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1825|3475| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|799|2072|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||799||799|2072| 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|9359|13782|lyfalmen||||100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9359||9359|13782| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|2185|3096|lyfalmen|V0467|2978||56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1548||1548|3096| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2527| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3246| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|6047| 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|18757|26085|lyfalmen|V0459|25055||100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18757||18757|26085| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|||0|0|0|0|CES|1|0|0|100|XEU|27346|47704|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27346||27346|47704| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|1301|2759|lyfalmen||||40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1301||1301|2759| 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3770|6136|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3770|6136| 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3770|6136|lyfalmen||||100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3770|6136| 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|||0|1|0|1|EPI|0|0|0|100|XEU|235864|297892|lyfsjukr||||15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||235864||235864|297892| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|58928|75837|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||58928||58928|75837| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|11678|16954|lyfalmen|V0095|4793||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||11678||11678|16954| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|11932|16857|lyfsjukr||||5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||11932||11932|16857| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|6861|9902|lyfsjukr||||5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6861||6861|9902| 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|||0|0|0|1|BAA|0|0|0|100|SEK|249356|314824|lyfsjukr||||300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||249356||249356|314824| 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|23868|27851|lyfalmen|V0350|27851||84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20164||20164|27851| 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|||0|0|0|1|FRP|0|0|0|100|DKK|4964|7164|lyfsjukr||||200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4964||4964|7164| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|3783|5460|lyfsjukr||||5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3783||3783|5460| 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|373976|471222|lyfsjukr||||50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||373976||373976|471222| 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|||0|1|0|1|JAS|0|0|0|100|SEK|559072|703518|lyfsjukr||||120|0||Vistor hf|Janssen-Cilag AB|Abírateron||559072||559072|703518| 057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|25150|33446|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25150||25150|33446| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|20473|28239|lyfalmen||||112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20473|28239| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|||0|0|E|0|BOI|0|0|0|100|DKK|433|1571|lyfalmen||||5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||433||433|1571| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|135292|171674|lyfsjukr||||30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||135292||135292|171674| 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|164294|286603|vetorma||||5000|0||Icepharma hf|Lohmann Animal Health|||||164294|286603| 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|249578|435376|vetorma||||10000|0||Icepharma hf|Lohmann Animal Health|||||249578|435376| 058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|||0|0|0|0|SPM|0|0|0|100|XEU|17642|24686|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17642||17642|24686| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1052|2418|lyfalmen||||100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1052||1052|2418| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|101810|129654|lyfsjukr||||210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||101810||101810|129654| 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|42709|56145|lyfalmen||||1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||42709||42709|56145| 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1277|2726|lyfalmen||||100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1277||1277|2726| 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|2382|4237|lyfalmen||||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2382||2382|4237| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|4540|7189|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4540||4540|7189| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|||0|0|E|0|AGT|0|0|0|100|XEU|2513|3096|lyfalmen|V0006|2566||56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1548||1548|3096| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|1549|3098|lyfalmen||||250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1549||1549|3098| 059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|||0|0|E|0|LAL|0|0|1|100|IKR|2297|4121|lyfalmen||||5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2297||2297|4121| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|||0|1|*|0|ASP|0|0|0|100|XEU|100548|128733|lyfalmen||||2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||100548||100548|128733| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|34662|46046|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||34662||34662|46046| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|91943|117271|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||91943||91943|117271| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|||0|0|E|0|BPC|0|0|0|100|SEK|41710|48064|lyfalmen||||30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||36270||36270|48064| 059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|||0|1|*|0|APE|0|0|0|100|XEU|55761|72525|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||55761||55761|72525| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|382395|482451|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||382395||382395|482451| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|191213|242517|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||191213||191213|242517| 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|||0|0|B|0|NOH|0|1|0|100|DKK|5721|8805|lyfalmen||||100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5721||5721|8805| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|2788|5526|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||2788|5526| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|1461|2906|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||1461|2906| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|||0|0|0|0|PFA|1|0|0|100|DKK|8630|16743|vetalmen||||20|0||Icepharma hf|Pfizer Animal Health|||||8630|16743| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|||0|0|E|0|DAC|0|0|0|100|DKK|7088|10675|lyfalmen|V0133|10675||84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7088||7088|10675| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|7089|10676|lyfalmen|V0133|10675||84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7089||7089|10676| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|||0|0|0|0|PAL|0|0|0|100|DKK|1727|3013|vetorma||||26|0||Icepharma hf|Pfizer Oy Animal Health|||||1727|3013| 061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|||0|1|0|1|IPI|0|0|0|100|DKK|162253|205510|lyfsjukr||||1|0||Icepharma hf|Pfizer Limited|Temsirolímus||162253||162253|205510| 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|4504|6500|lyfsjukr||||10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4504||4504|6500| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|16085|22069|lyfsjukr||||1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16085||16085|22069| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|22645|30302|lyfsjukr||||1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22645||22645|30302| 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|466|1616|lyfalmen|V0307|1473||30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||466||466|1616| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|||0|1|*|0|AGP|0|0|0|100|XEU|60395|43249|lyfalmen|V0187|43249||150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||32433||32433|43249| 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|1673|3267|lyfalmen||||10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1673||1673|3267| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|6751|9743|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Metótrexat||6751||6751|9743| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|460|664|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||460||460|664| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|940|2265|lyfalmen|V0308|1979||60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||940||940|2265| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|||0|0|E|0|AGT|0|0|1|100|XEU|1872|3540|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1872||1872|3540| 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|18265|31862|vetorma||||1000|0||Icepharma hf|Bayer Animal Health GmbH|||18265||18265|31862| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|41196|53583|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41196||41196|53583| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50297|65005|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50297||50297|65005| 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|||0|0|0|0|GLB|0|0|0|100|GBP|17183|16958|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11681||11681|16958| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|4270|6820|lyfalmen||||10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4270||4270|6820| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2976| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|||0|0|0|0|ACA|0|0|0|100|XEU|2568|4489|lyfalmen|V0123|3837||28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2566||2566|4489| 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|||0|0|E|0|DAC|0|0|1|100|XEU|4581|6304|lyfalmen|V0458|6304||100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3893||3893|6304| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|7893|11392|lyfsjukr||||2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7893||7893|11392| 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|||0|0|0|0|PAS|0|0|0|100|XEU|2567|4478|vetorma||||12|0||Vistor hf|Pfizer Oy Animal Health|||2567||2567|4478| 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|987|2329|lyfalmen|V0309|2045||30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||987||987|2329| 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|2067|3806|lyfalmen|V0310|3226||60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2067||2067|3806| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|1098626|1380658|lyfsjukr||||20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1098626|1380658| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|439450|553392|lyfsjukr||||20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||439450|553392| 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|2171|3949|lyfalmen|V0311|3291||30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2171||2171|3949| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|4394507|5516989|lyfsjukr||||20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4394507|5516989| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|2197254|2759436|lyfsjukr||||20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2197254|2759436| 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|||0|0|E|0|BOI|0|0|0|100|DKK|2131|3894|lyfalmen||||100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2131||2131|3894| 064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|||0|0|0|0|SPM|0|0|0|100|XEU|834|2120|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||834||834|2120| 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|||0|0|0|1|OCT|0|0|0|100|DKK|59374|76397|lyfsjukr||||1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||59374||59374|76397| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|||0|0|0|0|SLL|0|0|0|100|DKK|1980|3687|lyfalmen||||25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1980||1980|3687| 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|15690|21573|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15690||15690|21573| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|||0|0|*|0|PER|0|0|0|100|DKK|2539|3764|lyfalmen|V0376|2164||2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2036||2036|3764| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|||0|1|*|0|LVR|0|0|0|100|SEK|62260|78072|lyfalmen|V0451|78072||1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||60181||60181|78072| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|||0|0|*|0|PER|0|0|0|100|DKK|7611|10933|lyfalmen|V0376|6493||8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7277||7277|10933| 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|4866|7023|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4866||4866|7023| 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|||0|0|0|0|DOR|1|0|0|100|DKK|4143|8128|vetalmen||||100|0||Icepharma hf|Dopharma Reserch B.V|||4143||4143|8128| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|6777|10249|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6777||6777|10249| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|||0|0|0|1|FRP|0|0|0|100|DKK|33386|43782|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33386||33386|43782| 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|||0|0|0|0|GOG|0|0|1|100|DKK|859|2154|lyfalmen||||51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||859||859|2154| 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr||||120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|||0|0|B|0|DAC|0|0|0|100|NOK|1552|3102|lyfalmen|V0036|3102||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1552||1552|3102| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|||0|1|0|1|AGP|0|0|0|100|XEU|15484|21315|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15484||15484|21315| 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8760|12643|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8760||8760|12643| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|||0|0|0|0|UCN|0|0|0|100|SEK|1493|3021|lyfalmen||||100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1493||1493|3021| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|||0|0|*|0|APC|0|0|0|100|DKK|1881|2577|lyfalmen|V0376|2164||2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1168||1168|2577| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|1567|2842|lyfalmen|V0179|1824||7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2842| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|5748|7816|lyfalmen|V0179|7816||30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7816| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0180|875||1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0180|1749||2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3757| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|14199|13974|lyfalmen|V0419|13506||30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9500||9500|13974| 068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|||1|0|0|0|VEQ|1|0|0|100|XEU|6178|12035|vetalmen||||50|0||Icepharma hf|Vétoquinol AG|||6178||6178|12035| 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|112193|142685|lyfsjukr||||15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||112193||112193|142685| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|||0|1|0|1|GTS|0|0|0|100|GBP|82530|105458|lyfsjukr||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||82530||82530|105458| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|1828|3480|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1828||1828|3480| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|6053|9259|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6053||6053|9259| 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|26810|16329|lyfalmen|V0342|16329||98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||11221||11221|16329| 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|2545|3673|lyfsjukr||||400|0||Actavis Group hf|Braun|Natríumklóríđ||2545||2545|3673| 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|3167|4571|lyfsjukr||||400|0||Actavis Group hf|Braun|Kalíumklóríđ||3167||3167|4571| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|14351|20556|lyfalmen||||30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14351||14351|20556| 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|||0|0|E|0|FEL|0|0|0|100|DKK|45298|59394|lyfalmen||||100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||45298||45298|59394| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|435|1388|lyfalmen|V0448|1388||100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||299||299|1388| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|18847|26198|lyfalmen||||1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18847|26198| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|27259|36755|lyfalmen||||1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||27259|36755| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|35303|46850|lyfalmen||||1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||35303|46850| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|NOK|47538|61543|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||47538||47538|61543| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|||0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen||||100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|||0|0|*|0|JAS|0|1|0|100|SEK|12810|18622|lyfalmen||||100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12810||12810|18622| 071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|||0|0|0|0|PAB|0|0|0|100|SEK|6437|12533|vetalmen||||1250|0||Vistor hf|Pharmaxim AB|||6437||6437|12533| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|||0|0|*|0|ACA|0|1|0|100|XEU|706|1945|lyfalmen||||100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||706||706|1945| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|67968|87182|lyfsjukr||||1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||67968||67968|87182| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|339843|428385|lyfsjukr||||5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||339843||339843|428385| 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|8835|13065|lyfalmen||||30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8835|13065| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|11002|9497|lyfalmen|V0144|9002||12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||6227||6227|9497| 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|||0|1|0|1|GZE|0|0|0|100|SEK|91563|116794|lyfsjukr||||20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||91563|116794| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|||0|0|E|0|PSA|0|0|0|100|XEU|3190|2061|lyfalmen|V0009|2061||30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||791||791|2061| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|||0|0|0|0|ORF|1|0|0|100|DKK|7119|13842|vetalmen||||5|0||Vistor hf|Orion-Farmos|||7119||7119|13842| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|||0|0|E|0|PSA|0|0|0|100|XEU|10032|8326|lyfalmen|V0029|8326||100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5371||5371|8326| 072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19375||19375|26861| 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|||1|0|0|1|JAS|0|0|0|100|SEK|666|961|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||666||666|961| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|||0|1|0|1|ABB|0|0|0|100|DKK|150244|190439|lyfsjukr||||2|0|27,5900|Vistor hf|Abbott|Adalimumab||150244||150244|190439| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|16717|23525|lyfalmen||||1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16717||16717|23525| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|16717|23525|lyfalmen||||2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16717||16717|23525| 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|76374|97732|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||76374||76374|97732| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1068|2440|lyfalmen||||100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1068||1068|2440| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|||0|0|E|0|GSK|0|0|0|100|GBP|3963|6400|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3963||3963|6400| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1664|3255|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1664||1664|3255| 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|51775|27100|lyfalmen|V0185|24342||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||19566||19566|27100| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|724|1584|lyfalmen|V0066|1584||100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||442||442|1584| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|309|1402|lyfalmen|V0047|1278||20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||309||309|1402| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|761|2020|lyfalmen|V0305|1003||50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||761||761|2020| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|971|2307|lyfalmen|V0305|2006||100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||971||971|2307| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|523|1694|lyfalmen|V0439|1478||20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||523||523|1694| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|1420|2921|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1420||1420|2921| 073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|3766|6570|vetorma||||1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3766||3766|6570| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|||0|0|*|0|APT|0|0|0|100|GBP|1409|2906|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1409||1409|2906| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|||0|0|0|0|DAC|0|0|0|100|DKK|4705|7415|lyfalmen|V0142|7415||4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4705||4705|7415| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|||0|0|0|0|NOE|0|0|0|100|DKK|3638|5956|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3638||3638|5956| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007|30.06.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4839|7598|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4839||4839|7598| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|GBP|424|1553|lyfalmen|V0391|1553||28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||420||420|1553| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|17963|24426|lyfsjukr||||50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||17963||17963|24426| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|486|1644|lyfalmen||||25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||486||486|1644| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|||0|0|0|0|AGT|0|0|1|100|DKK|694|1928|lyfalmen||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||694||694|1928| 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|||0|0|0|0|AGT|0|0|0|100|DKK|1092|2473|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1092||1092|2473| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|||0|0|0|0|SCA|1|0|0|100|DKK|20978|36595|vetorma||||25|0||Vistor hf|Scan Vet Animal Health AS|||20978||20978|36595| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|434|1573|lyfalmen|V0510|1539||98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||434||434|1573| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|793|2020|lyfalmen|V0512|2001||98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||761||761|2020| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|GBP|1004|2352|lyfalmen||||60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1004||1004|2352| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|||0|0|B|0|APT|0|0|0|100|GBP|536|1712|lyfalmen||||100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||536||536|1712| 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|||0|0|*|0|APT|0|0|0|100|GBP|2683|4603|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2649||2649|4603| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|4954|7756|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4954||4954|7756| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|14860|21194|lyfalmen||||90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14860||14860|21194| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|||0|0|0|0|JAS|0|0|1|100|SEK|1813|3459|lyfalmen||||10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1813||1813|3459| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|4954|7756|lyfalmen||||30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4954||4954|7756| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|2006|2809|lyfalmen|V0363|2616||30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1338||1338|2809| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|14860|21194|lyfalmen||||90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14860||14860|21194| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|XEU|1891|3566|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1891||1891|3566| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|NOK|3148|5285|lyfalmen||||300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3148||3148|5285| 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|||0|0|0|0|NBV|0|0|0|100|XEU|2635|4583|lyfalmen||||4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2635|4583| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|||0|0|E|0|LVR|0|0|1|100|DKK|13455|19431|lyfalmen|V0196|19431||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13455||13455|19431| 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|DKK|18088|25246|lyfalmen||||84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||18088|25246| 075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|20171|27860|lyfalmen|V0441|27860||90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||20171||20171|27860| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|16423|23156|lyfalmen|V0440|23156||90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||16423||16423|23156| 075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|4150|5508|lyfalmen|V0445|5508||98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3311||3311|5508| 075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|31786|41774|lyfsjukr||||1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31786||31786|41774| 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|119303|151608|lyfsjukr||||4|0||Vistor hf|Aventis Pharma SA|Docetaxel||119303||119303|151608| 075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|99138|126301|lyfsjukr||||1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||99138||99138|126301| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|||0|0|0|0|DEC|0|0|0|100|DKK|969|1928|vetalmen||||20|0||Vistor hf|Dechra Veterinary Products A/S|||969||969|1928| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6130|8847|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6130||6130|8847| 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6130|8847|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6130||6130|8847| 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6130|8847|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6130||6130|8847| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|||0|0|0|0|AUK|0|0|0|100|GBP|465|1615|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||465||465|1615| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|||0|0|0|0|AEA|0|0|1|100|XEU|455|1601|lyfalmen||||20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||455||455|1601| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|903|1865|lyfalmen|V0449|1865||100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||648||648|1865| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|6639|10061|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6639||6639|10061| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|||0|0|*|0|MSD|0|0|0|100|DKK|22610|30921|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||22610||22610|30921| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|0|0|POF|0|1|0|100|IKR|445|1588|lyfalmen|V0045|1588||20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1986|3099|lyfalmen|V0290|3099||60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|893|2200|lyfalmen||||100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||893||893|2200| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1249|2687|lyfalmen||||100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1249|2687| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1780|3414|lyfalmen||||100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1780|3414| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|7211|12579|vetorma||||100|0||Vistor hf|Merial (MSD)|||7211||7211|12579| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|||0|0|0|0|GLB|0|0|0|100|GBP|7409|11005|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7329||7329|11005| 076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|233|1298|lyfalmen||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||233||233|1298| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|685|1916|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||685||685|1916| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|10031|8326|lyfalmen|V0029|8326||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5371||5371|8326| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|||0|0|E|0|GSK|0|0|0|100|GBP|830|2114|lyfalmen||||10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||830||830|2114| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12606||28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|543|1722|lyfalmen||||20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||543||543|1722| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|826|2109|lyfalmen||||40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||826||826|2109| 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1409|2906|lyfalmen|V0560|2906||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1409||1409|2906| 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|2014|3734|lyfalmen|V0561|3734||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2014||2014|3734| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|||0|1|0|1|SAG|0|0|0|100|SEK|126164|160218|lyfsjukr||||15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||126164||126164|160218| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|||0|0|0|0|MSD|0|0|0|100|DKK|9002|6144|lyfalmen|V0069|2440||98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3776||3776|6144| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|2833|4089|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2833||2833|4089| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|4799|6926|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4799||4799|6926| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|8926|12882|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||8926||8926|12882| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|||0|0|0|0|RRL|0|0|0|100|DKK|3689|6025|lyfalmen||||10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3689||3689|6025| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|||0|0|*|0|SPL|0|1|0|100|DKK|18636|25933|lyfalmen||||10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||18636||18636|25933| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|||0|0|B|0|ACA|0|1|0|100|XEU|3524|5800|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3524||3524|5800| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|||0|0|0|1|BRS|0|0|0|100|DKK|2092|3019|lyfsjukr||||5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2092||2092|3019| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|||0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|||0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577| 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|||0|0|0|0|ANI|1|0|0|100|XEU|4044|7938|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4044|7938| 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|LYF|0|0|0|100|XEU|17764|19567|lyfalmen|V0421|19567||30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||13563||13563|19567| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|||0|0|0|0|BAN|1|0|0|100|DKK|10310|17985|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||10310||10310|17985| 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|16715|9980|lyfalmen|V0170|9980||30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6580||6580|9980| 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|36936|25199|lyfalmen|V0185|24342||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||18051||18051|25199| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|||0|0|B|0|LBK|0|1|0|100|DKK|2270|4084|lyfalmen||||100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2270||2270|4084| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|6230|9501|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6230||6230|9501| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2674|3585|lyfalmen|V0143|2470||4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1905||1905|3585| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|0|100|GBP|3235|5404|lyfalmen||||30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3235||3235|5404| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|34414|60034|vetorma||||500|0||Vistor hf|Merial (MSD)|||34414||34414|60034| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|7559|7410|lyfalmen|V0143|7410||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4701||4701|7410| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2952|3681|lyfalmen|V0144|3001||4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1975||1975|3681| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|15105|20839|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||15105||15105|20839| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|11003|9497|lyfalmen|V0144|9002||12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6227||6227|9497| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|29779|39255|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||29779||29779|39255| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.07.2012||R|||0|0|E|0|ASA|0|0|0|100|SEK|38230|50524|lyfalmen|V0209|50524||12|0|34,7222|Vistor hf|Astra Zeneca A/S|Natríumhýalúrónat||38230||38230|50524| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||10|0||Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||20|0||Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||50|0||Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||5|0||Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||600|0||Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||1|0||Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|8101|5917|lyfalmen|V0515|5917||100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3610||3610|5917| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|4654|7345|lyfalmen||||21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4654||4654|7345| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|1843|2660|lyfsjukr||||10|0|3,3333|Icepharma hf|Roche|Mídazólam||1843||1843|2660| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|||0|0|*|0|DAC|0|1|0|100|XEU|19727|15623|lyfalmen|V0456|10819||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10705||10705|15623| 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|||0|0|*|0|SAA|0|0|0|100|NOK|5977|9155|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5977||5977|9155| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|||0|0|*|0|SDE|0|0|0|100|NOK|8978|13260|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8978||8978|13260| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|38250|18314|lyfalmen|V0184|16329||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||12565||12565|18314| 082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|||0|0|B|0|SPL|0|0|1|100|DKK|2264|4076|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2264||2264|4076| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||36|0||Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|3334|5040|lyfalmen||||60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2969||2969|5040| 082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|5908|9061|lyfalmen||||60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5908||5908|9061| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|948|2276|lyfalmen||||125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||948||948|2276| 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|||0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||| 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|4823|7577|lyfalmen||||20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4823||4823|7577| 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|5702|8779|lyfalmen||||20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5702||5702|8779| 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|9048|4891|lyfalmen|V0080|4891||100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2860||2860|4891| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|13230|19149|lyfalmen||||56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13230||13230|19149| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|19305|26773|lyfalmen|V0186|7410||28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19305||19305|26773| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|13818|19887|lyfalmen|V0344|13867||56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13818||13818|19887| 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|7535|11286|lyfalmen||||20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7535||7535|11286| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|77217|98790|lyfsjukr||||450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||77217||77217|98790| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|29984|40175|lyfalmen|V0346|29781||112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||29984||29984|40175| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|||0|1|0|1|SNO|0|0|0|100|NOK|8554|12346|lyfsjukr||||11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8554||8554|12346| 084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2125|2440|lyfalmen|V0069|2440||98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||1068||1068|2440| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|270|1348|lyfalmen||||10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||270||270|1348| 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|2042|3291|lyfalmen|V0311|3291||30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1690||1690|3291| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|521|1692|lyfalmen||||20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||521||521|1692| 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|73581|94227|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||73581||73581|94227| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|61552|79130|lyfsjukr||||0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||61552||61552|79130| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|80242|102586|lyfsjukr||||0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||80242||80242|102586| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|99271|126468|lyfsjukr||||0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||99271||99271|126468| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|20518|27633|lyfsjukr||||0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20518||20518|27633| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|32046|42100|lyfsjukr||||0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32046||32046|42100| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|41035|53381|lyfsjukr||||0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||41035||41035|53381| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|12708|17831|lyfsjukr||||0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12708|17831| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|48443|62678|lyfsjukr||||0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||48443|62678| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|149200|189129|lyfsjukr||||1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||149200|189129| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|962|2295|lyfalmen||||10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||962||962|2295| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|11417|16597|lyfalmen||||60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11417||11417|16597| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|37156|49176|lyfalmen||||100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||37156||37156|49176| 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|||1|0|E|0|PER|0|0|0|100|DKK|15555|22067|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15555||15555|22067| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|||0|1|*|0|GAN|0|0|0|100|NOK|44367|58226|lyfalmen||||2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||44367||44367|58226| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|||0|0|0|0|SAO|0|0|1|100|XEU|2632|4579|lyfalmen||||15|0||Icepharma hf|Santen Oy|Levófloxacín||2632||2632|4579| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|29984|40175|lyfalmen|V0345|29781||112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||29984||29984|40175| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|GBP|821|2102|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102| 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|20405|28153|lyfalmen|V0412|23471||375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20405||20405|28153| 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|35376|46942|lyfalmen|V0412|46942||750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||35376||35376|46942| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|||0|1|0|1|ELD|0|0|0|100|XEU|94423|120383|lyfsjukr||||56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||94423||94423|120383| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|||0|0|0|0|AEU|0|0|0|100|DKK|40057|52817|lyfalmen||||1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40057||40057|52817| 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|3011|5098|lyfalmen|V0465|4384||3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3011||3011|5098| 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|8899|13152|lyfalmen|V0465|13152||9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8899||8899|13152| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|4168|5250|lyfalmen|V0364|4800||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3122||3122|5250| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|5644|6092|lyfalmen|V0365|5555||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3738||3738|6092| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|8640|12470|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8640||8640|12470| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|15020|20733|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15020||15020|20733| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|30322|40599|lyfalmen||||600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||30322||30322|40599| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|60643|78652|lyfalmen||||1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||60643||60643|78652| 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|||0|1|0|1|BSP|0|0|0|100|DKK|53807|69410|lyfsjukr||||1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||53807||53807|69410| 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|||0|0|0|0|BOY|0|0|0|100|SEK|18615|25907|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18615||18615|25907| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|||0|0|0|1|ROA|0|0|0|100|DKK|50462|65212|lyfsjukr||||100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||50462||50462|65212| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|2993|5073|lyfalmen||||28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||2993||2993|5073| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|||0|0|0|0|SNO|0|0|0|100|NOK|440|1581|lyfalmen|V0060|1581||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||440||440|1581| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|161551|204629|lyfsjukr||||60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||161551||161551|204629| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|298|1387|lyfalmen|V0312|446||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||298||298|1387| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|262|1337|lyfalmen|V0312|1337||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||262||262|1337| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|2209|4001|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2209||2209|4001| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|||0|0|E|0|MEC|0|0|0|100|SEK|896|2205|lyfalmen||||5|0|27,7778|Icepharma hf|Merck AB|Klómífen||896||896|2205| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|3507|1990|lyfalmen|V0009|1924||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||739||739|1990| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|||0|0|*|0|AGP|0|0|0|100|XEU|10752|9901|lyfalmen|V0420|8321||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||6522||6522|9901| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|||0|0|0|0|CHP|0|0|0|100|XEU|31524|54992|vetorma||||104|0||Icepharma hf|Chanelle Pharmaceuticals|||31524||31524|54992| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||| 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|DKK|4462|8740|vetalmen||||76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4462||4462|8740| 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|||0|0|0|0|CES|1|0|0|100|SEK|28631|49945|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28631||28631|49945| 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|||0|0|E|0|GGL|0|0|1|100|GBP|1404|2900|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1404||1404|2900| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|1561|3114|lyfalmen||||20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1561||1561|3114| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|6024|9219|lyfalmen||||100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6024||6024|9219| 088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|404|1532|lyfalmen||||6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||404||404|1532| 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|5084|7934|lyfalmen||||30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5084||5084|7934| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|||0|0|B|0|LEP|0|0|0|100|DKK|9823|14416|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9823||9823|14416| 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|15070|21458|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15070||15070|21458| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008|31.07.2012|R|||0|1|0|1|GGL|0|0|0|100|GBP|178960|226477|lyfsjukr||||70|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||||178960|226477| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|||0|0|*|0|AGP|0|0|0|100|XEU|22812|21083|lyfalmen|V0421|19567||30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||14771||14771|21083| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|6394|6493|lyfalmen|V0376|6493||8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4031||4031|6493| 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|||0|0|0|0|PER|0|0|0|100|DKK|1756|3381|lyfalmen||||63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1756||1756|3381| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|161551|204629|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||161551||161551|204629| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|||0|0|E|0|MYD|0|0|0|100|SEK|4094|6579|lyfalmen||||100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4094||4094|6579| 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||| 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||R|||0|0|E|0|LYF|0|0|1|100|XEU|1618|2273|lyfalmen|V0362|2273||100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín||946||946|2273| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|||0|0|B|0|FRO|0|0|0|100|DKK|2331|4168|lyfalmen||||100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2331||2331|4168| 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|1594|3159|lyfalmen||||20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1594||1594|3159| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|3166|5310|lyfalmen||||40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3166||3166|5310| 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|||0|0|0|0|PAD|0|0|1|100|DKK|951|2280|lyfalmen||||100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||951||951|2280| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|||0|0|0|1|NOM|0|0|0|100|DKK|5827|8410|lyfsjukr||||10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5827||5827|8410| 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|||0|0|E|0|SNO|0|0|1|100|NOK|1818|3466|lyfalmen||||16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1818||1818|3466| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.1990|31.05.2012|R|||0|0|0|0|REB|0|0|0|100|GBP|933|2255|lyfalmen||||60|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||933||933|2255| 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|||0|1|0|1|ACK|0|0|0|100|USD|17179|23442|lyfsjukr||||60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||17179|23442| 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|2859|4126|lyfsjukr||||2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2859||2859|4126| 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|4942|7133|lyfsjukr||||5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4942||4942|7133| 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|14501|20081|lyfsjukr||||18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14501||14501|20081| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|||1|0|0|0|NOH|0|0|0|100|DKK|3367|5585|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3367||3367|5585| 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|1796|2592|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1796|2592| 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|7346|10602|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7346|10602| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|||0|0|E|0|CHA|0|0|1|100|DKK|3972|6412|lyfalmen||||30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3972||3972|6412| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|1288|2619|lyfalmen|V0021|1905||90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1199||1199|2619| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|2226|3577|lyfalmen|V0022|2500||90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1899||1899|3577| 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|624|1833|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||624||624|1833| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|||0|0|0|0|LBK|0|0|0|100|DKK|3870|6273|lyfalmen||||15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3870|6273| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|1|0|0|100|DKK|9171|17782|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||9171||9171|17782| 092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|446|1589|lyfalmen||||8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||446||446|1589| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|||0|0|E|0|SBM|0|0|0|100|NOK|8095|10992|lyfalmen|V0009|1924||28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7320||7320|10992| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|||0|0|E|0|NAS|0|0|0|100|DKK|2272|4087|lyfalmen||||18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2272||2272|4087| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|||0|0|*|0|DAC|0|1|0|100|DKK|9260|13646|lyfalmen|V0277|13646||100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9260||9260|13646| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|||0|0|0|0|NOH|0|0|0|100|DKK|23972|32630|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||23972||23972|32630| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|452|1597|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||452||452|1597| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|588|1783|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||588||588|1783| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3347|3679|lyfalmen|V0203|3679||12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||1974||1974|3679| 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|1147|2548|lyfalmen||||28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1147|2548| 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|2632|4579|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2632|4579| 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|5115|7976|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5115|7976| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|||0|0|E|0|GSK|0|0|0|100|GBP|7155|10767|lyfalmen||||1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7155||7155|10767| 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|||0|0|B|0|NOH|0|0|0|100|DKK|1467|2986|lyfalmen||||160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1467||1467|2986| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|||0|0|0|0|PAL|1|0|0|100|DKK|26432|46109|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||26432||26432|46109| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|62260|79462|lyfalmen|V0451|78072||1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||61288||61288|79462| 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|||0|0|B|0|DAC|0|0|0|100|XEU|1185|2600|lyfalmen|V0496|2600||100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1185||1185|2600| 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|16120|22776|lyfalmen||||28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16120||16120|22776| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|23078|31508|lyfalmen|V0183|31508||1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||23078||23078|31508| 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|45490|59635|lyfalmen||||98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||45490||45490|59635| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|560754|705629|lyfsjukr||||0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||560754||560754|705629| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|603903|759781|lyfsjukr||||1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||603903||603903|759781| 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|5210|8106|lyfalmen|V0236|7694||6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5210||5210|8106| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|7721|11541|lyfalmen|V0236|11541||9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7721||7721|11541| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|||0|0|0|0|BOI|0|0|0|100|DKK|1781|3543|vetalmen||||15|0||Vistor hf|Boehringer Ingelheim|||1781||1781|3543| 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|12976|18830|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12976||12976|18830| 094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|18587|25872|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18587||18587|25872| 094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|83635|107507|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||83635||83635|107507| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|||0|1|0|1|VII|0|0|0|100|GBP|84228|107589|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||84228||84228|107589| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|||0|0|0|0|APE|0|0|1|100|XEU|47261|61858|lyfalmen||||1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47261|61858| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|6448|11248|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6448||6448|11248| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|||0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen||||100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|5038|5252|lyfalmen|V0143|4940||8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3124||3124|5252| 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|||0|0|E|0|AGT|0|0|0|100|DKK|5784|8891|lyfalmen||||50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5784||5784|8891| 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18210|25399|lyfalmen||||28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18210||18210|25399| 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18210|25399|lyfalmen||||28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18210||18210|25399| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|1913|3596|lyfalmen||||100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1913||1913|3596| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|2996|5077|lyfalmen||||200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2996||2996|5077| 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18210|25399|lyfalmen||||28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18210||18210|25399| 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|2511|3624|lyfsjukr||||50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2511|3624| 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|3475|5015|lyfsjukr||||100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3475|5015| 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|1062|1501|lyfalmen|V0225|1501||100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||382||382|1501| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|3631|7145|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3631||3631|7145| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|4791|9372|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4791||4791|9372| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|8725|16926|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8725||8725|16926| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|2425|3500|lyfsjukr||||60|0||Icepharma hf|Baxter Medical AB|Mesna||2425||2425|3500| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|12774|17914|lyfsjukr||||10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12774||12774|17914| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|99866|127214|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||99866||99866|127214| 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2388|2748|lyfalmen|V0088|2748||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1293||1293|2748| 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2486|2780|lyfalmen|V0089|2780||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1317||1317|2780| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|||0|0|0|0|GGL|0|0|1|100|GBP|2121|3880|lyfalmen||||5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2121||2121|3880| 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|16062|22703|lyfalmen||||30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16062||16062|22703| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|683875|860146|lyfsjukr||||21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||683875||683875|860146| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|724944|911687|lyfsjukr||||21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||724944||724944|911687| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|762463|958774|lyfsjukr||||21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||762463||762463|958774| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|836777|1052038|lyfsjukr||||21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||836777||836777|1052038| 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|16062|22703|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16062||16062|22703| 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|1311|2772|lyfalmen||||30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1311||1311|2772| 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|32126|42863|lyfalmen||||60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32126||32126|42863| 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|||0|1|E|0|SNO|0|0|0|100|NOK|18920|26290|lyfalmen||||20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||18920||18920|26290| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008|31.07.2012|R|||0|1|0|1|IPI|0|0|0|100|DKK|90844|115892|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||90844||90844|115892| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|27125|35924|lyfsjukr||||10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||27125||27125|35924| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|||0|0|0|0|AUW|1|0|0|100|XEU|8056|15641|vetalmen||||10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8056|15641| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2187|3953|lyfalmen|V0461|3953||20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2174||2174|3953| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|||0|0|E|0|SCP|0|0|1|100|DKK|1100|2484|lyfalmen||||120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1100||1100|2484| 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|||0|0|0|0|PER|0|1|0|100|DKK|11077|16132|lyfalmen|V0334|6012||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11077||11077|16132| 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|||0|0|0|0|PER|0|1|0|100|DKK|21030|28938|lyfalmen|V0335|6012||98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21030|28938| 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|2419|4288|lyfalmen||||100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2419||2419|4288| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|3195|4414|lyfalmen|V0023|2891||90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2511||2511|4414| 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|2738|2887|lyfalmen|V0233|2780||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1395||1395|2887| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|1917|2492|lyfalmen|V0234|2407||6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1106||1106|2492| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|1094|2455|lyfalmen|V0329|2455||30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1079||1079|2455| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|6547|3158|lyfalmen|V0072|3121||98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1593||1593|3158| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|8390|3237|lyfalmen|V0073|3195||98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1651||1651|3237| 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|||0|0|B|0|BIG|0|0|1|100|SEK|612|1816|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||612||612|1816| 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|||0|0|B|0|BIG|0|0|1|100|SEK|612|1816|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||612||612|1816| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||| 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|987|1999|lyfalmen|V0243|1999||50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||746||746|1999| 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|1683|2488|lyfalmen|V0244|2421||50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1103||1103|2488| 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|4752|5117|lyfalmen|V0245|5117||100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||3025||3025|5117| 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|8514|9921|lyfalmen|V0232|9921||100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||6537||6537|9921| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|18576|25195|lyfsjukr||||25|0||Actavis Group hf|Braun|Flúmazeníl||18576||18576|25195| 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|17462|24460|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17462||17462|24460| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|||0|1|0|1|ASZ|0|0|0|100|SEK|99592|126870|lyfsjukr||||10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||99592||99592|126870| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|6128|3749|lyfalmen|V0284|3749||100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||2025||2025|3749| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|14070|15000|lyfalmen|V0285|14998||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||10250||10250|15000| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|IKR|23001|30017|lyfalmen|V0286|27947||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||21890||21890|30017| 099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|2923|3979|lyfalmen|V0247|3979||60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2193||2193|3979| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|4041|6047|lyfalmen|V0248|6047||60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3705||3705|6047| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|8208|10100|lyfalmen|V0249|10100||60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6668||6668|10100| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|733|1982|lyfalmen|V0414|1982||98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||733||733|1982| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|13082|18963|lyfalmen||||28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13082|18963| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|13082|18963|lyfalmen||||28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13082|18963| 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|||0|0|B|0|ACA|0|1|0|100|XEU|1888|3562|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1888||1888|3562| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|12502|13259|lyfalmen||||100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8977||8977|13259| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|17292|24247|lyfalmen||||100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17292||17292|24247| 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|2023|3746|lyfalmen||||28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2023||2023|3746| 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|6530|9912|lyfalmen||||98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6530||6530|9912| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1348|2823|lyfalmen|V0330|2823||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1348||1348|2823| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|3068|5176|lyfalmen|V0331|5176||96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3068||3068|5176| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|3848|2947|lyfalmen|V0088|2804||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1439||1439|2947| 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|0|0|AGP|0|1|0|100|XEU|5494|8494|lyfalmen|V0332|8494||96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5494||5494|8494| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|4464|2982|lyfalmen|V0089|2837||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1464||1464|2982| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|||0|0|E|0|DAC|0|0|1|100|DKK|5119|7981|lyfalmen|V0227|7432||100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5119||5119|7981| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|||0|0|0|0|BOI|0|0|0|100|SEK|17586|33940|vetalmen||||250|0||Vistor hf|Boehringer Ingelheim|||||17586|33940| 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|||0|0|E|0|APR|0|0|0|100|DKK|3190|5343|lyfalmen||||100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3190|5343| 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|6840|10336|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6840||6840|10336| 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|20518|28295|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20518||20518|28295| 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|3794|6169|lyfalmen|V0041|3646||98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3794||3794|6169| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|||0|0|0|1|AZA|0|0|0|100|SEK|1902|2745|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||1902||1902|2745| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|||0|0|0|1|AZA|0|0|0|100|SEK|3091|4461|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||3091||3091|4461| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|3457|2947|lyfalmen|V0088|2748||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1439||1439|2947| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|4374|2982|lyfalmen|V0089|2780||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1464||1464|2982| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|2952|2481|lyfalmen|V0069|2440||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1098||1098|2481| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|2649|2112|lyfalmen|V0033|2112||10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||828||828|2112| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|10477|8711|lyfalmen|V0182|8663||40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5652||5652|8711| 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|4395|6135|lyfalmen|V0334|6135||100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3769||3769|6135| 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|7054|6135|lyfalmen|V0335|6135||100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3769||3769|6135| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1906| 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|13854|19269|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13854||13854|19269| 104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3039|3195|lyfalmen|V0073|3195||98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||1620||1620|3195| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|||0|0|E|0|FEL|0|0|0|100|DKK|3133|5265|lyfalmen||||2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3133||3133|5265| 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|||0|0|0|0|NER|0|0|1|100|DKK|2155|3927|lyfalmen||||21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2155||2155|3927| 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|||0|0|B|0|FER|0|0|0|100|DKK|8260|12278|lyfalmen||||28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8260||8260|12278| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|||0|0|B|0|FER|0|0|0|100|DKK|4639|7325|lyfalmen|V0017|7325||700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4639||4639|7325| 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|5250|8161|lyfalmen||||100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5250||5250|8161| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|128281|162875|lyfsjukr||||2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||128281|162875| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|4373|6062|lyfalmen|V0004|1712||28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3716||3716|6062| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|13307|16453|lyfalmen|V0011|5498||100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11312||11312|16453| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|17696|19535|lyfalmen|V0012|5498||100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13538||13538|19535| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|||0|0|0|0|DAC|0|0|0|100|SEK|1245|2682|lyfalmen|V0545|2682||63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1245||1245|2682| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|3939|6367|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3939||3939|6367| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|13695|19732|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13695||13695|19732| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|4541|7191|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4541||4541|7191| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|15795|22368|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15795||15795|22368| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2467|4354|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2467||2467|4354| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2917|4969|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2917||2917|4969| 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|1838|3493|lyfalmen||||10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1838||1838|3493| 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|3676|6007|lyfalmen||||10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3676||3676|6007| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|2660|4618|lyfalmen||||14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2660||2660|4618| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|||0|0|0|1|GSK|0|0|0|100|GBP|19466|26312|lyfsjukr||||5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19466||19466|26312| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|||0|0|0|1|GSK|0|0|0|100|GBP|10765|15393|lyfsjukr||||5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10765||10765|15393| 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2019|1835|lyfalmen|V0278|1835||28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||626||626|1835| 107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|||0|0|B|0|ADG|0|0|0|100|XEU|1265|2709|lyfalmen||||100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1265||1265|2709| 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|||0|0|B|0|PER|0|0|0|100|DKK|1568|3124|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1568||1568|3124| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|||0|0|0|0|CRO|0|0|0|100|XEU|1535|2678|vetorma||||6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|||||1535|2678| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|||0|0|E|0|ACA|0|0|0|100|XEU|921|2239|lyfalmen||||60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||921||921|2239| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|||0|0|B|0|BAP|0|0|0|100|SEK|2886|4927|lyfalmen||||100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2886||2886|4927| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|3289|5478|lyfalmen||||30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3289||3289|5478| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|9763|14334|lyfalmen||||90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9763||9763|14334| 108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|13707|7252|lyfalmen|V0282|7252||56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4586||4586|7252| 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1193|2611|lyfalmen||||120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1193||1193|2611| 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1655|3243|lyfalmen|V0443|3241||120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1655||1655|3243| 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|2180|1712|lyfalmen|V0004|1712||28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||536||536|1712| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24201|32917|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24201||24201|32917| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19375|26861|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19375||19375|26861| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7522|11269|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7522||7522|11269| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|416|1548|lyfalmen|V0230|1548||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||416||416|1548| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|||0|0|*|0|SAO|0|0|0|100|XEU|516|1685|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||516||516|1685| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||3|0||Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|||0|0|0|0|ORG|0|0|0|100|DKK|1535|3079|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1535||1535|3079| 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|||0|0|B|0|ORC|0|0|0|100|DKK|3924|6347|lyfalmen||||100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3924||3924|6347| 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|112476|143040|lyfsjukr||||60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||112476||112476|143040| 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|5846|7295|lyfalmen|V0373|7295||15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4617||4617|7295| 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|||0|0|0|0|GSH|0|0|1|100|DKK|747|2001|lyfalmen||||100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||747||747|2001| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|||0|0|0|0|ORG|0|0|0|100|DKK|21684|29759|lyfalmen||||1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21684||21684|29759| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|8180|3806|lyfalmen|V0203|3679||12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2067||2067|3806| 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8482|12582|lyfalmen|V0024|11395||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8482||8482|12582| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|25212|34186|lyfalmen|V0024|34186||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25212||25212|34186| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8592|12732|lyfalmen|V0025|11518||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8592||8592|12732| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3825|6211|lyfalmen||||2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3825||3825|6211| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|25505|34554|lyfalmen|V0025|34554||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25505||25505|34554| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|6555|9946|lyfalmen||||4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6555||6555|9946| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|||0|1|0|1|NOE|0|0|0|100|DKK|664364|835659|lyfsjukr||||112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||664364||664364|835659| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|729|1976|lyfalmen||||20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||729||729|1976| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|926|2246|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||926||926|2246| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1414|2913|lyfalmen||||40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1414||1414|2913| 114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|||0|0|B|0|GSK|0|0|1|100|GBP|999|2345|lyfalmen||||60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|52274|67486|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||52274||52274|67486| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|4119|6613|lyfalmen||||28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4119||4119|6613| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|||0|0|*|0|MSD|0|0|0|100|DKK|2350|4194|lyfalmen|V0373|2432||5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2350||2350|4194| 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|||0|0|0|0|GAN|0|0|1|100|XEU|2203|3992|lyfalmen||||4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2203||2203|3992| 114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011|30.06.2012|R|||0|0|0|0|GAN|0|0|0|100|SEK|3275|5459|lyfalmen||||30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3275||3275|5459| 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|||0|0|0|0|GAN|0|0|0|100|SEK|6322|9627|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6322||6322|9627| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1899|3577|lyfalmen||||10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1899||1899|3577| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr||||10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|1593|3158|lyfalmen||||20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1593||1593|3158| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11389|16558|lyfalmen||||60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11389||11389|16558| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1899|3577|lyfalmen||||10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1899||1899|3577| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11389|16558|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11389||11389|16558| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|||0|0|*|0|MSD|0|0|0|100|DKK|1891|3566|lyfalmen|V0369|2969||5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1891||1891|3566| 115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|3867|6269|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3867||3867|6269| 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||55|0||Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|||0|0|0|1|GSK|0|0|0|100|GBP|3883|5604|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3883||3883|5604| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|||0|0|0|1|GSK|0|0|0|100|GBP|2030|2930|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2030||2030|2930| 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1179|1953|lyfalmen|V0056|1781||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||712||712|1953| 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1866|2200|lyfalmen|V0057|2200||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||893||893|2200| 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|||0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa||||10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2590|4522|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2590||2590|4522| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2976|5050|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2976||2976|5050| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|755|2012|lyfalmen|V0562|2009||100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||755||755|2012| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|376|1493|lyfalmen|V0563|1493||30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||376||376|1493| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|915|2231|lyfalmen|V0564|2229||100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||915||915|2231| 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|17655|24702|lyfalmen||||84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17655||17655|24702| 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|7519|4891|lyfalmen|V0081|4891||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2860||2860|4891| 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6016|9208|lyfalmen||||28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6016||6016|9208| 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6460|9816|lyfalmen||||28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6460||6460|9816| 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|19072|26481|lyfalmen||||84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19072||19072|26481| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|||0|0|0|0|WLV|0|0|0|100|DKK|8228|12234|lyfalmen||||0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8228||8228|12234| 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|10726|20768|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||10726||10726|20768| 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3291|5481|lyfalmen||||100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3291||3291|5481| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|||0|0|E|0|ROC|0|0|0|100|DKK|4520|7162|lyfalmen|V0435|7058||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4520||4520|7162| 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|15033|21412|lyfalmen||||100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15033|21412| 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|26569|35889|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26569|35889| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|1602|3170|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1602||1602|3170| 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|4594|7263|lyfalmen||||10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4594|7263| 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|45941|60201|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45941|60201| 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|53138|69233|lyfalmen||||100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||53138|69233| 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|67609|86732|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||67609||67609|86732| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|9691|16905|vetorma||||250|0||Icepharma hf|Bayer Animal Health GmbH|||9691||9691|16905| 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|2356|4202|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2356||2356|4202| 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|5632|8683|lyfalmen||||98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5632||5632|8683| 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|8434|12516|lyfalmen||||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8434||8434|12516| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|7492|14558|vetalmen||||1200|0||Icepharma hf|Kela Laboratoria NV|||7492||7492|14558| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|13141|25405|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||13141||13141|25405| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|3978|1835|lyfalmen|V0278|1835||28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||626||626|1835| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|5654|2492|lyfalmen|V0279|2415||28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1106||1106|2492| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|21926|7608|lyfalmen|V0282|7252||56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4846||4846|7608| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|16750|9507|lyfalmen|V0283|9507||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||6234||6234|9507| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2313|4143|lyfalmen||||100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2313||2313|4143| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr||||4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||R|||0|0|E|0|ACA|0|0|0|100|XEU|932|2254|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||932||932|2254| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|17237|9113|lyfalmen|V0280|8988||56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5946||5946|9113| 118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|7510|11252|lyfalmen|V0015|10493||50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7510||7510|11252| 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|23056|31480|lyfalmen|V0015|31480||150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23056||23056|31480| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|XEU|487|1645|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||487||487|1645| 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|||0|1|0|1|AEU|0|0|0|100|DKK|77134|98686|lyfsjukr||||5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||77134||77134|98686| 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|959|2045|lyfalmen|V0309|2045||30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||779||779|2045| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|||0|0|0|0|POF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|463778|583924|lyfsjukr||||30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||463778||463778|583924| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|463778|583924|lyfsjukr||||30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||463778||463778|583924| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|||0|0|E|0|SAL|0|0|0|100|USD|1020|2374|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1020||1020|2374| 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|||0|1|0|1|LIL|0|0|0|100|XEU|47932|62037|lyfsjukr||||1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||47932||47932|62037| 120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||| 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|31694|41658|lyfsjukr||||2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||31694||31694|41658| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|||0|0|0|0|LVR|0|0|0|100|DKK|17771|24848|lyfalmen|V0253|8987||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17771||17771|24848| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|5718|8801|lyfalmen||||28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5718||5718|8801| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|||0|0|0|1|ORG|0|0|0|100|DKK|9456|13647|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9456||9456|13647| 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|||0|0|B|0|GSK|0|0|1|100|GBP|467|1618|lyfalmen||||200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618| 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|8021|5388|lyfalmen|V0011|5388||98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3223||3223|5388| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|||0|0|E|0|AUK|0|0|1|100|GBP|425|1555|lyfalmen|V0391|1553||28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||421||421|1555| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|||0|0|B|0|NOH|0|1|0|100|DKK|1757|3382|lyfalmen|V0314|2306||100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1757||1757|3382| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|283|1366|lyfalmen||||28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||283||283|1366| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|||0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma||||50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747| 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|550|1731|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||550||550|1731| 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|857|2151|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||857||857|2151| 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|27985|48818|vetorma||||100|0||Icepharma hf|Icepharma hf|||27985||27985|48818| 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|244|1313|lyfalmen||||100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||244|1313| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|||0|0|E|0|AVS|0|0|0|100|NOK|46510|60915|lyfalmen||||56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||46510||46510|60915| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|||0|0|0|0|CHP|0|0|0|100|XEU|1814|3608|vetalmen||||42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1814|3608| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|||0|0|0|0|SBM|0|0|0|100|NOK|38820|51264|lyfalmen||||30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||38820|51264| 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|1902|2407|lyfalmen|V0234|2407||6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1044||1044|2407| 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2716|2780|lyfalmen|V0233|2780||12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1317||1317|2780| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|||0|0|E|0|NOH|0|0|0|100|DKK|997|2343|lyfalmen||||30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||997||997|2343| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|509|1675|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||509||509|1675| 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|10937|15940|lyfalmen|V0464|15940||8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10937||10937|15940| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|||1|0|0|1|RBP|0|0|0|100|DKK|1270|1833|lyfsjukr||||7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1270||1270|1833| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|837|1584|lyfalmen|V0066|1584||100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||442||442|1584| 125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|||0|0|0|0|BMM|0|0|0|100|XEU|2469|3837|lyfalmen|V0123|3837||28|0|28,0000|BMM Pharma AB|BMM Pharma AB|Terbínafín||2089||2089|3837| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|||0|0|E|0|LVR|0|0|0|100|DKK|15412|21887|lyfalmen||||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15412||15412|21887|31.05.2012 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|118078|150070|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||118078|150070| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|30303|39913|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30303|39913| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|25243|33562|lyfsjukr||||1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25243||25243|33562| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|8414|12144|lyfsjukr||||1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8414||8414|12144| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|47744|61801|lyfsjukr||||50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||47744||47744|61801| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|95514|121753|lyfsjukr||||100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||95514||95514|121753| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|190960|241537|lyfsjukr||||200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||190960||190960|241537| 126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37961|50186|lyfalmen|V0031|50186||100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37961|50186| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|||0|0|E|0|MCS|0|0|0|100|SEK|1049|2414|lyfalmen|V0447|2101||100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1049||1049|2414| 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|8677|6178|lyfalmen|V0279|2415||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3801||3801|6178| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|||0|0|0|0|BID|1|0|0|100|DKK|12255|23704|vetalmen||||30|0||Vistor hf|Boehringer Ingelheim Danmark|||12255||12255|23704| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|||0|0|E|0|LEP|0|0|0|100|DKK|1228|2659|lyfalmen||||100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1228||1228|2659| 128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|4040|5831|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Mesna||4040||4040|5831| 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|31282|29939|lyfalmen|V0280|8988||56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21828||21828|29939| 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|33999|23087|lyfalmen|V0282|7252||56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16368||16368|23087| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|238|1304|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||238||238|1304| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|||0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen||||100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3244| 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|||0|0|B|0|BOI|0|0|0|100|DKK|4366|6951|lyfalmen||||60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4366||4366|6951| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|18806|23140|lyfalmen|V0285|14998||100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16410||16410|23140| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|29769|35148|lyfalmen|V0286|27947||100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25978||25978|35148| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|2364|4213|lyfalmen||||10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2364||2364|4213| 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|13936|26932|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||13936||13936|26932| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYC|0|0|0|100|DKK|3985|6430|lyfalmen||||125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||3985||3985|6430| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|1848|3507|lyfalmen||||10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1848||1848|3507| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|11339|16490|lyfalmen||||53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11339|16490| 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|||0|0|0|0|PHA|0|0|0|100|NOK|65664|107131|veteldis||||500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||65664|107131| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|3388|5614|lyfalmen||||10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3388|5614| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|478|1633|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||478||478|1633| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|752|2008|lyfalmen||||100|0|15,0000|Vistor hf|Recip AB|Fenemal||752||752|2008| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1003|2351|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenemal||1003||1003|2351| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1110|2497|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Fenemal||1110||1110|2497| 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|XEU|2598|2913|lyfalmen|V0009|1924||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1414||1414|2913| 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5721|8805|lyfalmen|V0132|8805||26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5721||5721|8805| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|3786|6158|lyfalmen|V0032|5505||10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||3786||3786|6158| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|11357|16515|lyfalmen|V0032|16515||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||11357||11357|16515| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|37709|49870|lyfalmen||||100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||37709||37709|49870| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008||R|||0|0|B|0|AUK|0|1|0|100|GBP|264|1258|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||204||204|1258| 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|8087|10830|lyfalmen|V0348|10830||28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7201||7201|10830| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|9223|4017|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2221||2221|4017| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|7391|4017|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2221||2221|4017| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|||1|0|E|0|REP|0|0|1|100|SEK|1501|3032|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Kódein||1501||1501|3032| 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|||1|0|0|0|JAS|0|0|0|100|SEK|7859|11730|lyfalmen||||30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7859||7859|11730| 132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|1163|2570|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1163||1163|2570| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|||0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa||||100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|||0|0|0|0|JAS|0|0|0|100|SEK|1399|2893|lyfalmen||||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1399||1399|2893| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|28585|37757|lyfsjukr||||0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28585||28585|37757| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|38023|49601|lyfsjukr||||1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||38023||38023|49601| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|49683|64235|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||49683|64235| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|||0|0|E|0|SAD|0|0|0|100|DKK|8214|12215|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8214||8214|12215| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|91897|117213|lyfsjukr||||14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||91897||91897|117213| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|||0|0|0|0|ABS|0|0|1|100|DKK|1508|3042|lyfalmen||||50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1508||1508|3042| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|3976|6418|lyfalmen|V0378|5761||9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3976||3976|6418| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|11919|17283|lyfalmen|V0378|17283||27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11919||11919|17283| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4696|6778|lyfsjukr||||25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4696||4696|6778| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|||0|1|0|1|BRS|0|0|0|100|DKK|69948|89667|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||69948||69948|89667| 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|||0|1|0|1|GSI|0|0|0|100|DKK|129603|164534|lyfsjukr||||30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||129603||129603|164534| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|52684|68001|lyfsjukr||||1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||52684||52684|68001| 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|2115|3872|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2115||2115|3872| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|||0|0|B|0|MYL|0|0|0|100|SEK|1022|2377|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1022||1022|2377| 135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|2337|4176|lyfalmen||||60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2337||2337|4176| 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|||0|0|0|0|JAS|0|0|0|100|SEK|1683|3281|lyfalmen||||63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1683||1683|3281| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|7012|10571|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7012||7012|10571| 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|73581|94227|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||73581||73581|94227| 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|1|100|XEU|456|1473|lyfalmen|V0307|1473||30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||361||361|1473| 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|2294|3311|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2294||2294|3311| 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|7186|10371|lyfsjukr||||17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7186||7186|10371| 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|5296|7643|lyfsjukr||||25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5296||5296|7643| 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|8255|11914|lyfsjukr||||50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8255||8255|11914| 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|||0|1|0|1|HUK|0|0|0|100|XEU|5891|8502|lyfsjukr||||20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5891||5891|8502| 137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1672| 137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2049| 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|21120|28388|lyfsjukr||||25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21120||21120|28388| 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|6232|8994|lyfsjukr||||10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6232||6232|8994| 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|10461|15011|lyfsjukr||||10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10461||10461|15011| 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|6061|8748|lyfsjukr||||10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6061||6061|8748| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|XEU|738|1065|lyfsjukr||||500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||738||738|1065| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|DKK|1502|2168|lyfsjukr||||1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1502||1502|2168| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1682|3280|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1682||1682|3280| 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|4682|7295|lyfalmen|V0373|7295||15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4617||4617|7295| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|||0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|136072|172653|lyfsjukr||||20|0||Vistor hf|N.V. Organon|Sugammadex||136072||136072|172653| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|340070|428670|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Sugammadex||340070||340070|428670| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|1441|2950|lyfalmen|V0266|1133||30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1441||1441|2950| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|||0|0|0|1|LBK|0|1|0|100|DKK|11657|16512|lyfsjukr||||10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11657||11657|16512| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|||0|0|0|1|DES|0|0|0|100|DKK|632|912|lyfsjukr||||5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||632||632|912| 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|||0|0|0|0|SRR|1|0|0|100|NOK|95122|182821|vetalmen||||1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||95122||95122|182821| 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|||0|0|B|0|PER|0|0|1|100|DKK|1231|2663|lyfalmen|V0413|2384||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1231||1231|2663| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|4389|6163|lyfsjukr||||1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4270||4270|6163| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|20845|28043|lyfsjukr||||1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||20845||20845|28043| 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3822|5516|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3822||3822|5516| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|2724|4705|lyfalmen||||30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2724||2724|4705| 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|20518|28295|lyfalmen||||0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20518||20518|28295| 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|||0|0|0|0|BAB|0|0|0|100|SEK|4785|7525|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4785||4785|7525| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|8537|12657|lyfalmen|V0267|2817||100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8537||8537|12657| 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|||0|0|E|0|MYL|0|0|1|100|SEK|2714|3601|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1917||1917|3601| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|||0|0|0|1|SNO|0|0|0|100|NOK|3333|4810|lyfsjukr||||30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3333||3333|4810| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|||0|0|B|0|SNO|0|0|0|100|NOK|1092|2473|lyfalmen||||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1092||1092|2473| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|||0|0|0|0|MEB|0|0|1|100|SEK|2912|4962|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2912||2912|4962| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|||0|0|B|0|PER|0|0|1|100|DKK|1432|2938|lyfalmen||||1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1432||1432|2938| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|||0|0|0|1|PER|0|0|0|100|DKK|2249|3246|lyfsjukr||||1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2249||2249|3246| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|3968|6407|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3968||3968|6407| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|960|2292|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||960||960|2292| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1461|2977|lyfalmen||||2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1461||1461|2977| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|||0|0|E|0|BOI|0|0|0|100|DKK|1317|2780|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1317||1317|2780| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|||0|0|*|0|MSD|0|0|0|100|DKK|8358|12412|lyfalmen|V0386|9448||56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8358||8358|12412| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|600|1800|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||600||600|1800| 143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|||0|0|*|0|AGT|0|1|0|100|DKK|1193|2611|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1193||1193|2611| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|2009|3727|lyfalmen|V0174|3727||3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2009||2009|3727| 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|||0|0|E|0|MSD|0|0|0|100|DKK|2072|3813|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2072||2072|3813| 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|22777|31130|lyfalmen||||60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22777||22777|31130| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|79989|102269|lyfsjukr||||2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||79989||79989|102269| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|59784|76911|lyfsjukr||||2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||59784||59784|76911| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|37146|48501|lyfsjukr||||2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||37146||37146|48501| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|647|1864|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||647||647|1864| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|332|1433|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||332||332|1433| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|551|1733|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||551||551|1733| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|84587|108039|lyfsjukr||||1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||84587||84587|108039| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2201|3990|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2201||2201|3990| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||32|0||Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|20352|19854|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13792||13792|19854| 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|31960|41992|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||31960||31960|41992| 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|3009|4343|lyfsjukr||||2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3009||3009|4343| 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|6113|8823|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6113||6113|8823| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|||0|1|0|0|ELI|0|0|0|100|XEU|17814|24902|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17814||17814|24902| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|889|2195|lyfalmen|V0351|1106||10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||889||889|2195| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|2495|3601|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2495||2495|3601| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|1546|2231|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1546||1546|2231| 147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||| 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|||0|0|0|0|ROA|0|0|1|100|DKK|112128|143266|lyfalmen||||75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||112128||112128|143266| 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|82753|106400|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||82753||82753|106400| 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|82753|106400|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||82753||82753|106400| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|||0|0|*|0|LFS|0|1|0|100|DKK|847|2138|lyfalmen||||100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||847||847|2138| 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr||||5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|||0|1|0|1|HOP|0|0|0|100|SEK|6396|9231|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6396||6396|9231| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|||0|1|0|1|HOP|0|0|0|100|SEK|13409|18711|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13409||13409|18711| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|||0|1|0|1|HOS|0|0|0|100|SEK|28685|37882|lyfsjukr||||1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28685||28685|37882| 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|||0|0|0|0|BAN|1|0|0|100|DKK|3611|7106|vetalmen||||25|0||Icepharma hf|Bayer Animal Health GmbH|||3611||3611|7106| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|||0|0|0|0|PCO|0|1|0|100|SEK|2134|3898|lyfalmen||||75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2134||2134|3898| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|2161|2577|lyfalmen|V0376|2164||2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1168||1168|2577| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|||0|0|E|0|SAD|0|0|0|100|DKK|16026|22658|lyfalmen|V0571|22658||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16026||16026|22658| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|52121|67294|lyfsjukr||||2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52121|67294| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|3765|6129|lyfalmen||||28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3765|6129| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|6245|9522|lyfalmen|V0120|7474||56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6245|9522| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|||0|0|0|0|GSK|0|0|0|100|GBP|3790|6163|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3790|6163| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|||0|0|*|0|LBK|0|1|0|100|DKK|6528|9909|lyfalmen||||10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6528||6528|9909| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1199|2619|lyfalmen||||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1199||1199|2619| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|15852|22439|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15852|22439| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|48947|61047|lyfalmen||||98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||46615||46615|61047| 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|5162|8040|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5162||5162|8040| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|||0|0|E|0|MYL|0|0|0|100|SEK|5434|4132|lyfalmen|V0148|4010||90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2305||2305|4132| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|1566|3121|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1566||1566|3121| 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|4455|4583|lyfalmen|V0006|4583||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2635||2635|4583| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|1997|2882|lyfsjukr||||5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||1997||1997|2882| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|||0|0|0|0|DAC|0|0|0|100|XEU|2568|4488|lyfalmen|V0123|3837||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2565||2565|4488| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|||0|0|0|0|AZD|0|0|0|100|SEK|3963|6400|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3963||3963|6400| 152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|5792|8902|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5792||5792|8902| 152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|ASZ|0|0|0|100|SEK|10627|15516|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10627||10627|15516| 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|||0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|18701|9980|lyfalmen|V0269|9980||100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||6580||6580|9980| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|1266|2711|lyfalmen|V0181|1474||4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1266||1266|2711| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|||0|0|0|0|AZD|0|0|1|100|SEK|1813|3459|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1813||1813|3459| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|39584|51560|lyfsjukr||||1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||39584|51560| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2290|4112|lyfalmen|V0561|3734||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2290||2290|4112| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|1602|3170|lyfalmen|V0560|2906||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1602||1602|3170| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|||0|0|E|0|ACA|0|0|1|100|XEU|2275|4091|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2275||2275|4091| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|||0|0|0|1|GIS|0|0|0|100|DKK|227774|287739|lyfsjukr||||10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||227774||227774|287739| 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|542|1720|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||542|1720| 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|34908|46355|lyfalmen|V0452|46355||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||34908||34908|46355| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|4371|6958|lyfalmen|V0181|5526||15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4371||4371|6958| 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|319|1415|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||319||319|1415| 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|528|1701|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||528||528|1701| 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|||0|0|E|0|SHS|0|0|1|100|DKK|1563|3117|lyfalmen||||1|0|50,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||1563||1563|3117| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009|31.07.2012|R|||0|0|B|0|LEP|0|0|0|100|DKK|8265|12285|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8265||8265|12285| 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|9378|13808|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9378||9378|13808| 154484|G04CA0102|Xatral Uno|forđatfl|10|mg|30|stk|1|ţpakki||G04CA01|01.01.2003|31.05.2012|R|||0|0|E|0|SNO|0|0|0|100|NOK|3512|5783|lyfalmen||||30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3512||3512|5783| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|1052|2418|lyfalmen||||20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1052||1052|2418| 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|29028|38313|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29028||29028|38313| 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|38030|49610|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38030||38030|49610| 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|41785|54323|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||41785||41785|54323| 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|30926|40695|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||30926||30926|40695| 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|38043|49626|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38043||38043|49626| 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|27254|36086|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27254||27254|36086| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|3774|6142|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3774||3774|6142| 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|35536|46480|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35536||35536|46480| 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|1515|3051|lyfalmen|V0259|3051||28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1515||1515|3051| 154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|||0|0|E|0|SNO|0|0|0|100|NOK|7502|11241|lyfalmen|V0550|7638||90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7502||7502|11241| 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|4307|6032|lyfalmen|V0334|6012||98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3694||3694|6032| 154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|2373|2452|lyfalmen|V0265|2452||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1077||1077|2452| 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|6912|6032|lyfalmen|V0335|6012||98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3694||3694|6032| 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|447985|564766|lyfalmen||||252|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||447985||447985|564766| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|1564|3118|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Chlorambucíl||1564||1564|3118| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|2202|3979|lyfalmen|V0247|3979||60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2193||2193|3979| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3710|6047|lyfalmen|V0248|6047||60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3705||3705|6047| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|6671|10100|lyfalmen|V0249|10100||60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6668||6668|10100| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1515|3051|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1515||1515|3051| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|649|1867|lyfalmen||||100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||649||649|1867| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|6825|10315|lyfalmen|V0181|10315||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6825||6825|10315| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5829|8953|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5829||5829|8953| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5878|9020|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5878||5878|9020| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|||0|0|0|0|REP|0|0|1|100|SEK|439|1579|lyfalmen||||15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||439||439|1579| 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|2339|3376|lyfsjukr||||15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2339||2339|3376| 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|1371|1979|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1371||1371|1979| 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|6406|9245|lyfsjukr||||45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6406||6406|9245| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|||0|0|0|0|ROC|0|0|0|100|DKK|9425|13872|lyfalmen||||84|0|28,0000|Icepharma hf|Roche|Orlístat||9425||9425|13872| 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|||0|1|0|1|HOP|0|0|0|100|XEU|8580|12383|lyfsjukr||||60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8580||8580|12383| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|882|2185|lyfalmen||||6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||882||882|2185| 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|||0|0|0|0|PAL|0|0|0|100|DKK|7261|12666|vetorma||||260|0||Icepharma hf|Pfizer Oy Animal Health|||7261||7261|12666| 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2701|2415|lyfalmen|V0279|2415||28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||1050||1050|2415| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|||0|0|E|0|NOH|0|0|0|100|DKK|1518|3055|lyfalmen|V0239|3055||100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1518||1518|3055| 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|1598|3165|lyfalmen||||10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1598|3165| 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|29450|39505|lyfalmen||||100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||29450|39505| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|||0|0|E|0|NOH|0|0|0|100|DKK|947|2274|lyfalmen|V0239|1528||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||947||947|2274| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|103014|131165|lyfsjukr||||1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||103014|131165| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|206029|260449|lyfsjukr||||1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||206029|260449| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|584190|735041|lyfsjukr||||1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||584190|735041| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|52574|67863|lyfsjukr||||1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||52574|67863| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|74999|96006|lyfsjukr||||1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||74999||74999|96006| 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|||0|0|E|0|DES|0|0|0|100|DKK|816|2095|lyfalmen||||5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||816||816|2095| 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1044|2407|lyfalmen|V0469|2407||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1044|2407| 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|3355|5568|lyfalmen|V0219|5568||5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3355||3355|5568| 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|5776|8880|lyfalmen|V0220|8880||5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5776||5776|8880| 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|7493|11229|lyfalmen|V0221|11229||5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7493||7493|11229| 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|8731|12922|lyfalmen|V0223|12922||5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8731||8731|12922| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|5165|4656|lyfalmen|V0318|2506||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2688||2688|4656| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|20220|27921|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20220||20220|27921| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|13245|12308|lyfalmen|V0320|4154||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8282||8282|12308| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|1873|2640|lyfalmen|V0062|2040||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1214||1214|2640| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|3242|3692|lyfalmen|V0067|1921||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1983||1983|3692| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|6681|4898|lyfalmen|V0071|2164||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2865||2865|4898| 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|472|1625|lyfalmen||||25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||472||472|1625| 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|1623|3199|lyfalmen||||100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1623||1623|3199| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|||0|0|0|1|APC|0|0|0|100|DKK|100416|127905|lyfsjukr||||2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||100416||100416|127905| 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|4183|8205|vetalmen||||50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4183||4183|8205| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|2199|3096|lyfalmen|V0010|2980||56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1548||1548|3096| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|||0|0|0|1|AGT|0|0|0|100|DKK|2264|3268|lyfsjukr||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2264||2264|3268| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|36980|48292|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36980||36980|48292| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|53843|69455|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53843||53843|69455| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|||0|0|*|0|SNO|0|1|0|100|NOK|1015|2367|lyfalmen||||100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1015||1015|2367| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|||0|0|0|0|BRS|0|0|0|100|DKK|2359|4206|lyfalmen||||50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2359||2359|4206| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|71831|92030|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71831||71831|92030| 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|||0|0|E|0|BOI|0|0|1|100|DKK|1198|2618|lyfalmen||||15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1198||1198|2618| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|76374|97732|lyfsjukr||||120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||76374||76374|97732| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|||0|0|B|0|PER|0|0|1|100|DKK|592|1789|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||592||592|1789| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|0|1|PER|0|0|0|100|DKK|919|1326|lyfsjukr||||1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||919||919|1326| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|||0|0|0|1|PER|0|0|0|100|DKK|834|1204|lyfsjukr||||5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||834||834|1204| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|605|1807|lyfalmen||||1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||605||605|1807| 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5083|7932|lyfalmen|V0131|7932||26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5083||5083|7932| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|60135|78015|lyfalmen|V0452|46355||100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60135||60135|78015| 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|14171|19557|lyfsjukr||||28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14083||14083|19557| 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|158472|200765|lyfsjukr||||8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||158472||158472|200765| 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|777|2042|lyfalmen|V0512|2042||100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||777||777|2042| 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|432|1570|lyfalmen|V0510|1570||100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||432||432|1570| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|||0|0|B|0|PER|0|0|0|100|DKK|1914|3597|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1914||1914|3597| 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|||0|0|0|0|LEV|1|0|0|100|XEU|5417|10574|vetalmen||||5|0||Le Vet B.V.|Le Vet B.V.|||||5417|10574| 162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|||0|0|B|0|GUK|0|0|0|100|SEK|2004|3720|lyfalmen|V0041|3720||100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||2004||2004|3720| 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|760|1822|lyfalmen|V0108|1822||100|0|33,3400|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||616||616|1822| 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|855|1982|lyfalmen|V0109|1982||100|0|66,6700|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||733||733|1982| 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|||0|0|E|0|BLU|0|0|0|100|XEU|1377|2551|lyfalmen|V0110|2551||100|0|133,3333|Bluefish Pharmaceuticals AB|Bluefish Pharmaceuticals AB|Simvastatín||1149||1149|2551| 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|1633|3144|lyfalmen|V0373|2432||5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1583||1583|3144| 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4734|4455|lyfalmen|V0148|4455||100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2541||2541|4455| 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|2337|4176|lyfalmen||||120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2337||2337|4176| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|||1|0|0|0|NOH|0|0|0|100|DKK|1142|2541|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1142||1142|2541| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|1710|3318|lyfalmen|V0351|3318||30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1710||1710|3318| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|||0|0|E|0|AEA|0|0|0|100|XEU|202|1255|lyfalmen||||20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||202|1255| 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|3455|5040|lyfalmen||||120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2969||2969|5040| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|||0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen||||454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114| 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|353017|444919|lyfsjukr||||42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||353017||353017|444919| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|||0|0|*|0|APT|0|0|0|100|XEU|3445|5691|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Merkaptópúrín||3445||3445|5691| 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3875|5593|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3875||3875|5593| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|||0|0|E|0|MYL|0|0|0|100|SEK|3047|5147|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3047|5147| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|10045|14720|lyfalmen||||100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10045||10045|14720| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|1051|2417|lyfalmen||||100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1051||1051|2417| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|||0|0|B|0|MYL|0|1|0|100|SEK|970|2306|lyfalmen|V0314|2306||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||970|2306| 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|7443|11161|lyfalmen|V0014|11161||60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7443||7443|11161| 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|834|2120|lyfalmen||||100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||834||834|2120| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|||0|0|0|0|LAS|1|0|0|100|XEU|6892|13406|vetalmen||||10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6892||6892|13406| 165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992|31.07.2012|R|||0|0|B|0|AZD|0|0|0|100|SEK|4538|7187|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4538||4538|7187| 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|5156|8032|lyfalmen|V0059|3930||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5156||5156|8032| 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|3328|5531|lyfalmen|V0058|2835||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3328||3328|5531| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|270945|341918|lyfsjukr||||8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||270945||270945|341918| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|36980|48292|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36980||36980|48292| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|53843|69455|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53843||53843|69455| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|713|1954|lyfalmen||||100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||713||713|1954| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|207|1262|lyfalmen||||25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||207||207|1262| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|||0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa||||10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|24268|14994|lyfalmen|V0341|14994||98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||10245||10245|14994| 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|4095|5910|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4095||4095|5910| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|71831|92030|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71831||71831|92030| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|243495|307469|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||243495||243495|307469| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|||0|0|0|0|IBV|0|0|0|100|DKK|4673|9145|vetalmen||||60|0||Vistor hf|Intervet International BV|||||4673|9145| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|||0|0|B|0|SNO|0|0|0|100|NOK|1930|3619|lyfalmen||||100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1930||1930|3619| 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|||0|1|E|0|PER|0|0|0|100|DKK|15176|21591|lyfalmen||||8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15176||15176|21591| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2258|4068|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2258||2258|4068| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|4274|6826|lyfalmen|V0428|6826||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4274||4274|6826| 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4868|7638|lyfalmen|V0550|7638||90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4868||4868|7638| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|||0|1|E|0|IPI|0|0|0|100|DKK|130581|166424|lyfalmen||||1|0||Icepharma hf|Pfizer Limited|Clostridíum||130581||130581|166424| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|448|1592|lyfalmen|V0333|1592||7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||448||448|1592| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|650|1868|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||650|1868| 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|4712|5388|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3223||3223|5388| 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|3048|5148|lyfalmen|V0240|5148||200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3048||3048|5148| 168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988|30.06.2012|R|||0|0|E|0|NOH|0|0|0|100|DKK|1261|2704|lyfalmen||||30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1261||1261|2704| 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|5626|8675|lyfalmen|V0433|8674||200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5626||5626|8675| 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|54892|70772|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||54892||54892|70772| 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|238660|301401|lyfsjukr||||50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||238660||238660|301401| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|||0|0|0|1|ROA|0|0|0|100|DKK|21673|29082|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21673||21673|29082| 169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|5569|8597|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5569||5569|8597| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3003|5087|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3003||3003|5087| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3232|5400|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3232||3232|5400| 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|24262|32331|lyfsjukr||||4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24262|32331| 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|60216|77454|lyfsjukr||||10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60216|77454| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|5987|9169|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5987||5987|9169| 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|113821|144728|lyfsjukr||||20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||113821||113821|144728| 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.07.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|16026|22658|lyfalmen|V0571|22658||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16026||16026|22658| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|3896|6308|lyfalmen||||100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3896||3896|6308| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|6819|10307|lyfalmen||||100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6819||6819|10307| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|2457|4340|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2457||2457|4340| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|11397|16186|lyfsjukr||||1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11397||11397|16186| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|27417|36291|lyfsjukr||||1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27417||27417|36291| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|41125|53494|lyfsjukr||||2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||41125||41125|53494| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|3347|3679|lyfalmen|V0203|3679||12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1974||1974|3679| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12363|4397|lyfalmen|V0207|3374||12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4397| 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|57402|73922|lyfsjukr||||4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||57402||57402|73922| 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|||0|0|0|0|DEC|1|0|0|100|DKK|2108|4193|vetalmen||||25|0||Vistor hf|Dechra Veterinary Products A/S|||2108||2108|4193| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3723|6072|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3723||3723|6072| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|4011|6466|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4011||4011|6466| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|||0|0|B|0|LDR|0|0|0|100|NOK|1587|3150|lyfalmen||||100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1587||1587|3150| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|4544|7195|lyfalmen|V0247|3979||60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4544||4544|7195| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|7481|11213|lyfalmen|V0248|6047||60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7481||7481|11213| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|43232|56139|lyfsjukr||||75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||43232||43232|56139| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|28822|38054|lyfsjukr||||50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||28822||28822|38054| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|13509|19499|lyfalmen|V0249|10100||60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13509||13509|19499| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|25354|34364|lyfalmen||||60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25354||25354|34364| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|66291|85078|lyfsjukr||||100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||66291||66291|85078| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|29920|29781|lyfalmen|V0346|29781||112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||21702||21702|29781| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|3480|5739|lyfalmen||||100|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Búsúlfan||3480||3480|5739| 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|||0|0|B|0|AZD|0|0|0|100|SEK|11828|17159|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11828||11828|17159| 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|6355|9672|lyfalmen||||56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6355||6355|9672| 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|11806|17129|lyfalmen||||56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11806||11806|17129| 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|20483|28251|lyfalmen||||56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20483||20483|28251| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|1125||4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114| 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|26711|36067|lyfalmen||||56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26711||26711|36067| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|||0|0|0|0|MAB|0|0|1|100|DKK|428|1564|lyfalmen||||50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||428||428|1564| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|2931|4988|lyfalmen||||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||2931||2931|4988| 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3571| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|6257|9538|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6257||6257|9538| 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|16596|22582|lyfsjukr||||2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16494||16494|22582| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|||0|0|0|0|MYL|0|0|1|100|SEK|359|1470|lyfalmen||||30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||359||359|1470| 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|15848|21772|lyfsjukr||||2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||15848||15848|21772| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|||0|0|0|1|AGT|0|0|0|100|DKK|1375|1984|lyfsjukr||||20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1375||1375|1984| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|686|1917|lyfalmen||||14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||686||686|1917| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|702|1939|lyfalmen||||14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||702||702|1939| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|1812|3458|lyfalmen|V0368|2750||5|0|25,0000|Vistor hf|Allergan|Brímónidín||1812||1812|3458| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.09.1999||R|||0|0|0|0|MYL|0|0|0|100|SEK|276|1356|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||276|1356|31.05.2012 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|5316|8251|lyfalmen|V0368|8251||15|0|75,0000|Vistor hf|Allergan|Brímónidín||5316||5316|8251| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|2648|2273|lyfalmen|V0033|2112||10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||946||946|2273| 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|||0|0|0|0|ELD|0|1|0|100|XEU|6610|4949|lyfalmen|V0278|1835||28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2902||2902|4949| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|||0|0|E|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen||||1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|166728|211126|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||166728||166728|211126| 179171|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.02.2012|30.06.2012|R|||1|0|0|1|AGP|0|0|0|100|XEU|5479|7908|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5479||5479|7908| 179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|12805|9914|lyfalmen|V0253|8987||100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||6532||6532|9914| 179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10670|15575|lyfalmen||||28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10670|15575| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|129763|164735|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||129763||129763|164735| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|||0|0|B|0|UCB|0|0|0|100|DKK|5598|8637|lyfalmen||||100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5598||5598|8637| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|||0|0|E|0|PER|0|0|1|100|DKK|796|2068|lyfalmen||||5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||796||796|2068| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|||0|0|0|0|PFV|0|0|0|100|DKK|8039|15609|vetalmen||||100|0||Icepharma hf|Pfizer vet.|||8039||8039|15609| 181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|9773|14105|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Metótrexat||9773||9773|14105| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|||0|0|0|0|IBV|0|0|0|100|SEK|5973|11642|vetalmen||||100|0||Vistor hf|Intervet International BV|||5973||5973|11642| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|||0|0|0|0|IBV|1|0|0|100|DKK|5389|10520|vetalmen||||50|0||Vistor hf|Intervet International BV|||5389||5389|10520| 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5786|8894|lyfalmen||||1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5786|8894| 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|1412057|1774014|lyfsjukr||||168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1412057||1412057|1774014| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|||0|0|B|0|BRS|0|0|0|100|DKK|1188|2604|lyfalmen||||100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1188||1188|2604| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|848|2139|lyfalmen||||21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||848||848|2139| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|488|1646|lyfalmen||||100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||488||488|1646| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen||||100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|619|1826|lyfalmen||||15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||619||619|1826| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5009|7831|lyfalmen|V0017|7325||700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5009||5009|7831| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|21719|29802|lyfalmen|V0170|9980||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21719||21719|29802| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|55198|71819|lyfalmen|V0185|24342||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55198||55198|71819| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|1177|2589|lyfalmen||||16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1177||1177|2589| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|5418|8390|lyfalmen|V0235|7932||6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5418||5418|8390| 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|||0|0|0|1|WTE|0|0|0|100|DKK|77142|98696|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||77142||77142|98696| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|2923|4977|lyfalmen||||250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2923||2923|4977| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|||0|0|*|0|GPL|0|0|0|100|USD|2089|3837|lyfalmen||||100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2089||2089|3837| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|||0|0|0|1|NOH|0|0|0|100|DKK|7156|10328|lyfsjukr||||10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7156||7156|10328| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|2493|4389|lyfalmen||||5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2493||2493|4389| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|1027|2384|lyfalmen|V0413|2384||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1027||1027|2384| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|497|1659|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||497||497|1659| 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|460|664|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||460||460|664| 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|997|2343|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||997||997|2343| 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|881|2184|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||881||881|2184| 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3860|5571|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3860||3860|5571| 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3678|5308|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3678||3678|5308| 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3794|5476|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3794||3794|5476| 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|||0|0|B|0|AZD|0|0|0|100|SEK|4565|7224|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4565||4565|7224| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|||0|0|E|0|PER|0|0|1|100|DKK|521|1692|lyfalmen||||4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||521||521|1692| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|B|0|AGP|0|1|0|100|XEU|3821|6206|lyfalmen||||96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3821||3821|6206| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|1606|3176|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1606||1606|3176| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|||25|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|448|1592|lyfalmen||||25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||448||448|1592| 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|||0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen||||20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|1064|1536|lyfsjukr||||2|0||Icepharma hf|Pfizer ApS|Metótrexat||1064||1064|1536| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|1866|3531|lyfalmen||||250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1866||1866|3531| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|||0|0|E|0|AGT|0|0|1|100|DKK|2469|4356|lyfalmen||||5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2469||2469|4356| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|||0|0|E|0|AGT|0|0|1|100|DKK|785|2053|lyfalmen||||1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||785||785|2053| 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|13661|5388|lyfalmen|V0012|5388||98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3223||3223|5388| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|90315|115228|lyfsjukr||||2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||90315||90315|115228| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|166728|211126|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||166728||166728|211126| 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|768|2029|lyfalmen||||15|0||Vistor hf|Janssen-Cilag AB|Blöndur||768||768|2029| 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|394|1518|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||394||394|1518| 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|834|2120|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||834||834|2120| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|2384|4240|lyfalmen||||250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2384||2384|4240| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|||0|0|0|0|BAP|0|0|0|100|SEK|1485|3010|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1485||1485|3010| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|||0|0|B|0|APT|0|0|0|100|GBP|6137|9374|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6137||6137|9374| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|26557|35212|lyfsjukr||||2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26557|35212| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|||0|0|0|0|IBV|1|0|0|100|DKK|2555|5079|vetalmen||||10|0||Vistor hf|Intervet International BV|||2555||2555|5079| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|1|100|DKK|851|2143|lyfalmen||||20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||851||851|2143| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|0|100|DKK|2785|4789|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2785||2785|4789| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2206|3997|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2206||2206|3997| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|||0|1|*|0|APT|0|0|0|100|XEU|2103|3856|lyfalmen||||25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Melphalan||2103||2103|3856| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|7127|10286|lyfsjukr||||200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7127||7127|10286| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|||0|0|0|1|LFS|0|1|0|100|DKK|405|585|lyfsjukr||||5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||405||405|585| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|||0|0|*|0|PER|0|0|0|100|DKK|35818|47497|lyfalmen||||100|0||Icepharma hf|Pfizer ApS|Estramústín||35818||35818|47497| 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|8450|6489|lyfalmen|V0515|5917||100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4028||4028|6489| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|||0|0|0|0|PER|0|0|1|100|DKK|628|1838|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||628||628|1838| 199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|8087|5388|lyfalmen|V0011|5388||98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3223||3223|5388| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|93538|119273|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||93538|119273| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|||0|0|E|0|PER|0|0|0|100|DKK|4637|7322|lyfalmen|V0126|7322||8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4637||4637|7322| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|||0|0|0|1|JAB|0|0|0|100|XEU|55810|71924|lyfsjukr||||5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||55810||55810|71924| 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|2717342|3412147|lyfsjukr||||40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2717342||2717342|3412147| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|5587|8444|lyfalmen||||60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5457||5457|8444| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|||0|0|0|1|ROC|0|0|0|100|DKK|670|967|lyfsjukr||||1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||670||670|967| 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|30780|59275|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||30780||30780|59275| 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|12204|5388|lyfalmen|V0012|5388||98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3223||3223|5388| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|||0|0|0|1|NOM|0|0|0|100|DKK|583|841|lyfsjukr||||1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||583||583|841| 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen||||1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10088| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|0|0|SNO|0|1|0|100|NOK|6465|9823|lyfalmen||||90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6465||6465|9823| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|3633|5949|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3633||3633|5949| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|||0|0|0|0|ORG|0|0|0|100|DKK|2492|4388|lyfalmen||||66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2492||2492|4388| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|*|0|SNO|0|1|0|100|NOK|19449|26954|lyfalmen||||90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||19449||19449|26954| 373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|||0|0|B|0|GSK|0|0|0|100|GBP|4280|6834|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4280||4280|6834| 373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|7069|10649|lyfalmen|V0436|10648||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7069||7069|10649| 373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|9758|14327|lyfalmen|V0437|14327||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9758||9758|14327| 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|MED|0|0|0|100|XEU|7379|8321|lyfalmen|V0420|8321||30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||5367||5367|8321| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|1570|3127|lyfalmen|V0126|1831||2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1570||1570|3127| 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|395166|497816|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||395166||395166|497816| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|||0|0|*|0|MCK|0|0|0|100|SEK|694|1928|lyfalmen|V0500|1655||100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||694||694|1928| 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5695|8219|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5695||5695|8219| 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|4563|7221|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4563||4563|7221| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|||0|0|E|0|GSK|0|0|1|100|GBP|11938|17309|lyfalmen||||60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11938||11938|17309| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|9172|13526|lyfalmen||||6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9172||9172|13526| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|10885|15869|lyfalmen||||8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10885||10885|15869| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|12717|18505|lyfalmen||||10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12717||12717|18505| 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|31512|42093|lyfalmen|V0459|42093||168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||31512||31512|42093| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|20165|27852|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20165||20165|27852| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|92400|118507|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||92400||92400|118507| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|4260|6806|lyfalmen||||14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4260||4260|6806| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|11562|9244|lyfalmen|V0182|9096||42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6042||6042|9244| 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|||0|0|0|0|ALM|0|0|0|100|XEU|16241|22928|lyfalmen||||100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||16241||16241|22928| 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|147141|186544|lyfsjukr||||4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||147141||147141|186544| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|114246|145261|lyfsjukr||||2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||114246||114246|145261| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|160966|203895|lyfsjukr||||2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||160966||160966|203895| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|203802|257654|lyfsjukr||||2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||203802||203802|257654| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1500|3031|lyfalmen||||12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1500||1500|3031| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1854|3515|lyfalmen||||12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1854||1854|3515| 380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|8311|6489|lyfalmen|V0515|5917||100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||4028||4028|6489| 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5554|8576|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5554||5554|8576| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|7558|7410|lyfalmen|V0143|7410||12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4701||4701|7410| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|7094|10683|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7094||7094|10683| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|||0|0|0|0|BAN|0|0|0|100|DKK|1278|2229|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1278|2229| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|||0|0|0|0|BAN|0|0|0|100|DKK|7699|13431|vetorma||||20|0||Icepharma hf|Bayer Animal Health GmbH|||7699||7699|13431| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|6112|6001|lyfalmen|V0144|6001||8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3671||3671|6001| 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|58581|76064|lyfalmen|V0184|16329||98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||58581||58581|76064| 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|921|1979|lyfalmen|V0308|1979||60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||731||731|1979| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|||0|0|0|0|ICE|0|0|0|100|XEU|726|1444|vetalmen||||100|0||Icepharma hf|Icepharma hf|||726||726|1444| 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|||0|0|0|1|CEP|0|0|0|100|DKK|199769|252593|lyfsjukr||||200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||199769||199769|252593| 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|3373|5593|lyfalmen||||25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3373||3373|5593| 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|4251|6794|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4251||4251|6794| 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|||0|0|0|0|AZD|0|0|1|100|SEK|8249|12263|lyfalmen||||20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8249||8249|12263| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|796|1568|lyfalmen|V0466|1568||28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||431||431|1568| 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2365|4214|lyfalmen|V0410|4214||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2365||2365|4214| 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2161|3935|lyfalmen||||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2161||2161|3935| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|685|1916|lyfalmen|V0128|1916||84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||685||685|1916| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|634|1846|lyfalmen||||84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||634||634|1846| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|966|2300|lyfalmen|V0367|1325||3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||966||966|2300| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2673|3585|lyfalmen|V0143|2470||4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||1905||1905|3585| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|5186|2817|lyfalmen|V0267|2817||100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||1344||1344|2817| 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|59129|76752|lyfalmen||||2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||59129||59129|76752| 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|18587|25872|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18587||18587|25872| 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|81828|104577|lyfsjukr||||50|0||Vistor hf|Orion Corporation|Dexmedetómid||81828||81828|104577| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|||0|0|E|0|BRS|0|0|1|100|DKK|2914|4965|lyfalmen||||100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2914||2914|4965| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|6982|10530|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6982||6982|10530| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|2758|4752|lyfalmen|V0037|4752||20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2758||2758|4752| 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|30747|41133|lyfalmen||||1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||30747||30747|41133| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|13456|19432|lyfalmen|V0196|19431||100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13456||13456|19432| 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|||0|0|0|0|AZD|0|0|1|100|SEK|2716|4694|lyfalmen||||50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2716||2716|4694| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|243495|307469|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||243495||243495|307469| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|||0|0|E|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen||||50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|||0|0|0|0|PAL|0|0|0|100|DKK|5607|10939|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5607||5607|10939| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4712|5292|lyfalmen|V0327|5292||100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3153||3153|5292| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|148346|186896|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||147421||147421|186896| 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|28418|37706|lyfalmen|V0356|37706||360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28017||28017|37706| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|172931|218911|lyfsjukr||||300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||172931||172931|218911| 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|4041|6507|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4041||4041|6507| 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|||0|1|0|1|MKA|0|0|0|100|SEK|36893|48183|lyfsjukr||||20|0||Icepharma hf|Merck KgaA|Cetúxímab||36893||36893|48183| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|9877|14255|lyfsjukr||||60|0||Icepharma hf|Roche|Capecitabín||9877||9877|14255| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|56631|72954|lyfsjukr||||120|0||Icepharma hf|Roche|Capecitabín||56631||56631|72954| 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||| 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|7594|3422|lyfalmen|V0012|3079||56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1786||1786|3422| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|3507|1990|lyfalmen|V0009|1924||28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||739||739|1990| 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|401|1527|lyfalmen|V0225|1501||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||401||401|1527| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|||0|0|E|0|GSK|0|0|0|100|IKR|2049|2856|lyfalmen|V0244|2711||56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1372||1372|2856| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|9003|13295|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9003||9003|13295| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|41196|53583|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41196||41196|53583| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|113799|144700|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||113799||113799|144700| 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|||0|0|E|0|SNO|0|0|1|100|NOK|1522|3061|lyfalmen||||8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1522||1522|3061| 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|||0|0|0|0|PER|0|0|0|100|DKK|5141|8012|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5141||5141|8012| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|223|1284|lyfalmen||||25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||223||223|1284| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|405|1533|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||405||405|1533| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|193|1243|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||193||193|1243| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|10887|15872|lyfalmen|V0459|14031||56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10887||10887|15872| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|757|2014|lyfalmen||||100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||757||757|2014| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|1211|2635|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1211||1211|2635| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1188|2604|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1188||1188|2604| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1907|3588|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1907||1907|3588| 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|650|1868|lyfalmen||||0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||650||650|1868| 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|||0|0|0|0|BID|0|0|0|100|DKK|1667|3316|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1667||1667|3316| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|20526|25175|lyfalmen|V0470|25175||100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||18032||18032|25175| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|||0|0|0|0|IBV|1|0|0|100|DKK|5127|10017|vetalmen||||20|0||Vistor hf|Intervet International BV|||5127||5127|10017| 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|5855|8988|lyfalmen||||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5855||5855|8988| 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|36890|48179|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Metótrexat||||36890|48179| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|||0|0|E|0|SNO|0|0|0|100|NOK|1453|2967|lyfalmen||||14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1453||1453|2967| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1853| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|||0|0|0|1|BOI|0|0|0|100|DKK|64975|83426|lyfsjukr||||1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||64975||64975|83426| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|||0|0|0|1|ROC|0|0|0|100|DKK|683|986|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||683||683|986| 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|||0|0|0|0|AEL|1|0|0|100|XEU|8094|15714|vetalmen||||10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8094||8094|15714| 405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|1859|3522|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1859||1859|3522| 405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|19811|27408|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19811||19811|27408| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|18083|25239|lyfalmen||||28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18083||18083|25239| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|20631|28437|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20631||20631|28437| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|22612|30923|lyfalmen||||28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22612||22612|30923| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|20398|28145|lyfalmen||||100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20398||20398|28145| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|61502|79730|lyfalmen||||100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||61502||61502|79730| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|72197|93152|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||72197||72197|93152| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|81856|105274|lyfalmen||||100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||81856||81856|105274| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|6242|9518|lyfalmen||||30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6242||6242|9518| 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|79239|101327|lyfsjukr||||8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||79239||79239|101327| 407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3324|3121|lyfalmen|V0072|3121||98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1566||1566|3121| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|2222|4018|lyfalmen||||100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2222||2222|4018| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|167|1207|lyfalmen||||25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||167||167|1207| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|363|1475|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||363||363|1475| 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|||0|0|0|0|KRK|0|0|0|100|XEU|1947|3226|lyfalmen|V0310|3226||60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1643||1643|3226| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2865|4898|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2865||2865|4898| 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2246|4051|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2246||2246|4051| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|||0|0|0|0|PER|0|0|1|100|DKK|4262|6809|lyfalmen||||35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4262||4262|6809| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3707|6050|lyfalmen||||28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3707||3707|6050| 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|||0|0|E|0|AZD|0|0|1|100|SEK|4307|6871|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4307||4307|6871| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12412|18122|lyfalmen||||98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12412||12412|18122| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2960|5028|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2960||2960|5028| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|||0|0|0|0|PAB|1|0|0|100|DKK|10563|20455|vetalmen||||120|0||Vistor hf|Pharmaxim AB|||10563||10563|20455| 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|79123|101845|lyfalmen||||1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||79123||79123|101845| 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|10058|14738|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10058||10058|14738| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|1155|2559|lyfalmen||||20|0|6,2000|Vistor hf|Recip AB|Klórókín||1155||1155|2559| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|||0|0|0|0|JAS|0|0|0|100|SEK|789|2058|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||789||789|2058| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|||0|0|E|0|MYL|0|0|1|100|SEK|690|1923|lyfalmen||||50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||690||690|1923| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|4862|7017|lyfsjukr||||50|0|16,6667|Icepharma hf|Roche|Mídazólam||4862||4862|7017| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|||0|1|0|1|VII|0|0|0|100|GBP|26332|34929|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||26332||26332|34929| 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|||0|0|E|0|GSK|0|0|0|100|GBP|7704|11518|lyfalmen||||6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7704||7704|11518| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|||0|1|*|0|AZA|0|0|0|100|SEK|23079|31509|lyfalmen|V0183|31508||1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||23079||23079|31509| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|||0|0|0|1|SNO|0|0|0|100|NOK|3819|5512|lyfsjukr||||3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3819||3819|5512| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|||0|0|0|0|MER|1|0|0|100|DKK|8502|16498|vetalmen||||100|0||Vistor hf|Merial|||8502||8502|16498| 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|127382|161747|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||127382||127382|161747| 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|61537|79774|lyfalmen||||1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||61537||61537|79774| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|||0|0|*|0|MYL|0|0|0|100|SEK|3468|5723|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3468||3468|5723| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|||0|0|*|0|MYL|0|0|0|100|SEK|4260|6806|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4260||4260|6806| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|28335|16329|lyfalmen|V0342|16329||98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||11221||11221|16329| 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|3798|6174|lyfalmen||||90|0|54,0000|Icepharma hf|Servier|Indapamíđ||3798||3798|6174| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|||0|0|E|0|NOH|0|0|0|100|DKK|1318|2782|lyfalmen||||300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1318||1318|2782| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|CHF|15022|19038|lyfalmen|V0034|18986||25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13142||13142|19038| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|||0|0|E|0|NAS|0|0|0|100|DKK|1894|3570|lyfalmen||||15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1894||1894|3570| 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|12805|8987|lyfalmen|V0253|8987||100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||5854||5854|8987| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|||0|0|0|0|MSD|0|0|0|100|DKK|9471|9522|lyfalmen|V0088|2748||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6245||6245|9522| 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4158|1815|lyfalmen|V0005|1815||28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||611||611|1815| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|||0|0|E|0|PCO|0|0|0|100|GBP|5276|8196|lyfalmen||||300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5276||5276|8196| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|||1|0|0|1|RBP|0|0|0|100|DKK|4890|7057|lyfsjukr||||7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4890||4890|7057| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|||0|0|E|0|GOG|0|0|1|100|XEU|2879|4917|lyfalmen||||10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2879||2879|4917| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|||0|0|E|0|GOG|0|0|1|100|DKK|25925|35081|lyfalmen||||150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||25925||25925|35081| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1251|2690|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1251||1251|2690| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|||0|1|0|1|VII|0|0|0|100|GBP|43100|55973|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||43100||43100|55973| 417880|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.07.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|99138|126301|lyfsjukr||||1000|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||99138||99138|126301| 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|34168|45426|lyfalmen|V0460|45426||180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||34168|45426| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|4939|7735|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4939||4939|7735| 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|||0|1|0|1|BIO|0|0|0|100|DKK|134344|170484|lyfsjukr||||19|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||134344||134344|170484| 418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|||0|0|B|0|SPL|0|0|1|100|DKK|1597|3164|lyfalmen||||50|0||Vistor hf|Schering-Plough Europe|Betametasón||1597||1597|3164| 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|7524|11271|lyfalmen|V0014|11161||60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7524||7524|11271| 418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|23500|20549|lyfalmen|V0475|19998||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||14346||14346|20549| 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|3893|6304|lyfalmen|V0458|6304||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3893||3893|6304| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2041|4060|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2041||2041|4060| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2648|5257|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2648||2648|5257| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|3319|5519|lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3319||3319|5519| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|7096|10686|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7096||7096|10686| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|||0|1|0|1|MSD|0|0|0|100|DKK|52103|67272|lyfsjukr||||180|0|30,0000|Vistor hf|M.S.D.|Indínavír||52103||52103|67272| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|||0|1|0|1|ORP|0|0|0|100|DKK|39537|51501|lyfsjukr||||100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||39537||39537|51501| 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|871|2170|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||871||871|2170| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|12029|17642|lyfalmen||||10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12029||12029|17642| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|||0|0|B|0|SNO|0|0|0|100|NOK|1553|3103|lyfalmen|V0036|3102||30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1553||1553|3103| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|||0|0|B|0|AZD|0|0|0|100|SEK|1538|3083|lyfalmen|V0051|2928||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1538||1538|3083| 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|3516|5789|lyfalmen|V0049|4163||98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3516||3516|5789| 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|6058|9266|lyfalmen|V0054|7268||98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6058||6058|9266| 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|||0|1|0|1|CSB|0|0|0|100|SEK|74553|95447|lyfsjukr||||1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||74553||74553|95447| 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|6756|3679|lyfalmen|V0011|3079||56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1974||1974|3679| 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|||0|0|0|1|BRU|0|0|0|100|XEU|21785|29223|lyfsjukr||||1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||21785||21785|29223| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|||0|0|0|0|IBV|0|0|0|100|DKK|1618|2823|vetorma||||24|0||Vistor hf|Intervet International BV|||||1618|2823| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|820|2101|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||820||820|2101| 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|4761|6827|lyfsjukr||||28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4730||4730|6827| 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|||0|0|0|0|ACA|0|0|0|100|SEK|2185|3968|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2185||2185|3968| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|686|1917|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||686||686|1917| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|896|2205|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||896||896|2205| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|||0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen||||30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738| 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|858|2153|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||858||858|2153| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|1007|2356|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1007||1007|2356| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50297|65005|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50297||50297|65005| 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3246| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|27516|27734|lyfalmen|V0344|27734||112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||20071||20071|27734| 429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|4207|6734|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4207||4207|6734| 429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|41389|54488|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||41389||41389|54488| 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|100698|128258|lyfsjukr||||105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||100698||100698|128258| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|||0|0|E|0|PER|0|0|0|100|DKK|4076|6555|lyfalmen||||100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4076||4076|6555| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|||1|0|0|1|JAS|0|0|0|100|SEK|1730|2497|lyfsjukr||||50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1730||1730|2497| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|1439|2077|lyfsjukr||||50|0|3,3333|Icepharma hf|Roche|Mídazólam||1439||1439|2077| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|||0|0|0|0|IBV|0|0|0|100|DKK|4463|8742|vetalmen||||100|0||Vistor hf|Intervet International BV|||4463||4463|8742| 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|29168|16329|lyfalmen|V0184|16329||98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||11221||11221|16329| 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|35004|46475|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||35004||35004|46475| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2951|3681|lyfalmen|V0144|3001||4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||1975||1975|3681| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|||0|0|0|0|SPM|0|0|0|100|XEU|2441|4318|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2441||2441|4318| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|759|2017|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||759||759|2017| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|||0|0|B|0|REP|0|0|0|100|SEK|1183|2597|lyfalmen||||100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1183||1183|2597| 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|||0|1|0|1|AVS|0|0|0|100|NOK|238608|301336|lyfsjukr||||8|0||Vistor hf|Aventis Pharma SA|Docetaxel||238608||238608|301336| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|1410|2908|lyfalmen||||20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1410|2908| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|4781|7519|lyfalmen||||100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4781||4781|7519| 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|||0|0|E|0|NDR|0|0|0|100|SEK|38230|50524|lyfalmen|V0209|50524||12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||38230|50524| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|1144|2544|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1144||1144|2544| 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|||0|0|0|0|NOB|1|0|0|100|XEU|3692|7262|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3692||3692|7262| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|||0|0|E|0|ORC|0|0|0|100|DKK|11032|16070|lyfalmen||||100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11032||11032|16070| 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|2580|4508|lyfalmen||||28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2580||2580|4508| 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|5648|8705|lyfalmen||||28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5648||5648|8705| 433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|8621|12772|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8621||8621|12772| 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|594|1713|lyfalmen|V0004|428||7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||537||537|1713| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|1133|1976|vetorma||||10|0||Vistor hf|Intervet International BV|||||1133|1976| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|MCS|0|0|1|100|SEK|912|2226|lyfalmen||||50|0||Vistor hf|McNeil Sweden AB|Blöndur||912||912|2226| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5786|8894|lyfalmen||||1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5786||5786|8894| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5786|8894|lyfalmen||||1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5786||5786|8894| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|XEU|10234|14979|lyfalmen||||100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10234||10234|14979| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|||0|0|E|0|ASZ|0|0|0|100|SEK|6826|10317|lyfalmen||||6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6826||6826|10317| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|||0|0|E|0|ASZ|0|0|0|100|SEK|4736|7458|lyfalmen||||6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4736||4736|7458| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|8423|11029|lyfalmen|V0284|3749||100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7347||7347|11029| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|929|2250|lyfalmen|V0284|2249||60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||929||929|2250| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|2849|4876|lyfalmen||||250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2849||2849|4876| 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|235532|297475|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||235532||235532|297475| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|||0|0|0|0|NOH|0|0|0|100|DKK|3528|5805|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3528||3528|5805| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|739|1990|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||739||739|1990| 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|241545|305021|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||241545||241545|305021| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|973|2310|lyfalmen||||100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||973||973|2310| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|3560|5849|lyfalmen||||100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3560||3560|5849| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|10030|8326|lyfalmen|V0029|8326||100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||5371||5371|8326| 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|67702|86849|lyfsjukr||||125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||67702||67702|86849| 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|32507|42679|lyfsjukr||||28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32507||32507|42679| 438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|6149|9390|lyfalmen|V0265|2452||28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6149||6149|9390| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|||0|0|E|0|SAL|0|0|1|100|USD|1285|2737|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1285||1285|2737| 438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|3221|5385|lyfalmen|V0259|3051||28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3221||3221|5385| 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|11077|16132|lyfalmen|V0334|6012||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11077||11077|16132| 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|345767|435820|lyfsjukr||||56|0|-1,0000|Icepharma hf|Roche Registration Limited|Vemurafeníb||345767||345767|435820| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|||0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|0|0|SCP|0|0|1|100|DKK|1877|3547|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1877||1877|3547| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|E|0|SCP|0|0|1|100|DKK|5908|9061|lyfalmen|V0362|2273||100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5908||5908|9061| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|164154|207896|lyfsjukr||||3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||164154||164154|207896| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2859|4890|lyfalmen||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2859||2859|4890| 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|||0|0|B|0|AZD|0|0|0|100|SEK|8702|12883|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8702||8702|12883| 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|||0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen||||70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|1477|2132|lyfsjukr||||10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1477||1477|2132| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|2332|3366|lyfsjukr||||10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2332||2332|3366| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|923|2242|lyfalmen|V0046|2242||100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||923||923|2242| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|1278|2727|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1278||1278|2727| 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|||0|1|0|1|GIL|0|0|0|100|DKK|125017|158779|lyfsjukr||||30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||125017||125017|158779| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|||0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa||||59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|||0|0|E|0|BAP|0|0|0|100|SEK|1015|2367|lyfalmen||||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1015||1015|2367| 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|11389|16558|lyfalmen|V0460|15142||60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11389|16558| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|||0|0|*|0|NAS|0|0|1|100|DKK|3439|5683|lyfalmen||||1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3439||3439|5683| 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|26222|35454|lyfalmen||||90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26222||26222|35454| 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7592|11364|lyfalmen||||20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7592||7592|11364| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|DKK|3117|5243|lyfalmen|V0061|3313||30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3117||3117|5243| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|2269|4083|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2269||2269|4083| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|||0|0|B|0|LEO|0|0|1|100|DKK|1583|3144|lyfalmen||||30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1583||1583|3144| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|||0|0|0|0|IBV|0|0|0|100|DKK|1442|2868|vetalmen||||50|0||Vistor hf|Intervet International BV|||1442||1442|2868| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|10559|15423|lyfalmen||||4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10559||10559|15423| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|6018|9211|lyfalmen||||2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6018||6018|9211| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|7448|11167|lyfalmen||||2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7448||7448|11167| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|8864|13104|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8864||8864|13104| 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|643|1858|lyfalmen||||10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||643||643|1858| 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1255|2696|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1255||1255|2696| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|||0|0|E|0|NOH|0|0|1|100|DKK|2111|3867|lyfalmen|V0202|3611||50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2111||2111|3867| 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|||0|0|0|1|Bru|0|0|0|100|XEU|1142|1648|lyfsjukr||||0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1142||1142|1648| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|1418|2919|lyfalmen||||98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1418||1418|2919| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|5530|7981|lyfsjukr||||10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5530||5530|7981| 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|||0|0|*|0|ELI|0|0|0|100|XEU|5361|8312|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5361||5361|8312| 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|||1|0|0|0|LEV|1|0|0|100|XEU|4649|9099|vetalmen||||100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4649||4649|9099| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|||0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367||12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|1|100|NOK|895|1767|lyfalmen|V0060|1054||20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||576||576|1767| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|0|100|NOK|3108|4155|lyfalmen|V0313|4136||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2322||2322|4155| 450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7419|12942|vetorma||||2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7419||7419|12942| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|56004|72168|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56004||56004|72168| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|84007|107311|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||84007||84007|107311| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|112008|142453|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||112008||112008|142453| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|5709|8007|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5138||5138|8007| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|15078|21468|lyfalmen||||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15078||15078|21468| 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|||0|0|E|0|ROA|0|0|1|100|DKK|1158|2563|lyfalmen||||5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1158||1158|2563| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|||0|0|0|0|LHS|0|0|0|100|XEU|11115|19390|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11115||11115|19390| 452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|||0|0|0|0|LAB|0|0|1|100|SEK|12104|17736|lyfalmen||||3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12104||12104|17736| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|||0|0|0|0|LCC|0|0|0|100|DKK|2338|4177|lyfalmen||||90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2338||2338|4177| 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|2370|4221|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2370||2370|4221| 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|6966|10508|lyfalmen||||98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||6966||6966|10508| 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|4576|7239|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4576||4576|7239| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|||0|0|0|0|MEF|0|0|0|100|XEU|1468|2561|vetorma||||6|0||Vistor hf|Merial (MSD)|||||1468|2561| 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|13492|19478|lyfalmen||||98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13492||13492|19478| 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|8757|12958|lyfalmen||||28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8757||8757|12958| 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|24591|33407|lyfalmen||||98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24591||24591|33407| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|||0|0|0|1|PER|0|1|0|100|DKK|2747|3965|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2747||2747|3965| 453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|||0|0|0|0|SPM|0|0|0|100|XEU|2290|4112|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2290||2290|4112| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|15303|21750|lyfalmen||||28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15303||15303|21750| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|43416|38891|lyfalmen|V0341|14994||98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||28961||28961|38891| 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|2110|1713|lyfalmen|V0004|1712||28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||537||537|1713| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|17179|24105|lyfalmen||||28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17179||17179|24105| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|47834|43340|lyfalmen|V0342|16329||98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32506||32506|43340| 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa||||10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|||0|1|0|1|SKB|0|0|0|100|GBP|55534|71578|lyfsjukr||||1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||55534||55534|71578| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|||0|0|0|0|BID|0|0|0|100|DKK|1146|2280|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1146||1146|2280| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|1035|2395|lyfalmen||||30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1035||1035|2395| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|3718|6065|lyfalmen||||120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3718||3718|6065| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|21879|30003|lyfalmen||||21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||21879||21879|30003| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|918|2235|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||918||918|2235| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|||0|0|0|0|AGT|0|0|1|100|XEU|1038|2399|lyfalmen||||15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1038||1038|2399| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|2152|3923|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2152||2152|3923| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|796|1568|lyfalmen|V0003|1568||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||431||431|1568| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|||0|0|0|0|CHE|0|0|1|100|SEK|1194|2612|lyfalmen||||25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1194||1194|2612| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|||0|0|0|0|LEP|0|0|1|100|DKK|1439|2947|lyfalmen||||20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1439||1439|2947| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|ţpakki||J01CA08|01.12.1980|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|2224|4021|lyfalmen||||30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2224||2224|4021| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|ţpakki||J01CA08|01.12.2007|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|9199|13563|lyfalmen||||100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9199||9199|13563| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|24163|32870|lyfalmen||||28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24163||24163|32870| 459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|2475|1835|lyfalmen|V0278|1835||28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||626||626|1835| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|855|1234|lyfsjukr||||2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||855||855|1234| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|1565|2259|lyfsjukr||||4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1565||1565|2259| 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7592|11364|lyfalmen||||20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7592||7592|11364| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|2230|4029|lyfalmen||||30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2230||2230|4029| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|4527|7172|lyfalmen||||60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4527||4527|7172| 460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|||0|0|0|0|MEX|0|0|0|100|XEU|4005|6458|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4005||4005|6458| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|||0|0|0|0|ASP|0|0|1|100|XEU|561|1746|lyfalmen||||20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||561||561|1746| 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7096|13798|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7096||7096|13798| 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|5577|8608|lyfalmen||||5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||5577||5577|8608| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|||0|0|0|0|ACA|0|0|1|100|XEU|187|1235|lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||187||187|1235| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|696|1931|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||696||696|1931| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|696|1931|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||696||696|1931| 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|7745|11574|lyfalmen||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7745||7745|11574| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|12065|17687|lyfalmen||||28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12065||12065|17687| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|1|0|0|100|DKK|6690|13018|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||||6690|13018| 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|9351|13771|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9351||9351|13771| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|0|0|0|100|DKK|5337|10420|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||5337||5337|10420| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|||0|0|*|0|LPL|0|1|0|100|DKK|1766|3395|lyfalmen||||100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1766||1766|3395| 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|||0|0|*|0|APC|0|0|0|100|DKK|4069|6493|lyfalmen|V0376|6493||8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4031||4031|6493| 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1185|2357|vetalmen||||100|0||Vistor hf|Intervet International BV|||1185||1185|2357| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|||0|0|0|0|IBV|1|0|0|100|DKK|1119|2226|vetalmen||||100|0||Vistor hf|Intervet International BV|||1119||1119|2226| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|||0|0|0|0|IBV|0|0|0|100|DKK|1200|2387|vetalmen||||100|0||Vistor hf|Intervet International BV|||1200||1200|2387| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|||0|0|0|0|IBV|0|0|0|100|XEU|631|1255|vetalmen||||12|0||Vistor hf|Intervet International BV|||631||631|1255| 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|666|1890|lyfalmen||||25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||666||666|1890| 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|2061|3798|lyfalmen||||100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2061||2061|3798| 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|1475|2997|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1475||1475|2997| 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|5765|8865|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5765||5765|8865| 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|2743|4731|lyfalmen||||25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2743||2743|4731| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|7899|11784|lyfalmen||||50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7899||7899|11784| 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|4512|7151|lyfalmen||||25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4512||4512|7151| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|||0|0|B|0|MAS|0|1|0|100|SEK|4621|7300|lyfalmen||||100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4621||4621|7300| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|15238|21006|lyfsjukr||||0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15238||15238|21006| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|23352|31189|lyfsjukr||||0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23352||23352|31189| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|18444|25030|lyfsjukr||||1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18444||18444|25030| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|29749|39217|lyfsjukr||||1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||29749||29749|39217| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|33802|44967|lyfalmen||||60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||33802||33802|44967| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|15410|21885|lyfalmen||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15410||15410|21885| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|55327|71318|lyfsjukr||||1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||55327||55327|71318| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|29343|39371|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29343||29343|39371| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|||0|0|0|1|JAS|0|1|0|100|SEK|514|742|lyfsjukr||||5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||514||514|742| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|6395|6646|lyfalmen|V0317|4676||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4143||4143|6646| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|||1|0|0|1|JAS|0|0|0|100|SEK|391|564|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||391||391|564| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|9311|6333|lyfalmen|V0318|4475||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3914||3914|6333| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|23527|12751|lyfalmen|V0320|7418||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8606||8606|12751| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|4530|3640|lyfalmen|V0207|3374||12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1945||1945|3640| 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|4416|5317|lyfalmen|V0467|5317||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3171||3171|5317| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|||0|0|0|0|PER|0|0|0|100|DKK|5622|8670|lyfalmen||||98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5622||5622|8670| 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|7571|10927|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7571||7571|10927| 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|6296|9592|lyfalmen|V0228|9571||100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6296||6296|9592| 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|5120|7983|lyfalmen|V0227|7432||100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5120||5120|7983| 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|3342|5551|lyfalmen|V0226|4872||100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3342||3342|5551| 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|6125|9358|lyfalmen||||120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6125||6125|9358| 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|30844|40592|lyfsjukr||||16|0||Vistor hf|Orion Corporation|Dexmedetómid||30844||30844|40592| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|||0|0|0|1|GEH|0|0|0|100|NOK|7299|10534|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7299||7299|10534| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9742|14060|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9742||9742|14060| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9733|14047|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9733||9733|14047| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|13977|19424|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||13977||13977|19424| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|||0|0|*|0|PER|0|0|0|100|DKK|1215|2641|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1215||1215|2641| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|IBV|0|0|0|100|DKK|2120|3698|vetorma||||20|0||Vistor hf|Intervet International BV|||||2120|3698| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|||0|0|*|0|BAM|0|0|0|100|SEK|3387|5612|lyfalmen||||100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3387||3387|5612| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|||0|0|0|0|ORC|1|0|0|100|DKK|4751|9295|vetalmen||||10|0||Vistor hf|Orion Corporation|||4751||4751|9295| 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|2160|3934|lyfalmen|V0048|2596||98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2160||2160|3934| 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|3267|5448|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3267||3267|5448| 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|13768|5388|lyfalmen|V0012|5388||98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3223||3223|5388| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|||0|0|0|1|MAB|0|0|0|100|SEK|15762|21664|lyfsjukr||||400|0||Vistor hf|Meda AB|Dextran||15762||15762|21664| 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|||1|0|0|1|AGP|0|0|0|100|XEU|5255|7584|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5255||5255|7584| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|1039|2400|lyfalmen||||30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1039||1039|2400| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|36454|47632|lyfsjukr||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||36454||36454|47632| 474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14368|10819|lyfalmen|V0456|10819||28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||7193||7193|10819| 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|||0|0|E|0|SPL|0|0|1|100|DKK|1847|3506|lyfalmen||||140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1847||1847|3506| 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|||0|0|0|0|PHM|0|0|0|100|DKK|27579|53128|vetalmen||||1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||27579|53128| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|796|1133|lyfalmen|V0266|1133||30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||113||113|1133| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|||0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen||||100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251| 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3243|5415|lyfalmen|V0130|5415||26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3243||3243|5415| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|292|1378|lyfalmen||||20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||292||292|1378| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|356|1466|lyfalmen||||30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||356||356|1466| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||1|0|0|0|ACA|0|0|1|100|NOK|995|2340|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||995||995|2340| 475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|3735|6088|lyfalmen||||60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3735||3735|6088| 475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|4920|7709|lyfalmen||||60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4920||4920|7709| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5556|8579|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5556||5556|8579| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|||0|0|*|0|ELI|0|0|0|100|XEU|6003|9191|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6003||6003|9191| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|77305|98900|lyfsjukr||||1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||77305|98900| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|GBP|1200|2620|lyfalmen||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1200||1200|2620| 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|11819|7277|lyfalmen|V0282|7252||56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4604||4604|7277| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|||0|0|0|0|GSK|0|0|0|100|GBP|5381|8340|lyfalmen||||12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5381||5381|8340| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|494|1655|lyfalmen|V0500|1655||100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||494||494|1655| 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|29241|39243|lyfalmen|V0454|39243||100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||29241||29241|39243| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|ţpakki||G03XC01|01.02.1999|31.05.2012|R|||0|0|E|0|DSG|0|0|0|100|SEK|4432|7042|lyfalmen||||28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4432||4432|7042| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|26084|15128|lyfalmen|V0341|14994||98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||10343||10343|15128| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|||0|0|E|0|DSG|0|0|0|100|SEK|12887|18718|lyfalmen||||84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12887||12887|18718| 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|||0|0|0|0|GSK|0|1|0|100|GBP|14507|20751|lyfalmen||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14507||14507|20751| 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|338|1441|lyfalmen|V0055|1269||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||338||338|1441| 483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37203|49235|lyfalmen|V0030|49182||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37203|49235| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|||0|0|0|1|PER|0|0|0|100|DKK|2766|3992|lyfsjukr||||50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2766||2766|3992| 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|||0|0|E|0|SHS|0|0|1|100|DKK|3526|5802|lyfalmen||||3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3526||3526|5802| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|4774|6890|lyfsjukr||||100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4774||4774|6890| 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2418|4287|lyfalmen|V0374|4287||2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2418||2418|4287| 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|290|1269|lyfalmen|V0055|1269||20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||212||212|1269| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|57058|73490|lyfsjukr||||3|0|83,9552|Vistor hf|Ferring|Triptórelín||57058||57058|73490| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|||0|0|0|0|MSD|0|0|0|100|DKK|5929|9089|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5929||5929|9089| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|152713|193537|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||152713||152713|193537| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|||0|0|E|0|MEB|0|0|1|100|SEK|1400|2894|lyfalmen||||300|0||Vistor hf|Meda AB (V)|Benzýdamín||1400||1400|2894| 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|55761|72525|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||55761||55761|72525| 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|||0|0|E|0|ANS|0|0|1|100|XEU|1238|2672|lyfalmen||||5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1238||1238|2672| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|||0|0|E|0|SAL|0|0|1|100|USD|491|1651|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||491||491|1651| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|||0|0|E|0|SAL|0|0|1|100|USD|700|1936|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||700||700|1936| 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4712|5292|lyfalmen|V0326|5292||100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3153||3153|5292| 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|32656|43528|lyfalmen|V0453|43528||100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||32656||32656|43528| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|968|2303|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||968||968|2303| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|2692|4661|lyfalmen|V0198|3842||60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2692||2692|4661| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|6268|9553|lyfalmen||||50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6268||6268|9553| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|11273|16400|lyfalmen||||50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11273||11273|16400| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|103046|131205|lyfsjukr||||2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||103046|131205| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463||10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389||30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618| 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2423|4293|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2423||2423|4293| 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2553|4471|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2553||2553|4471| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|3947|6378|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3947||3947|6378| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|10802|10560|lyfalmen|V0112|2527||100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7004||7004|10560| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|5247|8157|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5247||5247|8157| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|15330|14314|lyfalmen|V0113|3246||100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9748||9748|14314| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|19497|17984|lyfalmen|V0114|6047||100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12302||12302|17984| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|||0|1|0|1|ORG|0|0|0|100|DKK|49260|63704|lyfsjukr||||3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||49260||49260|63704| 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|||0|0|E|0|ROC|0|0|0|100|DKK|3275|5459|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3275||3275|5459| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|||0|0|0|0|AZD|0|0|0|100|SEK|12801|18610|lyfalmen|V0002|6977||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12801||12801|18610| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|23881|20119|lyfalmen|V0516|17852||100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||14003||14003|20119| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|||0|0|B|0|SNO|0|1|0|100|NOK|1433|2939|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1433||1433|2939| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|||0|0|E|0|NOH|0|0|0|100|DKK|2462|4347|lyfalmen||||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2462||2462|4347| 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|80643|103089|lyfsjukr||||20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||80643||80643|103089| 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|201606|254898|lyfsjukr||||50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||201606||201606|254898| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|||0|0|0|0|PER|0|0|0|100|DKK|2009|3727|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2009||2009|3727| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2254|4062|lyfalmen|V0128|1916||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2254||2254|4062| 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|||0|0|E|0|NAS|0|0|0|100|DKK|3275|5459|lyfalmen|V0410|4214||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3275||3275|5459| 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|||0|0|E|0|BII|0|0|0|100|DKK|1862|3526|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1862||1862|3526| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|19339|8597|lyfalmen|V0384|8597||15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5569||5569|8597| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|7522|8735|lyfalmen|V0382|6363||10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5670||5670|8735| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|10747|10322|lyfalmen|V0383|9946||20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6830||6830|10322| 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|2951|5016|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2951||2951|5016| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|29920|29781|lyfalmen|V0345|29781||112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||21702||21702|29781| 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4216|8268|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4216|8268| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|||0|0|B|0|APT|0|0|0|100|GBP|6137|9374|lyfalmen||||100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6137||6137|9374| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|||0|0|B|0|APT|0|0|0|100|GBP|1076|2451|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||1076||1076|2451| 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|||0|1|0|1|SOI|0|0|0|100|DKK|85756|109506|lyfsjukr||||3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||85756||85756|109506| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|||0|0|B|0|APT|0|0|0|100|GBP|3377|5598|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||3377||3377|5598| 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|468|1619|lyfalmen||||10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||468||468|1619| 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|844|2133|lyfalmen||||20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||844||844|2133| 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|||0|0|0|1|APE|0|0|0|100|XEU|246602|311368|lyfsjukr||||20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||246602||246602|311368| 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|3220|5384|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3220||3220|5384| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|338|1441|lyfalmen||||30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||338||338|1441| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|501|1388|lyfalmen|V0448|1388||100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||299||299|1388| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|1043|1865|lyfalmen|V0449|1865||100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||648||648|1865| 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|1498|2969|lyfalmen|V0369|2969||5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1455||1455|2969| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|||0|0|B|0|SPL|0|0|1|100|DKK|1357|2835|lyfalmen||||2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1357||1357|2835| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|16916|23775|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16916||16916|23775| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|18044|25190|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18044||18044|25190| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|22477|30754|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22477||22477|30754| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|27154|36623|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27154||27154|36623| 499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10670|15575|lyfalmen||||28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10670|15575| 501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|2773|4772|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2773||2773|4772| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|||0|0|E|0|ROC|0|0|0|100|DKK|3053|5155|lyfalmen|V0434|4437||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3053||3053|5155| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|||0|0|B|0|AML|0|1|0|100|DKK|2977|5051|lyfalmen||||100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||2977||2977|5051| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|30024|39563|lyfsjukr||||1|0|27,9851|Vistor hf|Ferring|Triptórelín||30024||30024|39563| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|6598|7074|lyfalmen||||28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||4456||4456|7074| 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|1647|3232|lyfalmen|V0494|3232||90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1647||1647|3232| 504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|||0|0|E|0|ORG|0|0|0|100|DKK|2037|3765|lyfalmen||||90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2037||2037|3765| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|||0|0|0|0|ROC|0|0|1|100|DKK|1158|2563|lyfalmen||||100|0|30,0000|Icepharma hf|Roche|Brómazepam||1158||1158|2563| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|||0|0|B|0|AML|0|1|0|100|DKK|8190|12182|lyfalmen||||100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8190||8190|12182| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|1800|2598|lyfsjukr||||5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1800||1800|2598| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|3595|5188|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3595||3595|5188| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|8204|11840|lyfsjukr||||25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8204||8204|11840| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|2458|4341|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2458||2458|4341| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|||0|0|0|0|ERC|0|0|0|100|DKK|399|1525|lyfalmen||||100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||399||399|1525| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|657|1146|vetorma||||24|0||Icepharma hf|Pfizer Oy Animal Health|||||657|1146| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2794|4874|vetorma||||120|0||Icepharma hf|Pfizer Oy Animal Health|||||2794|4874| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|||0|0|0|0|IBV|0|0|0|100|DKK|16040|27981|vetorma||||1000|0||Vistor hf|Intervet International BV|||16040||16040|27981| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999|31.05.2012|R|||0|0|0|0|IBV|0|0|0|100|DKK|2667|5294|vetalmen||||50|0||Vistor hf|Intervet International BV|||2667||2667|5294| 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|||0|0|B|0|ABS|0|0|0|100|DKK|2551|4469|lyfalmen||||98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2551||2551|4469| 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|5097|9960|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5097|9960| 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4088|8022|vetalmen||||50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4088||4088|8022| 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|12647|24457|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12647||12647|24457| 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|||0|1|0|1|SOF|0|0|0|100|NOK|733384|922279|lyfsjukr||||15|0||Vistor hf|SANOFI|Cabazitaxel||733384||733384|922279| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|9071|13388|lyfalmen||||10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9071||9071|13388| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2816| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|50020|64658|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||50020||50020|64658| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|16598|22713|lyfsjukr||||2|0|12,0000|Icepharma hf|Roche|Epóetín||16598||16598|22713| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|24845|33063|lyfsjukr||||2|0|18,0000|Icepharma hf|Roche|Epóetín||24845||24845|33063| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|40753|53028|lyfsjukr||||2|0|30,0000|Icepharma hf|Roche|Epóetín||40753||40753|53028| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|80592|103025|lyfsjukr||||4|0|60,0000|Icepharma hf|Roche|Epóetín||80592||80592|103025| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|187124|236723|lyfsjukr||||1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||187124|236723| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|||0|0|E|0|ACA|0|0|0|100|XEU|4150|5508|lyfalmen|V0445|5508||98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3311||3311|5508| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2703|4676|lyfalmen||||28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2703||2703|4676| 511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|36230|30860|lyfalmen|V0540|30860||28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||22562||22562|30860| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2685|4652|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2685||2685|4652| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|23712|31641|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||23712||23712|31641| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|14833|20498|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||14833||14833|20498| 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4712|5522|lyfalmen|V0325|5522||100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3321||3321|5522| 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|||0|0|0|1|FRP|0|0|0|100|DKK|5241|7564|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5241||5241|7564| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|22777|31130|lyfalmen||||60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22777||22777|31130| 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|2110|4197|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2110||2110|4197| 514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|||0|0|B|0|AZD|0|0|1|100|SEK|2078|3822|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2078||2078|3822| 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|3112|5236|lyfalmen||||100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3112||3112|5236| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|||0|0|B|0|PER|0|1|0|100|DKK|4404|4300|lyfalmen||||60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2428||2428|4300| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2564| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2577| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|5411|6385|lyfalmen|V0010|6385||120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3952||3952|6385| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|2947|5010|lyfalmen|V0462|2928||90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2947||2947|5010| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3208|5367|lyfalmen|V0471|3060||90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3208||3208|5367| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3450|5698|lyfalmen|V0472|3318||90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3450||3450|5698| 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||| 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|915|2231|lyfalmen||||20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||915||915|2231| 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|3372|5592|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3372||3372|5592| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|||0|0|0|0|ORG|0|0|0|100|DKK|2079|3823|lyfalmen||||84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2079||2079|3823| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|12890|16768|lyfalmen|V0286|16768||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||11542||11542|16768| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1123|2515|lyfalmen||||125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1123||1123|2515| 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|||0|0|0|0|AEG|0|0|1|100|SEK|1683|3281|lyfalmen||||100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1683||1683|3281| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|7242|10886|lyfalmen|V0431|9442||2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7242||7242|10886| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|4801|7546|lyfalmen|V0142|7415||4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4801||4801|7546| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5422|8396|lyfalmen|V0143|2470||4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5422||5422|8396| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|15276|21717|lyfalmen|V0143|7410||12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15276||15276|21717| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5815|8934|lyfalmen|V0144|3001||4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5815||5815|8934| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|16088|22736|lyfalmen|V0144|9002||12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16088||16088|22736| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|1355|1801|lyfalmen|V0056|1781||100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||601||601|1801| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|2163|2231|lyfalmen|V0057|2200||100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||915||915|2231| 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|362|1474|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||362||362|1474| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1712| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1722| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|31978|42678|lyfalmen|V0269|9980||100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||31978||31978|42678| 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|18263|25465|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||18263||18263|25465| 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3006|3061|lyfalmen|V0471|3060||90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1522||1522|3061| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|||0|0|0|0|BID|0|0|0|100|DKK|8367|16238|vetalmen||||320|0||Vistor hf|Boehringer Ingelheim Danmark|||8367||8367|16238| 522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|2275|4091|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2275||2275|4091| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|185488|234670|lyfsjukr||||1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||185488||185488|234670| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|338|1441|lyfalmen|V0055|1269||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||338||338|1441| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|401|1527|lyfalmen|V0225|1501||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||401||401|1527| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|2761|4756|lyfalmen||||250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2761||2761|4756| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|393|1517|lyfalmen||||10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||393||393|1517| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|||0|0|0|0|ACA|0|0|1|100|NOK|455|1601|lyfalmen||||40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||455||455|1601| 523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|||0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|1286|2738|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1286||1286|2738| 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|453|1599|lyfalmen||||28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||453||453|1599| 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|2851|4879|lyfalmen||||98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2851||2851|4879| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5214||98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|||0|0|0|0|INI|0|0|0|100|DKK|1895|3769|vetalmen||||1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1895||1895|3769| 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|888|2194|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||888||888|2194| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|771|2034|lyfalmen||||15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||771||771|2034| 525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|LVR|0|0|0|100|IKR|4621|4674|lyfalmen|V0006|4583||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2701||2701|4674| 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|1485|3010|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1485||1485|3010| 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|4950|7750|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4950||4950|7750| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|||0|0|0|0|CPA|0|0|0|100|DKK|10803|15757|lyfalmen||||30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10803||10803|15757| 525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37961|50186|lyfalmen|V0030|50186||100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37961|50186| 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|5398|7791|lyfsjukr||||1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5398||5398|7791| 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|4915|7094|lyfsjukr||||1000|0||Actavis Group hf|Braun|Natríumklóríđ||4915||4915|7094| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|4444|7058|lyfalmen|V0435|7058||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4444||4444|7058| 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|4133|6633|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4133||4133|6633| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|6646|12934|vetalmen||||188|0||Vistor hf|Intervet International BV|||6646||6646|12934| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|3535|5815|lyfalmen||||100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3535||3535|5815| 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|||0|0|0|1|SNO|0|0|0|100|NOK|15546|21393|lyfsjukr||||2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15546||15546|21393| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|||0|0|E|0|ALC|0|0|0|100|USD|1297|2753|lyfalmen||||5|0||K.Pétursson hf|Alcon|Emedastín||1297||1297|2753| 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|||0|0|E|0|BGB|0|0|0|100|SEK|17496|24503|lyfalmen|V0546|24503||4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||17496||17496|24503| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|9974|13756|lyfalmen|V0356|12569||120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9340||9340|13756| 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|||0|0|B|0|FEL|0|0|0|100|DKK|6852|10352|lyfalmen||||60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6852||6852|10352| 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|||0|0|0|0|PAL|0|0|0|100|DKK|4478|8771|vetalmen||||72|0||Icepharma hf|Pfizer Oy Animal Health|||4478||4478|8771| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|0|0|0|100|DKK|4761|9314|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4761||4761|9314| 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|68350|87662|lyfsjukr||||100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||68350||68350|87662| 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|28311|16329|lyfalmen|V0184|16329||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||11221||11221|16329| 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen||||50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6819| 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|11691|7410|lyfalmen|V0186|7410||28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4701||4701|7410| 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|||0|0|E|0|NAS|0|0|0|100|DKK|3092|5209|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3092||3092|5209| 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5942|8576|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5942||5942|8576| 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|3019|5109|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3019||3019|5109| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|8171|11793|lyfsjukr||||240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8171||8171|11793| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|20130|14422|lyfalmen|V0187|14416||50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||9827||9827|14422| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|668|1893|lyfalmen||||30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||668||668|1893| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|353|1462|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||353||353|1462| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1025|2381|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1025||1025|2381| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|284|1367|lyfalmen||||14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||284||284|1367| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1805|3448|lyfalmen||||100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1805||1805|3448| 533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14385|9507|lyfalmen|V0283|9507||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6234||6234|9507| 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|||0|0|B|0|AZD|0|0|0|100|SEK|2047|3779|lyfalmen||||100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2047||2047|3779| 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|||0|1|*|0|IPI|0|0|0|100|DKK|58504|75968|lyfalmen|V0567|75968||100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||58504||58504|75968| 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|3236|2492|lyfalmen|V0279|2415||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1106||1106|2492| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|||0|0|E|0|SNO|0|0|0|100|NOK|6655|10083|lyfalmen||||84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6655||6655|10083| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|457|1604|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||457||457|1604| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|583|1776|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||583||583|1776| 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12900|18735|lyfalmen|V0115|18735||100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18735| 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|109722|140246|lyfalmen||||1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||109722||109722|140246| 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|65014|83475|lyfsjukr||||56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||65014||65014|83475| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|587|1024|vetorma||||2|0||Icepharma hf|Pfizer Oy Animal Health|||||587|1024| 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|6294|9084|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6294||6294|9084| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2406| 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|||0|1|0|1|MSE|0|0|0|100|SEK|137087|173927|lyfsjukr||||6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||137087||137087|173927| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|||0|1|E|0|SNO|0|0|0|100|NOK|10667|15571|lyfalmen||||100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10667||10667|15571| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|5863|8999|lyfalmen|V0285|8999||60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||5863||5863|8999| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|220|1280|lyfalmen||||25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||220||220|1280| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|0|100|DKK|546|1726|lyfalmen||||100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||546||546|1726| 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|1790|3428|lyfalmen||||40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1790||1790|3428| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|2779|4780|lyfalmen||||250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2779||2779|4780| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|||0|0|*|0|MSD|0|0|0|100|DKK|5863|8999|lyfalmen|V0373|7295||15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5863||5863|8999| 541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989|30.06.2012|R|||0|0|B|0|AZD|0|0|1|100|SEK|2066|3805|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2066||2066|3805| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|||0|0|B|0|SGM|0|0|0|100|DKK|9480|13947|lyfalmen|V0199|13947||200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9480||9480|13947| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|||0|0|B|0|SGM|0|0|0|100|DKK|15356|21817|lyfalmen|V0200|21817||200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15356||15356|21817| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|5846|8437|lyfsjukr||||800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5846||5846|8437| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|||0|1|E|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen||||100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|||0|0|B|0|NOH|0|0|0|100|DKK|2898|4943|lyfalmen||||98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2898||2898|4943| 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|2204|3144|lyfalmen|V0373|2432||5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1583||1583|3144| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|7337|5046|lyfalmen|V0457|5046||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2973||2973|5046| 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|512054|644510|lyfsjukr||||336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||512054||512054|644510| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|12941|18786|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12941||12941|18786| 544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|972|2237|lyfalmen|V0005|454||7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||920||920|2237| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1019|2373|lyfalmen||||15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1019||1019|2373| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|902|2213|lyfalmen||||100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||902||902|2213| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|2226|4024|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2226||2226|4024| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|30132|40361|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||30132||30132|40361| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24294|33034|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||24294||24294|33034| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|30309|40583|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|grasfrjó||30309||30309|40583| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|25749|34860|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|grasfrjó||25749||25749|34860| 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|||0|0|0|0|ACA|0|0|1|100|XEU|1135|2532|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1135||1135|2532| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|||0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen||||60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791| 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|3402|2129|lyfalmen|V0004|1712||28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||841||841|2129| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|10681|15287|lyfsjukr||||100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10681||10681|15287| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|3520|5080|lyfsjukr||||10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3520||3520|5080| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|||0|1|E|0|ORG|0|0|0|100|DKK|7775|11615|lyfalmen||||0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7775||7775|11615| 548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|569|1660|lyfalmen|V0542|1660||100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||498||498|1660| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001||R|||0|0|0|0|SNO|0|0|0|100|NOK|15650|22186|lyfalmen||||84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15650||15650|22186| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|94256|120174|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||94256||94256|120174| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|||0|0|*|0|JAS|0|1|0|100|SEK|9644|14171|lyfalmen||||5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9644||9644|14171| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|139574|177048|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||139574||139574|177048| 549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37203|49235|lyfalmen|V0031|49182||98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37203|49235| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|2230|4029|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2230||2230|4029| 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen||||24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|11232|8988|lyfalmen|V0280|8988||56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5855||5855|8988| 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|||0|0|0|1|BAM|0|0|0|100|SEK|9205|13285|lyfsjukr||||10000|0|-1,0000|Icepharma hf|Baxter Medical AB|Mannitól||9205||9205|13285| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|10882|15865|lyfalmen|V0235|15865||12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10882||10882|15865| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|1858|3521|lyfalmen||||1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1858||1858|3521| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|3966|6404|lyfalmen|V0198|6404||100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3966||3966|6404| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|||1|0|E|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen||||20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1568||28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2978||56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|||0|0|0|0|EIS|0|0|0|100|SEK|1468|2987|lyfalmen|V0003|784||14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1468||1468|2987| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1568||28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2980||56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432| 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|23881|20119|lyfalmen|V0516|17852||100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||14003||14003|20119| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|||0|0|B|0|BAP|0|0|0|100|SEK|3625|5938|lyfalmen||||100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3625||3625|5938| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|||0|0|0|0|MYL|0|0|0|100|SEK|5115|7976|lyfalmen||||500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5115||5115|7976| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|3280|5466|lyfalmen||||100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3280||3280|5466| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|11966|17348|lyfalmen|V0237|17348||18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11966|17348| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|4092|6577|lyfalmen|V0237|5783||6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4092||4092|6577| 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|||0|0|0|0|BID|0|0|0|100|DKK|7585|14737|vetalmen||||500|0||Vistor hf|Boehringer Ingelheim Danmark|||7585||7585|14737| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|27117|35914|lyfsjukr||||1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||27117||27117|35914| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|4860|7627|lyfalmen||||100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4860||4860|7627| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|6610|10021|lyfalmen|V0242|6971||50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6610||6610|10021| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|9476|13942|lyfalmen|V0242|13942||100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9476||9476|13942| 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|||0|0|0|0|ASP|0|0|0|100|XEU|1589|3153|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1589||1589|3153| 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|279778|353004|lyfsjukr||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||279778|353004| 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|844|2133|lyfalmen||||28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||844||844|2133| 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|1937|3629|lyfalmen||||98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1937||1937|3629| 559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|||0|0|E|0|GRU|0|0|1|100|DKK|658|1879|lyfalmen||||20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||658||658|1879| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1555|3106|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1555||1555|3106| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|5707|8786|lyfalmen||||1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5707||5707|8786| 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|||0|0|B|0|MEB|0|0|0|100|SEK|3551|5836|lyfalmen||||30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3551||3551|5836| 559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|||0|0|0|1|BAX|0|0|0|100|SEK|13454|18767|lyfsjukr||||240|0||Icepharma hf|Baxter|Desflúran||13454||13454|18767| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|||0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1419| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|||0|0|E|0|GSK|0|0|1|100|GBP|3182|5332|lyfalmen||||25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3182||3182|5332| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|||0|0|E|0|GSK|0|0|1|100|GBP|1584|3146|lyfalmen||||4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1584||1584|3146| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6065|9276|lyfalmen||||125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6065||6065|9276| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6576|9975|lyfalmen||||100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6576||6576|9975| 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|99916|127277|lyfsjukr||||5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||99916||99916|127277| 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|462079|581792|lyfsjukr||||20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||462079||462079|581792| 561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|5877|9018|lyfalmen||||63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5877||5877|9018| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1707|3314|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1707||1707|3314| 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|||0|0|B|0|APC|0|0|0|100|XEU|2485|4378|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2485||2485|4378| 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|106535|135584|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||106535||106535|135584| 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|114414|146135|lyfalmen||||63|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||114414||114414|146135| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|21095|29019|lyfalmen|V0431|28327||6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||21095||21095|29019| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|35590|47211|lyfalmen|V0431|47211||10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||35590||35590|47211| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|783|2050|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||783||783|2050| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|708|1947|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||708||708|1947| 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|1377|2863|lyfalmen||||100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1377||1377|2863| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYC|0|0|0|100|DKK|205192|260061|lyfalmen||||60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||205192||205192|260061| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3563|5853|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3563||3563|5853| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3694|6032|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3694||3694|6032| 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2232|3374|lyfalmen|V0207|3374||12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1751||1751|3374| 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|11310|19730|vetorma||||1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||11310||11310|19730| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|81617|104312|lyfsjukr||||168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||81617||81617|104312| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|||0|0|B|0|UCB|0|0|0|100|DKK|11513|16728|lyfalmen||||100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11513||11513|16728| 565982|H01BA0401|Glypressin|stl|1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|||0|0|0|1|FEL|0|0|0|100|DKK|36181|47290|lyfsjukr||||42|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||36181||36181|47290| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|1448|2960|lyfalmen|V0444|2275||5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1448||1448|2960| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995|31.07.2012|R|||0|0|E|0|SNO|0|0|1|100|NOK|2326|4161|lyfalmen||||100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2326||2326|4161| 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|215005|271714|lyfsjukr||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||215005||215005|271714| 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5786|8894|lyfalmen||||1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5786|8894| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|3411|5645|lyfalmen|V0291|3373||60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3411||3411|5645| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|6903|10422|lyfalmen|V0292|5566||60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6903||6903|10422| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|10090|14782|lyfalmen|V0293|8178||60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10090||10090|14782| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|13250|19174|lyfalmen|V0294|10467||60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13250||13250|19174| 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1138|2536|lyfalmen||||3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1138||1138|2536| 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|1399|2893|lyfalmen|V0058|2893||100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1399||1399|2893| 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|2216|4010|lyfalmen|V0059|4010||100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2216||2216|4010| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|17135|23387|lyfsjukr||||5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17135||17135|23387| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|19702|26609|lyfsjukr||||20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19702||19702|26609| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|83635|107507|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||83635||83635|107507| 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|12805|9914|lyfalmen|V0253|8987||100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||6532||6532|9914| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|162396|205689|lyfsjukr||||5|0||Icepharma hf|Baxter|Fíbrínógen manna||162396||162396|205689| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|192694|243713|lyfsjukr||||10|0||Icepharma hf|Baxter|Fíbrínógen manna||192694||192694|243713| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|405780|511136|lyfsjukr||||20|0||Icepharma hf|Baxter|Fíbrínógen manna||405780||405780|511136| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|10355|5388|lyfalmen|V0011|5388||98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3223||3223|5388| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|5300|5493|lyfalmen|V0245|5015||98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||3300||3300|5493| 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|3716|6062|lyfalmen|V0464|5313||2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3716||3716|6062| 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3290|5479|lyfalmen|V0129|5479||26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3290||3290|5479| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|96323|122768|lyfsjukr||||1|0||Icepharma hf|Roche|Trastuzumab||96323||96323|122768| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|24317|32400|lyfsjukr||||5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24317||24317|32400| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|41173|53555|lyfsjukr||||10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||41173||41173|53555| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|2466|2102|lyfalmen|V0151|2049||28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||821||821|2102| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|7682|6920|lyfalmen|V0322|4247||98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4343||4343|6920| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|4548|2102|lyfalmen|V0152|2049||28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||821||821|2102| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|13616|6920|lyfalmen|V0323|6676||98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4343||4343|6920| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||40|0||Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|||0|0|0|1|SAA|0|0|0|100|NOK|7014|10123|lyfsjukr||||12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7014||7014|10123| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|1150|1950|lyfalmen|V0243|1679||42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||710||710|1950| 578259|A04AA0104|Ondansetron Billev|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|||0|0|E|0|MYL|0|0|0|100|SEK|3757|5827|lyfalmen|V0384|5731||10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||3544||3544|5827| 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|5955|10388|vetorma||||20|0||Icepharma hf|Icepharma hf|||5955||5955|10388| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|||0|0|B|0|AZD|0|0|0|100|SEK|1310|2771|lyfalmen||||10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1310||1310|2771| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|4761|2181|lyfalmen|V0005|1815||28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||879||879|2181| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|||0|0|*|0|PER|0|0|0|100|DKK|704|1942|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||704||704|1942| 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|2763|3277|lyfalmen|V0324|3277||100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1680||1680|3277| 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2899|2930|lyfalmen|V0462|2928||90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1426||1426|2930| 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3345|3319|lyfalmen|V0472|3318||90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1711||1711|3319| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|||0|0|0|0|ANI|1|0|0|100|XEU|14322|27673|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14322||14322|27673| 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|2418|4287|lyfalmen||||2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2418||2418|4287| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|27982|37000|lyfsjukr||||1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||27982||27982|37000| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|54002|69655|lyfsjukr||||1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||54002||54002|69655| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|108003|137426|lyfsjukr||||1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||108003||108003|137426| 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|67184|86198|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||67184||67184|86198| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|4951|8637|vetorma||||50|0||Icepharma hf|Pfizer Oy Animal Health|||4951||4951|8637| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|18656|32544|vetorma||||200|0||Icepharma hf|Pfizer Oy Animal Health|||18656||18656|32544| 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4536|3681|lyfalmen|V0011|3079||56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1975||1975|3681| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|45176|58578|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||45176||45176|58578| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|102777|130868|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||102777||102777|130868| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|||0|0|B|0|AZD|0|0|0|100|SEK|829|2113|lyfalmen||||28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||829||829|2113| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|49800|64382|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||49800||49800|64382| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|54189|69890|lyfsjukr||||2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||54189||54189|69890| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|99033|126169|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||99033||99033|126169| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1117|2507|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1117||1117|2507| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|118205|150230|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||118205||118205|150230| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|53975|69621|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||53975||53975|69621| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|111186|141421|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||111186||111186|141421| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|121540|154415|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||121540||121540|154415| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|3790|5470|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3790||3790|5470| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|2296|3314|lyfsjukr||||9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2296||2296|3314| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|||0|0|B|0|MAS|0|1|0|100|SEK|1879|3549|lyfalmen||||30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1879||1879|3549| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981|31.07.2012|R|||0|0|0|1|LEP|0|0|0|100|DKK|10163|14637|lyfsjukr||||20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10163||10163|14637| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|||0|0|0|1|LEP|0|0|0|100|DKK|4557|6577|lyfsjukr||||25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4557||4557|6577| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|4611|7287|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4611||4611|7287| 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|466|1610|lyfalmen|V0541|1610||100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||461||461|1610| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|32386|43190|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32386||32386|43190| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1724|3337|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1724||1724|3337| 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|14065|19534|lyfsjukr||||800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14065||14065|19534| 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|376572|474480|lyfsjukr||||224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||376572||376572|474480| 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|10039|4891|lyfalmen|V0095|4891||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||2860||2860|4891| 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|4799|7544|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4799||4799|7544| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|2175|3954|lyfalmen|V0461|3953||20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2175||2175|3954| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|9747|14312|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9747||9747|14312| 588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|8723|12912|lyfalmen||||2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8723||8723|12912| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|6039|10535|vetorma||||3|0||Icepharma hf|Pfizer Animal Health|||6039||6039|10535| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|2341|4084|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||2341||2341|4084| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5827|10165|vetorma||||6|0||Icepharma hf|Pfizer Animal Health|||5827||5827|10165| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3147|5490|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||3147||3147|5490| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3269|5703|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||3269||3269|5703| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|DKK|3157|5507|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||3157||3157|5507| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|||0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa||||20|0||Icepharma hf|Bayer AB|Klótrímazól|||||| 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|||0|0|B|0|ACA|0|0|0|100|XEU|2014|3734|lyfalmen|V0041|3646||98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2014||2014|3734| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|||0|0|*|0|LBK|0|1|0|100|DKK|22787|31143|lyfalmen||||10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||22787||22787|31143| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|||0|0|0|1|BOI|0|0|0|100|DKK|178945|226458|lyfsjukr||||1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||178945||178945|226458| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|806313|1013805|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||806313||806313|1013805| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|514|1682|lyfalmen|V0238|741||50|0|3,1250|Icepharma hf|Roche|Klónazepam||514||514|1682| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|910|2224|lyfalmen|V0238|2224||150|0|9,3750|Icepharma hf|Roche|Klónazepam||910||910|2224| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|1343|2816|lyfalmen||||100|0|25,0000|Icepharma hf|Roche|Klónazepam||1343||1343|2816| 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|21099|29024|lyfalmen||||12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21099||21099|29024| 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|6047| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|336|586|vetorma||||10|0||Icepharma hf|Pfizer Oy Animal Health|||||336|586| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2794|4874|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||||2794|4874| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|||0|0|0|1|NOH|0|0|0|100|DKK|5931|8560|lyfsjukr||||5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5931||5931|8560| 595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|644|1860|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||644||644|1860| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|64510|82843|lyfsjukr||||2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||64510|82843| 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|19278|26076|lyfsjukr||||10|0||Vistor hf|Orion Corporation|Dexmedetómid||19278||19278|26076| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|||0|0|0|0|PER|0|0|1|100|DKK|2324|4158|lyfalmen||||24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2324||2324|4158| 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|679341|854455|lyfsjukr||||10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||679341||679341|854455| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|||0|0|0|0|SNO|0|0|1|100|NOK|461|1610|lyfalmen||||150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||461||461|1610| 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|||1|0|0|0|PCO|0|0|0|100|DKK|4092|6577|lyfalmen||||100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4092|6577| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|||0|0|0|0|PCO|0|0|1|100|SEK|2806|4817|lyfalmen||||100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2806||2806|4817| 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen||||4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|||0|0|E|0|LDR|0|0|0|100|GBP|6416|9756|lyfalmen||||100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6416||6416|9756| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|||0|0|0|0|LDR|0|0|0|100|GBP|18434|25680|lyfalmen||||100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18434||18434|25680| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|3008|5094|lyfalmen||||1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3008||3008|5094| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|||0|0|E|0|PCO|0|0|1|100|DKK|5377|8334|lyfalmen||||100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5377||5377|8334| 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447| 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|||0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen||||10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen||||100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|||0|0|E|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen||||100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|PCO|0|0|1|100|DKK|5377|8334|lyfalmen||||100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5377||5377|8334| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen||||60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen||||150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen||||20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen||||20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen||||25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen||||100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen||||30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207| 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|||0|1|E|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen||||120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579|